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The launching of the Sustainable Development Goals (SDG) by the United Nations (UN) in 2015 has pro-
vided a strong signal from the world’s governments that sustainable development must happen at global 
scale without leaving anyone aside. The post-2015 Development Agenda has the ambitious challenge of 
empowering all of us to achieve healthy and stable economies, fair and well-governed societies, respect for 
human rights, respect for the environment, and consequently world peace. 
Reaching the SDG targets will not be possible without a strong and sustainable global agriculture. Beyond 
their direct impact on hunger and malnutrition, agriculture and biomass-based industry are the common 
thread connecting together the SDGs, from poverty alleviation to education, gender equality, water use, 
energy use, economic growth and development, sustainable consumption and production, climate change, 
and ecosystem management.
Sustainable agriculture and downstream processing industry are knowledge based. We have technologies 
and know-how to succeed, and UN organizations such as FAO (Food and Agriculture Organization of the 
UN), UNESCO (United Nations Educational, Scientific and Cultural Organization) and UNIDO (United Na-
tions Industrial Development Organization) are engaged to bring all knowledge and tools made available 
by science and technology to individuals and institutions of civil society that can play a vigorous part in the 
development of sustainable value chains.
Technological innovation is dependent on the iterative process of science, under amazingly fast evolution. 
Since the beginning of the 21st Century, plant sciences have dramatically progressed in understanding the 
structure, function and regulation of the mechanisms that translate the plant genome into phenotypes. 
The latest discoveries have shown that genomes are much more dynamic entities than ever expected. 
Tapping into the very complex and intriguing RNA regulatory mechanisms have unravelled how epigenetics 
can be regulated in a tissue and even cell-specific manner by the gene expression. This fundamental knowl-
edge has led to the development of novel genome-editing technologies, which adjust genomic sequences 
at a high degree of precision.  The new tool for in vivo mutagenesis (CRISPR/Cas) can be used not only in 
plants but in their symbionts and pathogens as well. The application will foster the development of novel 
crops adapted to an intensified and sustainable production of food, feed and biomass.
Scientific progress is making it possible to design new hybrid plants to address some of the challenges our 
world is facing today. This includes, among others, crops resilient to abrupt changes in environmental con-
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ditions, crops able to perform well in no-tilling agriculture (to prevent soil erosion), and through improved 
efficiency in nutrient use, crops that are less dependent on agro chemicals and their collateral damage on 
the soil microbiome. Such developments can impact crop productivity in some of the most densely-popu-
lated and vulnerable regions of the world.
Even though technological innovations are promising, their applications are not straightforward. This has 
been the case for Genetically Modified (GM) crop biotechnology. Its discovery in the 80s led to a series of 
technological inventions that opened a wide spectrum of agricultural and industrial applications. The inno-
vation has triggered one of the largest changes in the history of agriculture, yet it has faced an extremely 
hostile response to commercialization. The persistent lobbying and dissemination by ongovernmental or-
ganizations of alarming, though not supported by scientific evidence, information on the potential risks of 
GM crops has raised public suspicion and a general reluctance to adopt this novel technology. Plant scien-
tists have not been able to effectively balance this misinformation with science-based facts probably due to 
weak science communication strategies and poor exchanges with specialists in social, political, economic 
sciences and with the civil society. A major consequence for Europe is that legislators have established a 
discouraging, complex and costly regulatory system. By the same token, investment in GM technology was 
limited to companies with strong financial and human power. Small and medium enterprises and the public 
sector were set aside. Meanwhile, low-income economies are facing challenges in establishing a regulatory 
framework and in building sufficient capacity along the innovation chain. These different factors have led to 
a situation where only a few multinational corporates are able to propose a limited number of GM crops.
Nevertheless, in recent years several Public Sector research institutions in low-income countries and in 
emerging economies have made enormous efforts and progress to bring adapted GM crops in their agri-
cultural systems. Banana resistant to parasitic nematodes and weevils, potato resistant to blight, water-ef-
ficient maize, drought-tolerant groundnuts, rice, and sugarcane, Bt eggplant, cassava resistant to brown 
streak disease and cassava mosaic disease to name but a few, are public sector or public-private partner-
ship initiatives on field trial.  These examples show that low- and middle-income countries can develop their 
own tailored GM crops and become major actors in the world market.
This book, through its introductory overview chapter and selected country studies, explores the experience 
and achievements obtained by integrating GM technology in agricultural systems of developing countries 
and emerging economies. The emphasis is on the potential and concerns encountered with the adoption 
of these new technologies. The lessons learned over the last quarter century of experience should serve 
in the current debate on the challenges of sustainable agriculture intensification. The experiences of ag-
ricultural biotechnology provide a unique perspective on how to harness existing and future innovations 
to preserve the pristine nature still remaining on our planet, to cope with rapid population growth and to 
spread the benefits of science and technology to communities around the world.
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Abstract 
The Sustainable Developmental Goals aim to se-
cure immediate human needs, such as adequate 
food supply and healthcare and provision of clean, 
affordable, and accessible energy. These achieve-
ments have to be imbedded in a sustainability 
concept. Bioeconomy is at the core of this con-
cept in which agricultural (plant) biotechnology 
plays a major role in delivering biomass for food, 
feed, and industry. Modern plant biotechnology 
comprises the genetic modification technology 
and various molecular biological tools which en-
hances the plant breeding potential. It results in 
increased food supplies, increased farm income 
worldwide, and reduced environmental damage. 
Here we review the innovations in plant biotech-
nology that are available on the market or at the 
late developmental stages and their application 
to agriculture, agroforestry, industrial processes, 
and pharmaceutical industry. Special emphasis is 
given to approaches adapted to meet heteroge-
neous local needs and help support more inclu-
sive growth in low and middle-income countries.
Introduction
In the 21st century, humanity is faced by a myr-
iad of socioeconomic and resource challenges 
to supply diverse emerging and recurrent global 
needs to feed, clothe, and fuel a population grow-
ing in size, age, and wealth. Pressure on resource 
competition and scarcity as well as the identifica-
tion, evaluation, and quantification of the impact 
of the human pressure on the planet have cata-
lysed a global concern on the sustainability of the 
continuous development of human societies. The 
Holocene – the warm period of the past 10-12 
millennia – is the only state of the planet that we 
know for sure to support contemporary human 
societies and is now being destabilized. Indeed, 
since the later part of the 18th century, the effects 
of humans on the global environment have grown 
so dramatically that a new geological era, the An-
thropocene, has been proposed (Crutzen, 2002). 
There is an urgent need of a paradigm shift to 
maintain the Earth System (ES) in a safely operat-
ing space for humanity. Sustainable developmen-
tal goals have to be implemented to guarantee 
immediate human needs, such as food supply, 
healthcare, and energy, alongside measures for 
a stable ES functioning. Nine critical processes/
features have been proposed to regulate the ES 
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functioning: climate change, biosphere integrity, 
land system change, freshwater use, biochemical 
flows, ocean acidification, atmospheric aerosol 
loading, stratospheric ozone depletion, and novel 
entities. Scientifically based planetary boundary 
levels of human perturbation have been estab-
lished for these ES processes/features, beyond 
which the ES functioning may be substantially al-
tered (Steffen et al., 2015).
 
Embedded in this emerging ES thinking, the new 
bioeconomy proposes a global transition toward 
sustainability through a bio-based industry that 
integrates the use of renewable aquatic, and 
terrestrial resources and biological processes to 
create energy, materials and products with an 
environmentally friendly footprint. Besides bioin-
dustry, bioeconomy also encompasses research, 
climate, environment, and development policies.
 
The deployment of bioeconomy relies on techno-
logical developments, among which biotechnology 
plays a key role. Biotechnology-based industry is 
an emerging reality that generates economic op-
portunities for agriculture, healthcare, chemical, 
and manufacturing sectors, with far-reaching po-
tential impacts on socio-economic developments 
and environment. According to the Biotechnology 
Global Industry Guide (www.researchandmarkets.
com/reports/41522/biotechnology_global_indus-
try_guide), the total revenues of the global biotech-
nology industry were US$ 323.1 billion in 2014, 
representing a compound annual growth rate of 
7.2% between 2010 and 2014. The biotech indus-
try is revolutionary beyond industrial growth be-
cause it offers opportunities for society to walk a 
different path toward multiple sustainable goals. In 
the energy and chemical sectors, biotech innova-
tion reduces dependence on petroleum and fossil 
fuels and, consequently, cleans the environment 
and fights global climate change. In the healthcare 
sector, the biotech industry has developed and 
commercialized drugs, vaccines, and diagnostics 
with significant impact on length and quality of 
life. In the agricultural field, biotech innovations 
simultaneously increase food supplies, reduce en-
vironmental damage, conserve natural resources 
of land, water, and nutrients, and increase farm 
income in economies worldwide.
 
The future of the biotech industry, more specifi-
cally, the industrial and agricultural sector, holds 
considerably in biomass production. Although 
biomass has since long been used as feedstock, 
e.g. wood-based materials, pulp and paper pro-
duction, biomass-derived fibers, the transition 
toward the modern bioeconomy requires the 
sustainable raw material production and efficient 
biomass use, implying a set of principles that 
should be strived for: (i) increased yields for food, 
feed, and industrial feedstock with as minimal as 
possible increases in land, water, fossil fuels, and 
minerals for fertilizer production; (ii) flowing use 
of biomass as food, feed, material, and, finally, 
energy; and (iii) cyclic reaction in which products 
should be designed for disassembly and reuse, 
consumables should be returned harmlessly to 
the biosphere, durables should maximise their re-
use or upgrade, and renewable energy should be 
used to energize the process (Mathijs et al., 2015).
 
Agriculture is central for global development pro-
motion within the biophysical limits of a stable 
ES. The conventional tools of intensive agricul-
tural growth, i.e., mechanization, plant breeding, 
agrochemicals, and irrigation, diminish returns 
and threaten the ES resilience. Four ES features 
transgress the proposed planetary boundary lev-
els: climate change, biosphere integrity, biogeo-
chemical flows, and land system changes (Steffen 
et al., 2015). As agriculture is the anthropogenic 
perturbation with the most prominent impact, it 
is challenged to produce sustainable yields. Of 
the novel technologies of several kinds needed 
to achieve sustainably high-yield agriculture, one 
of the most important implementation is modern 
plant biotechnology, i.e. genetically modified (GM) 
technology and various molecular biological tools, 
that enhances the plant breeding potential and 
reduces the negative impact both within fields 
and surrounding lands.
 
Plant GM technology originated back in the 
1980s, when the first GM plant, resistant to the 
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antibiotic kanamycin, had been developed (Van 
Montagu, 2011 and references therein; Angenon 
et al., 2013). In the 1970s, Jeff Schell, Marc Van 
Montagu, and colleagues at the Ghent University 
(Belgium), who studied the tumor-inducing princi-
ple of Agrobacterium tumefaciens, discovered that 
a large plasmid was responsible for the formation 
of crown galls on infected plants and that part of 
its DNA was transferred to plant cells (Zaenen et 
al., 1974; Van Larebeke et al., 1975; Depicker et 
al., 1978). After it had become clear that Agro-
bacterium could be used as a vector to transfer 
foreign DNA to plant cells, fertile transgenic to-
bacco (Nicotiana tabacum) plants were generat-
ed that expressed and transmitted the chimeric 
antibiotic resistance genes to their progeny. A 
first company on plant genetic engineering, Plant 
Genetic Systems (Ghent, Belgium), was found-
ed (Van Lijsebettens et al., 2013 and references 
therein) and the GM technology was soon em-
ployed worldwide both in fundamental science to 
study gene function and in agriculture to produce 
transgenic crops with useful agronomic traits. The 
commercialization of GM crops started in 1996. 
Since then, the acreage of GM crops cultivated 
worldly has increased steadily to up to 100-fold 
the area planted. The average agronomic and 
economic benefits of GM crops are large and sig-
nificant (Klümper and Qaim, 2014) as is evidenced 
both in developed and developing countries. The 
agricultural sector is probably the segment of 
biotech industry that provides more benefits to 
the middle and low-income economies. In this 
introductory chapter we give an overview of the 
innovations in plant biotechnology that have been 
approved for commercialization or are at the late 
stages of development and their application to 
agriculture, agroforestry, industrial processes, 
and pharmaceutical industry.
Global GM crop plants
Genetic engineering has the potential to address 
the critical constrains of sustainable agriculture 
and the need for sufficient quantity of healthy food, 
feed, and biomass feedstock for the industry as well, 
but GM crops have delivered only a limited range of 
agronomic traits for the agriculture production. Of 
the possible GM crop options that have ever been 
commercialized in the world, only nine GM crops 
are grown commercially worldwide, among which 
soybean (Glycine max), maize (Zea mays), cotton 
(Gossypium hirsutum), and canola (Brassica napus) 
account for 99% of the worldwide GM crop acreage. 
In 2014, the largest share (50%) was for GM soy-
beans, followed by maize (30%), cotton (14%), and 
canola (5%) (James, 2014). Other crops that account 
for 1% of global GM planting are alfalfa (Medicago 
sativa), sugar beet (Beta vulgaris), papaya (Carica 
papaya), squash (Cucurbita pepo), and eggplant (So-
lanum melongena). Only three traits, herbicide tol-
erance (HT), insect resistance (IR), and hybrid vigor 
have been generated and introduced in almost all 
GM crops grown commercially over the past 20 
years. In 2014, 57% of the world’s land surface of 
GM crops was HT, 15% IR, and 28% both HT and IR, 
called stacked traits, whereas other traits, such as 
virus resistance and drought tolerance, collectively 
account for less than 1%. The drought-tolerant bio-
tech corn varieties are cultivated since 2013 only in 
the USA (James, 2014).
 
In Africa, where the GM technology is most need-
ed to foster agricultural transformation, the out-
put is deceiving. Only three African countries 
cultivate GM crops: South Africa with 2.7 million 
ha of maize, soybean, and cotton; Sudan with 0.1 
million ha of cotton; and Burkina Faso with 0.5 
million ha of cotton (James, 2014).
 
Despite this quite unsatisfying output in terms of 
crops and traits, farmer’s acceptance as well as 
global income, production, and environmental 
impacts of these biotech crops are impressive. 
Farmers who have been granted the opportunity, 
quickly adopted GM crops. By 2014, millions of 
farmers in 28 countries worldwide have chosen 
to plant GM crops over 181.5 million ha and grow 
almost half of the global plantings of soybean, 
maize, cotton, and canola. The GM traits have 
provided logistical advantages, risk reductions, 
and economic benefits.
 
Brookes and Barfoot (2015a) analyzed the changes 
in farm income thanks to the impact of GM 
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technologies on yields, key production costs, no-
tably seed cost and crop protection expenditure, 
but also impact on energy and labor costs where 
data were available, and the prospect of planting 
a second crop in one season. At the global lev-
el, GM technology has had a significant positive 
impact on farm income. The net economic bene-
fits of the four major GM crops (soybeans, maize, 
canola, and cotton) at the farm level amount to 
US$ 133.4 billion for 18 years of commercializa-
tion between 1996 and 2013. Approximately 70% 
of these gains have derived from yield and pro-
duction gains and 30% from cost savings, such 
as less ploughing, fewer pesticide sprays, and 
less labor. In 2013, the direct global farm income 
benefit was US$ 20.5 billion, which is equivalent 
to a 5.5% addition to the global production value 
of the four main crops. As expected, US farmers 
have been the largest beneficiaries of increased 
incomes, because they adopted the GM technol-
ogy early on and more than 80% of the four crops 
are GM since several years. More relevant is that 
farmers in developing and emerging economies 
got approximately 50% of the economic gains. 
The additional income benefits for soybean and 
maize farmers in South America (Argentina, Bo-
livia, Brazil, Colombia, Paraguay, and Uruguay) 
and cotton farmers in Asia (China and India) were 
US$ 31.1 billion and US$ 32.9 billion respective-
ly. Table 1 summarizes the economic impact of 
GM crops since their first commercialization year 
to 2013.
 
GM technology has also contributed to reduce 
the agriculture’s environmental footprint by facil-
itating environmentally friendly farming practices 
(Brookes and Barfoot 2015b). The GM IR traits 
replaced insecticides used to control pest. Since 
Biotech crop Total cumulative farmer’s 
income benefit 1996-2013 
(US$ billions)
Biotech trait Type of benefit Country
Soybean 14.8 HT soybeans (1st gener-
ation)
Lower production costs Brazil, USA, Canada, Uru-
guay, South Africa
Lower production costs + 
second crop gains
Argentina, Paraguay
Lower production costs + 
yield gains
Mexico, Bolivia, Romenia
HT soybean (2nd gener-
ation with higher yield 
potential)
Lower production costs + 
yield gains
USA, Canada
HT/IR soybean Cost savings as 1st 
generation HT soybean + 
insecticide savings + yield 
gains
Brazil, Argentina, Paraguay, 
Uruguay
Maize 7.36 HT maize Lower production costs USA, Canada, South Africa, 
Colombia
Lower production costs + 
yield gains
Argentina, Brazil, Philip-
pines
37.2 IR maize (resistance to corn 
boring pests)
Yields gains USA, South Africa, Hondu-
ras, Argentina, Philippines, 
Spain, Uruguay, Colombia, 
Canada, Brazil, Paraguay
IR maize (resistance to 
rootworm pests)
Yield gains USA, Canada
Cotton 1.49 HT cotton Lower production costs USA, South Africa, Aus-
tralia, Argentina, Uruguay, 
Paraguay
Lower production costs + 
yield gains
Brazil, Mexico, Colombia
40.78 IR cotton Yield gains USA, China, South Africa, 
Mexico, Argentina, India, 
Colombia, Burkina Faso, 
Pakistan, Burma
Canola 4.3 HT canola (tolerant to 
glyphosate)
Mostly yield gains where 
replacing triazine-tolerant 
canola
Australia
HT (tolerant to glufosinate)/
hybrid vigor canola
Mostly yield gains USA, Canada
Sugarbeet 0.14 HT sugarbeet Mostly yield gains USA, Canada
Table 1. Farm level economic benefits of GM crops
Adapted from Brookes and Barfoot (2015a).
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1996, the active insecticide ingredient use in cot-
ton and maize was reduced by 239 million and 
71.7 million kg, respectively, with the highest ben-
efits for cotton, because its culture requires an 
intensive treatment regime with insecticides. The 
adoption of GM IR cotton in China and India re-
sulted in a cumulative decrease in insecticides of 
over 192 million kg for the period 1996-2013. IR 
soybeans were first grown commercially in 2013, 
mostly in Brazil, and the savings in active insecti-
cide amounts in that year was above 0.4 million 
kg, corresponding to 1% of the total soybean in-
secticide use.
The environmental gains associated with the use 
of GM HT traits are related to the application of 
more environmentally friendly products and to 
simplified changes in farming systems. The adop-
tion of conservation tillage has led to additional 
soil carbon sequestration and a reduction in trac-
tor fuel use that amounted to 7,012 million liters 
between 1996 and 2013 (Carpenter, 2011). Less 
fuel, associated with fewer insecticide and herbi-
cide sprays and less or no ploughing, correspond-
ed to 28,005 million kg of CO2 eliminated from the 
atmosphere or, in terms of car equivalents, to 
12.4 million cars off the road for a year (Brookes 
and Barfoot 2015b).
 
The higher productivity of the currently commer-
cialized GM crops alleviates the pressure to con-
vert additional land for agriculture. To achieve the 
same tonnage of food, feed, and fiber obtained 
during the 1996-2013 period, 132 additional mil-
lion ha would have been needed with convention-
al crops only (James, 2014).
GM crops approved for 
commercialization in the world
In contrast to the limited number of GM crops 
on the market, an important number of crops, 
events, and traits have received approval for 
commercialization. As of 11th October 2015, a to-
tal of 40 countries granted regulatory approvals 
to 29 GM plants and 383 GM events, covering 36 
GM traits for use as food, feed and/or for culti-
vation (www.isaaa.org/gmapprovaldatabase). The 
fast-growing number of approved GM trait-con-
taining varieties and hybrids shows that GM tech-
nology does not narrow the genetic diversity of 
the crop plant. In addition to the commercial HT 
and IR GM traits used to construct the vast ma-
jority of GM crops on the market, GM traits have 
been also approved for abiotic stress tolerance, 
altered growth/yield, disease resistance, modified 
product quality, and pollination control systems. 
Table 2 summarizes the GM traits approved per 
GM plant. Remarkably, 13 different GM traits aim 
to change product quality in 13 different crops.
A number of noteworthy biotech crops/traits have 
been recently approved. In November 2014, the 
US Department of Agriculture (USDA) endorsed 
commercial planting of two crops employing an 
RNA interference (RNAi) approach: a transgen-
ic alfalfa with reduced lignin for improving fiber 
digestibility via RNAi of caffeoyl coenzyme 3-O- 
methyltransferase gene involved on the synthe-
sis of guaiacyl lignin subunit and a potato (Sola-
num tuberosum) with reduced levels of several 
enzymes, among which one that produces the 
potentially carcinogenic metabolite acrylamide. 
This Innate™ potato (J.R. Simplot, Boise, Idaho) 
also suffers less wastage from bruising (Waltz, 
2015). The Enlist™ Duo for maize and soybean 
(Dow AgroSciences, Indianapolis, IN, USA) that 
contains two stacked genes to confer tolerance 
to the herbicides glyphosate and 2,4-D-choline 
was approved in Canada in April 2014 and in the 
USA in September 2014 (James, 2014). Approval 
of the Arctic Apples, genetically engineered to re-
sist browning associated with cuts and bruises by 
reduction of the browning-causing enzyme levels 
was granted by the USDA in February 2015 and 
by the Food and Drug Administration (USA) in 
March 2015.
 
Developing countries also generated and ap-
proved novel biotech plants. In 2013, Indonesia 
ratified the environmental certificate for cultiva-
tion of drought-tolerant sugarcane (Saccharum 
spp.). In Brazil, a virus-resistant bean (Phaseolus 
vulgaris) was approved in 2011 and is due for 
commercialization in 2016 and a GM eucalyptus 
Commercial trait GM trait GM Plant
Abiotic Stress Tolerance Drought stress tolerance Maize
Sugarcane
Altered Growth/Yield Enhanced photosynthesis/yield Soybean
Volumetric wood increase Eucalyptus
Disease Resistance Black spot bruise tolerance Potato
Viral disease resistance Bean
Papaya
Plum
Squash
Sweet pepper
Tomato
Herbicide Tolerance Glufosinate herbicide tolerance Argentine canola
Cotton
Maize
Polish canola
Rice
Sugar beet
Glyphosate herbicide tolerance Cotton
Creeping bent grass
Maize
Polish canola
Potato
Soybean
Sugar beet
Wheat
Isoxaflutole herbicide tolerance Soybean
Mesotrione herbicide tolerance Soybean
Oxynil herbicide tolerance Argentine canola
Cotton
Tobacco
Sulfonylurea herbicide tolerance Carnation
Cotton
Flax
Maize
Soybean
Insect Resistance Coleopteran insect resistance Maize
Potato
Lepidopteran insect resistance Cotton
Eggplant
Maize
Poplar
Rice
Soybean
Tomato
Multiple insect resistance Cotton
Maize
Poplar
Modified Product Quality Altered lignin production Alfalfa
Non-browning phenotype Apple
Modified oil/fatty acid Argentine canola
Soybean
Phytase production Argentine canola
Maize
Modified flower color Carnation
Petunia
Rose
Modified amino acid Maize
Modified alpha amylase Maize
Delayed ripening/senescence Melon
Tomato
Delayed fruit softening Tomato
Modified starch/carbohydrate Potato
Reduced acrylamide potential Potato
Anti-allergy Rice
Nicotine reduction Tobacco
Pollination control system Fertility restoration Maize
Male sterility Argentine canola
Chicory
Maize
Table 2. Global status of GM technology: GM crops approved for commercialization in at least one country
Note. Source: ISAAA GM approval data base
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(Eucalyptus sp.) in 2015 (James, 2014; www.isaaa.
org/gmapprovaldatabase). FuturaGene, owned by 
the Brazil–based Suzano Pulp and Paper compa-
ny and the second largest producer of eucalyptus 
pulp globally, developed the transgenic eucalyp-
tus that contains a gene encoding an Arabidopsis 
thaliana protein that facilitates cell wall expansion 
and accelerates growth. According to FuturaGene, 
the GM tree produces 20% more wood than the 
conventional variety and is ready for harvest in 
five and a half years instead of seven.
 
There is a growing interest in GM forest trees due 
to the increasing global trend for timber produc-
tion from plantations and bioenergy applications. 
Since forests can be grown on marginal lands, 
competition with land resources suitable for ag-
ricultural production can be avoided. At the same 
time, the increased productivity from bioengi-
neered forests will provide an option to protect 
native forests.
 
A few GM forest trees have been produced com-
mercially. In China, poplar (Populus sp.) trees are 
cultivated for uses in furniture, boat making, pa-
per and chopsticks, because of their flexibility and 
close wood grain. (ISAAA, 2015). Since 2000, Chi-
na produces GM poplars to fight Asian longhorn 
beetle that devastated 7.04 million ha of poplar. 
Three clones of Populus nigra were developed 
with the Bacillus thuringiensis (Bt) gene cry1Aa and 
a hybrid white poplar (Populus alba) was trans-
formed by fusion of cry1Aa and the gene coding 
for a proteinase inhibitor from Sagittaria sagittifo-
lia. In the transgenic poplar plantations, the fast 
spread of the target insect pests was inhibited 
effectively and the number of insecticide applica-
tions was significantly reduced. The performance 
of the Bt black poplar plantations is significantly 
better than that of the clones deployed locally, re-
sulting in a substantial 90% reduction in leaf dam-
age. In 2014, GM poplar was cultivated in 543 ha 
in China (James, 2014).
 
ArborGen Inc. (Ridgeville, SC, USA), a tree seedling 
company, has developed a GM loblolly pine (Pinus 
taeda) cultivar with enhanced density. Lobloblly 
pines are used for lumber, plywood, and paper 
(ISAAA, 2015). As none of the inserted genes are 
derived from plant pests, the USDA deregulated 
the GM loblolly pine that can be cultivated without 
undergoing environmental studies (http://www.
capitalpress.com/Timber/20150128/usda-can-
not-restrict-gmo-pine).
Near-term innovations
Regulatory constraints, with delaying approvals 
and increasing costs, have discouraged biotech 
innovations, except in big corporations. The cost 
of discovery, development, and authorization of 
a new biotech crop or trait has been estimated 
to be approximately US$ 136 million (Prado et al., 
2014). Notwithstanding, good Research and De-
velopment  projects continue to be pursued both 
in developed and developing countries. A wide va-
riety of plants are being generated for resilience 
to biotic and abiotic stresses, increased water or 
nitrogen use efficiency (NUE), and nutritional im-
provements (Ricroch and Hénard-Damave, 2015). 
The major multinational agribusiness corpora-
tions often collaborate with public institutions, 
private entities, and philanthropic organizations 
in the least developed countries, particularly 
in Africa. Other relevant innovations for non-
food purposes, such as pharmaceutical, biofuel, 
starch, paper and textile industries are being 
pursued in developed countries.
Sustainable trait management
Management of several sustainable biotech traits 
is quickly becoming available. The main multina-
tional seed corporations continue to develop GM 
traits directed to broad-spectrum herbicides and 
resistance to chewing insects on a wide range of 
species. Most of these innovations are related to 
stacking different HT and/or IR genes. Gene stack-
ing simplifies and enhances pest management as 
demonstrated by IR and weed HR based on a sin-
gle gene technology (Que et al., 2010).
 
Nonetheless, research continue to focus on other 
kinds of sustainable agronomic traits and sever-
al traits and crops in the pipeline resulting from 
both private and public endeavors that target the 
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developing world are about to be commercial-
ized. Some case studies are listed below.
Water-Efficient Maize for Africa (WEMA)
Agriculture requires more water than any oth-
er human activity. Drought is a threat to farms 
around the world and in Africa drought is one of 
the major factors that prevent good yields. The 
Food and Agriculture Organization of the United 
Nations estimates that by 2025 approximately 
480 million Africans could be living in areas of wa-
ter scarcity. To face this challenge, plant scientists 
are developing drought-tolerant traits. The WEMA 
project is a public-private partnership that aims 
to improve food security and livelihoods for small 
farmers in Sub-Saharan Africa by finding ways to 
double the maize yields. In this project, GM and 
non-GM technology, including marker-assisted 
breeding, are combined to generate hybrid maize 
seeds with increased water use efficiency and re-
sistance to insect pests. To this end, the Bt gene 
will be stacked with the drought-tolerance bio-
tech trait (MON87460) that expresses the Bacillus 
subtilis cold-shock protein B (cspB), licensed from 
Monsanto. (http://wema.aatf-africa.org).
 
Centro de Investigación y de Estudios Avanzados del 
Instituto Politécnico Nacional (CINVESTAV-IPN)
In Mexico, the biotech maize CIEA-9 was devel-
oped with enhanced adaptation to severe drought 
and extreme temperatures. The antisense RNA 
expression was used for silencing trehalase in the 
popular maize inbred line B73 (derived from Iowa 
Stiff Stalk Synthetic). This biotech maize requires 
20% less water, endures high temperatures (up to 
50°C), and the seeds germinates at 8°C, demon-
strating their ability to withstand cold at early de-
velopment stages (Ortiz et al., 2014). In 2012, the 
Government of Mexico granted 4 ha for experi-
mental release of CIEA-9 in Sinaloa (Mexico). This 
permit was the first delivered to a Mexican public 
research center since the biosafety law was au-
thorized (Wolf and Otero, 2015).
Centro Internacional de Mejoramiento de Maíz y 
Trigo (CYMMYT; International Maize and Wheat Im-
provement Center)
Over the past five years, this Mexican center has 
analyzed experimental releases of genetically en-
gineered drought-resistant wheat (Triticum sp.). 
All the different events tested in experimental tri-
als on 0.1-ha plots at the Tlaltizapan Morelos site 
were drought resistant (Wolf and Otero, 2015).
ArborGen Inc.
This Brazilian company developed a GM eucalyp-
tus tree that can withstand extremely low tem-
perature. It contains a cold-inducible promoter 
driving a C repeat-binding protein from A. thalia-
na. This biotech tree combines the fast-growing 
and highly desirable fiber quality characteristics 
of a known Brazilian eucalyptus variety that can 
withstand freezing temperatures. Transgenic 
freeze-tolerant eucalyptus can grow up to 52.4 
feet (15.97 m) at 16.8oF (-8.4°C), compared to 
the control trees that grew only 0.3 feet (9 cm) 
(Hinchee et al., 2011). This freeze-tolerant tropical 
eucalyptus product (AGEH427) is currently going 
through the government review process for de-
regulation in the USA (www.arborgen.com).
Arcadia Biosciences Inc. (Davis, CA, USA)
The NUE trait contributes to improve yields in 
N-limited environments and reduces fertilizer 
costs and N fertilizer pollution (Hirel et al., 2011). 
Among the various genetic engineering strategies 
for NUE enhancement in crops, the overexpres-
sion of the gene coding for alanine aminotrans-
ferase that increases N uptake at early growth 
stages is a very promising candidate for commer-
cialization. The intellectual property associated 
with this invention has been licensed to Arcadia 
Biosciences Inc. The company possesses the 
rights to use this gene technology in major ce-
reals, such as wheat, sorghum (Sorghum bicolor), 
rice, maize, and barley (Hordeum vulgare), as well 
as in sugarcane. Field trials have been execut-
ed for rice in China, for rice and wheat in India. 
Its value for maize and rice is being assessed in 
Sub-Saharan Africa through private-public part-
nerships. Rice with NUE/water use efficiency and 
salt tolerance (NEWST) is on field trial in Uganda. 
The National Agricultural Research Organization 
(NARO), African Agriculture Technology Founda-
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tion (AATF), and Arcadia Biosciences cooperate 
on this research (Ortiz et al., 2014; James 2014).
Laboratorio Nacional de Genómica para la Biodiver-
sidad at CINVESTAV  
The National Laboratory of Genomics for Biodi-
versity at the Irapuato campus (Mexico) and a pri-
vate Mexican company are developing GM plants 
that will be able to absorb and optimize the use 
of phosphorus. The GM plants absorb phosphites 
rather than phosphates and so improve the use 
of fertilizers and weed control that compete for 
the phosphorus element. According to the devel-
opers, the trait can reduce the required amount 
of fertilizer by 30% to 50%, eliminates or reduces 
the use of herbicides, and is harmless to humans 
and animals. The group is developing a GM tobac-
co as first crop and, if successful, the trait will be 
introduced into maize for Africa in the near future 
(Wolf and Otero, 2015).
Examples of transgenic plants resistant to 
fungal disease
(1) Late blight of potato, one of the most devas-
tating diseases caused by a pathogen similar to 
fungi, Phytophthora infestans, accounts for 20% 
of potato harvest failures worldwide, translating 
into 14 million tons and valued at EURO 2.3 billion 
(Ortiz et al., 2014 and references therein). Sever-
al lines of transgenic potato containing R genes 
identified in wild relatives with high resistance to 
late blight have been produced (such as resistant 
genes from the wild Mexican relative Solanum bul-
bocastum, was used to breed the Fortuna cultivar 
and the Rpi-vnt1.1 gene isolated from Solanum 
venturii had been introduced into the potato vari-
ety Désiree). As these R genes had been identified 
in wild potato species, the use of the so-called cis-
genic technology facilitated the rapid transfer of 
these genes into cultivated potato varieties with-
out linkage drag. These plants have been shown 
to be resistant to late blight in several years of 
field tests (Gaffoor and Chopra, 2014 and refer-
ences therein; Ortiz et al., 2014, Jones, 2015).
(2)  In wheat, one of the most damaging fungal dis-
eases is powdery mildew. Transgenic wheat lines 
harboring different versions of a powdery mildew 
resistance gene (Pm3 R) have gone through field 
tests. Two years of field trials have revealed that 
the GM plants were more resistant to powdery 
mildew than the nontransgenic control plants 
(Gaffoor and Chopra, 2014).
(3)  The chestnut blight fungus secretes several 
toxic compounds, such as oxalic acid that low-
ers the pH of the surrounding plant tissue, with 
death of the infected tissue as a consequence. 
Plants transformed with a wheat gene encoding 
oxalate oxidase were able to detoxify the oxalic 
acid, thereby starving the fungus and restricting it 
to the bark of the tree (Castanea sp.). These plants 
were tolerant to the disease and have undergone 
rigorous laboratory testing and several years of 
successful field trials (Gaffoor and Chopra, 2014).
(4)  Banana (Musa sp.) plants have been engi-
neered to control a bacterial disease Xanthomonas 
wilt, better known as BXW. The transgenic plants 
containing genes from sweet pepper (Capsicum 
annuum) encoding a hypersensitive response-as-
sisting protein (Hrap) or a ferredoxin-like protein 
(Pflp) were evaluated over two successive crop 
cycles in a confined field trial in Uganda (Tripathi 
et al., 2014). Approximately 20% of the 40 Hrap 
lines and 16% of the 26 Pflp lines, for a total of 
11 transgenic lines, showed 100% resistance and 
retained the resistance in the ratoon crop. As elic-
itor-induced resistance is not specific against par-
ticular pathogens, this transgenic approach may 
also provide effective control of other bacterial 
diseases of banana, such as moko or blood dis-
ease in other parts of the world. Nearly 15 million 
people either rely on bananas for their income or 
consumption, making it an important food and 
cash crop in the Great Lakes region of East Afri-
ca. Food security studies revealed that in Uganda, 
Rwanda, and Burundi, bananas constitute >30% 
of the daily per capita caloric intake, rising to 60% 
in some regions (Tripathi et al., 2014).
Other ongoing biotech crop research activities for 
sustainable management that are on field trials 
in Africa include: (i) IR cowpea (Vigna unguicula-
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ta) in Burkina Faso (L’Institut pour l’Etude et la 
Recherche Agronomique, AATF, Network for the 
Genetic Development of Cowpea, and The Com-
monwealth Scientific and Industrial Research 
Organization), Ghana (AATF and Savanna Agricul-
tural Research Institute), and Nigeria (AATF and 
Institute of Agricultural Research); (ii) virus-resist-
ant cassava (Manihot esculenta) in Nigeria (Nation-
al Root Crops Research Institute), Kenya (Kenya 
Agricultural and Livestock Research organization 
[KALRO], International Institute of Tropical Ag-
riculture [IITA], Danforth Plant Science Center 
[DDPSC], and Masinde Murilo University of Sci-
ence and Technology), and Uganda (NARO, DDP-
SC, and IITA); (iii) Fungal resistance and drought/
salt-tolerant wheat in Egypt (Agricultural Genetic 
Engineering Research Institute); (iv) Virus resistant 
sweet potato Ipomoea batatas) in Kenya (KALCRO 
and DDPSC), (vi) IR sweet potato in Uganda (NARO 
and DDPSC); and (vii) nematode-resistant banana 
(NARO and University of Leeds, UK) (James, 2014).
Output traits for food and feed
Nutritionally enhanced food crops
 
A few nutritionally enhanced food crops have un-
dergone safety approval, namely maize with in-
creased lysine content and canola and a number 
of GM soybeans with improved fatty acid profile, 
including high stearidonic acid, an intermediate of 
omega-3-Fatty Acid. However, the last decade wit-
nessed great progress in R&D to generate nutri-
tionally improved biotech food crops specifically 
for targeting low-income families. Addressing nu-
tritional deficiencies by gene engineering would 
lead to decreased healthcare costs and increased 
economic performance. Biofortified staple crops 
harboring essential micronutrients to benefit the 
world’s poor and new functional GM food crops 
for enhancing human health are under develop-
ment. Several of these GM crops are currently be-
ing tested in developing countries. Some relevant 
examples are given below.
(1) Golden Rice, named for its golden color due 
to its high β-carotene content, is one of the first 
examples of a GM staple crop that was specifical-
ly designed to combat malnutrition and vitamin A 
(VitA) deficiency, because it is an essential nutri-
ent needed for the visual system, growth, devel-
opment, and a healthy immune system. Golden 
Rice was generated by the research group of Ingo 
Potrykus (ETH Zürich, Switzerland) (Ye et al., 2000) 
to offer a viable solution for eye damage of three 
million preschool-aged children due to VitA lack. 
The GM rice (GR1) was engineered with two genes 
from other organisms (daffodil [Narcissus poet-
icus] and the bacterium Erwinia uredovoia) that 
reconstitute the carotenoid biosynthetic pathway 
within the rice genome (Tang et al., 2009). The cur-
rent Golden Rice version, known as GR2, utilizes 
genes from two distinct proVitA pathways, includ-
ing the maize phytoene synthesis gene instead of 
the analogous daffodil gene used in the GR1 rice. 
Golden rice can produce β-carotene amounts 
that were up to 35 μg/g dry rice. Bioavailability 
testing has confirmed that Golden Rice is an ef-
fective source of VitA in humans (Hefferon, 2015 
and references therein).
(2)  Transgenic biofortified rice has also been engi-
neered to combat iron and folate deficiency, with 
improved mineral bioavailability, and with high 
content to essential amino acids, such as lysine 
(Blancquaert et al., 2015; Hefferon, 2015).
(3) The BioCassava Plus (BC+) program geneti-
cally engineered cassava with increased levels of 
iron and proVitA. Retention and bioavailability of 
transgenic cassava are similar to the findings on 
conventional biofortification research. The first 
field trials for a proVitA-biofortified cassava began 
in 2009, followed by trials for high-iron cassava, 
and delivery of the biofortified crops is expect-
ed in 2017. Additional traits included in BC+ are 
increased shelf life, reduced cyanide levels, and 
improved disease resistance (Tohme and Beyer, 
2014). The National Root Crops Research Insti-
tute of Nigeria is performing field trials with proVi-
tA-rich cassava (James, 2014).
(4)  Transgenic bananas with proVitA and iron are 
being developed by the NARO Uganda and the 
Queensland University of Technology. The per 
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capita consumption of bananas is estimated to 
be 0.7 kg per day in Uganda. Scientists applied 
the pro-Vitamin A genes used in Golden Rice to 
a popular local variety. Bananas with up to 20 
ppm proVitA have been generated and trials have 
started in Uganda. The ProVitA bananas are ex-
pected to be released in 2020. A human bioavail-
ability study began in late 2013 (Waltz, 2014). 
(5) Sorghum biofortified with VitA and bioavailable 
zinc and iron is tested by the Africa Harvest and 
Pioneer Hi-Bred in Nigeria (in collaboration with 
the National Biotechnology Development Agen-
cy) and in Kenya (in collaboration with KALRO) 
(James, 2014).
(6) Nutritional fatty acids associated with reducing 
coronary heart disease risks can be introduced 
into oilseed crops to improve human health. So 
far, 10 transgenes that have led to the accumu-
lation of high-value fatty acids in plants (Ortiz et 
al., 2014). High oleic acid GM soybeans produced 
by Pioneer Hi-Bred International, Inc. (Pioneer), 
a DuPont Company (Johnston, IA, USA), was the 
first biotech soybean product of this kind (Plen-
ish™). RNAi technology was used to decrease the 
expression of the endogenous soybean gene en-
coding fatty acid desaturase (gm-fad2-1) that pro-
duced seeds with an increased concentration of 
oleic acid (C18:1) and a correspondingly reduced 
concentration of linoleic acid (C18:2). The pur-
pose of this change in fatty acid profile is to pro-
vide a stable vegetable oil that is suitable for frying 
applications without the need for hydrogenation 
(De Maria, 2013).
(7) To synthesize Omega-3 long-chain polyun-
saturated fatty acids found routinely in fish oils, 
scientists of the Rothamsted Research Institute 
(Harpenden, UK) have metabolically engineered 
camelina (Camelina sativa) plants. The metabolic 
pathway to produce this fatty acid was reconsti-
tuted in camelina by substituting synthetic ver-
sions of up to seven genes from marine algae 
(Betancor et al., 2015). The levels of eiosapen-
taenoic acid and docosahexaenoic acid obtained 
were economically reasonable, thus representing 
a tangible success. Therefore, GM oilseeds can be 
a novel source of this essential oil. Omega-3 long-
chain polyunsaturated fatty acids are of great in-
terest due to their dietary benefits, such as im-
provements to brain function and development 
as well as for cardiovascular health. The camelina 
plants with a high content of these omega-3 oils 
in the laboratory/glasshouse are being evaluated 
for their performance in the field. Other beneficial 
fatty acids have also been made in plant seed oils, 
including γ-linolenic and stearidonic acid, as well 
as arachidonic acid (Hefferon, 2015).
(8) Transgenic tomato (Solanum lycopersicum) 
fruits with threefold enhanced hydrophilic an-
tioxidant capacity have been obtained through 
metabolic engineering. The “purple” tomato con-
tains genes from two snapdragon (Antirrhinum 
majus) transcription factors Delila and Rosea1 
that control anthocyanin biosynthesis (Butelli et 
al., 2008). Anthocyanins, compounds found in 
blueberries (Cyanococcus sp.) and cranberries 
(Vaccinium sp.) are believed to fight cardiovascu-
lar diseases and exhibit anti-inflammatory prop-
erties. Tomatoes were chosen because they are 
quite affordable antioxidant sources. The GM 
tomato with an as much as 30% significantly ex-
tended life span in the cancer-prone mice (Mus 
musculus), is currently being tested on heart pa-
tients in Britain (Hefferon, 2015). A recent study 
shows that the purple tomato not only is more 
healthy, but also has a longer shelf life and is 
more resistant to diseases than not GM toma-
toes (Zhang et al., 2013).
(9) Transgenic tomato plants that accumulat-
ed trans-resveratrol and trans-resveratrol-glu-
copyranoside have been obtained by transfor-
mation with the stilbene gene from grape (Vitis 
vinifera). These GM tomato lines showed a sig-
nificantly increased antioxidant capability and 
ascorbate content. The GM tomato extracts were 
able to counteract the pro-inflammatory effects 
of phorbol ester in a culture of monocyte-mac-
rophages (Hefferon, 2015).
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Nutrionally enhanced feed crops
GM feed crops have been developed to improve 
the nutritional value of animal feed as well as to 
produce more environmentally friendly manure. 
Biotech crops engineered with increased levels of 
amino acids are an alternative to the direct ad-
dition of supplemental amino acids in animal di-
ets. Examples of these types of crops include GM 
maize with enhanced production and accumula-
tion of free lysine in the corn kernel; protein-en-
riched GM soybean with more digestible lysine, 
methionine, threonine, and valine; high-methio-
nine GM lupine (Lupinus sp.); high-tryptophan 
GM rice; and GM alfalfa with increased levels of 
cysteine, methionine, aspartate, and lysine (ISAAA, 
2012; Hefferon, 2015).
 
GM feed crops with phytase enzyme have been 
shown to improve phosphorus availability. 
Non-ruminants cannot efficiently absorb phos-
phorus stored in plants as phytate salts. The un-
digested phosphates excreted by these animals 
can accumulate in the soil and water, leading to 
phosphorous pollution and organic matter ac-
cumulation. In addition, phytic acid forms insolu-
ble salts with zinc and other cations that reduce 
the bioavailability of trace minerals. GM corn, 
soybean, canola, and wheat expressing phytase 
transgenes have shown a positive effect on per-
formance, phosphorus retention, and excretion. 
Other antinutritive factors that have been tackled 
by plant gene engineering include GM soybeans 
with reduced levels of the antinutritive oligosa-
charides raffinose and stachyose and GM cotton 
seeds with low contents of the phenolic pigment 
gossypol (ISAAA, 2012).
Production of pharmaceuticals in 
biotech plants
Plants can be genetically engineered to harness 
endogenous metabolic pathways and the pro-
tein biosynthesis machinery to produce complex 
small-molecule compounds and recombinant bi-
ologicals. A number of plant species have been 
genetically engineered in several metabolic path-
ways to produce defined secondary metabolites 
of high pharmaceutical value, including paclitaxel, 
tropane, morphine, and terpenoid indole alka-
loids either as whole plants or cultured organs/
cells. Several advances are being implemented in 
terms of quality, purity, and yield, as well as proce-
dures to meet regulatory requirements to move 
from these products from proof-of-principle to 
commercial production (Fisher et al., 2015). 
 
One of the key features of plant-based produc-
tion platforms that distinguish them from other 
biological manufacturing concepts is the lack of 
a single biotechnological basis or a standardized 
platform. The technologies encompass stable 
transgene integration and transient expression 
in plants by means of bacterial, viral, or hybrid 
vectors (Chen and Lai, 2015). The platforms range 
from plant cells or simple plants, growing in bio-
reactors containing fully defined synthetic media, 
to whole plants growing in soil or in hydroponic 
environments. Whereas transient expression can 
produce very large amounts of the protein of in-
terest within a short time, transgenic plants are 
preferable when the transgenic seed production 
is needed. Many pharmaceutical products can be 
improved and made in a shortened time or on 
an enlarged scale in plant-based systems. These 
features are relevant when products can be pro-
duced with a superior quality and/or with plant 
specifications or when production scale and costs 
are important factors.
 
The production of recombinant pharmaceutical pro-
teins by means of using GM plants, often described 
as molecular farming, originated from the need for 
safe and inexpensive biopharmaceuticals in de-
veloping countries. Plants synthesizing expressing 
vaccine proteins can be grown using local farming 
techniques, only need to be partially processed, are 
easily transportable, and do not require refrigeration. 
Vaccines produced in food or feed crops effectively 
elicit an immune response to a particular pathogen 
when consumed fresh, dried, or lyophilized into a 
powder and reconstituted as a juice when needed. 
Therefore plant made vaccines could be easily avail-
able at low costs at remote regions of the planet 
(Hefferon, 2015).
These developments open interesting opportuni-
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ties for low-income countries and investment in 
manufacturing pharmaceuticals in plants increas-
es globally. When production needs to be scaled 
up, the capital investments on plant-manufactur-
ing platforms in special molecular farming are ex-
pected to be considerably lower than with mam-
malian cell culture platforms. Companies in the 
USA and Europe have invested in the establish-
ment of new currently good plant-manufacturing 
practice facilities (Lössl and Clarke, 2013).
 
In 2012, an important breakthrough was achieved 
when the first plant-made pharmaceutical product 
was approved for use in humans, namely ELELY-
SO® (taliglucerase alfa) (Pfizer, New York, NY, USA), 
a recombinant form of human glucocerebrosidase 
produced in transgenic carrot (Daucus carota) root 
bioreactors for the treatment of the lysosomal 
storage disorder Gaucher’s disease (Stoger et al., 
2014). Another product gained global attention be-
cause of its role in an experimental Ebola therapy. 
The monoclonal antibody ZMapp, developed by 
Mapp Pharmaceuticals (Mountain View, CA, USA), 
was produced in tobacco plants at Kentucky Bio-
processing, a unit of Reynolds American. The drug 
was first successfully tested in humans during the 
2014 West Africa Ebola virus outbreak, but has not 
yet been subjected to a randomized controlled tri-
al (Zhang et al., 2014). This spectacular example of 
molecular farming proved it to be a fast and cheap 
way to produce novel biologicals.
 
Besides these success stories, a number of plant-de-
rived pharmaceutical products are currently on the 
market or undergoing clinical development for 
several clinical applications, including antibiotic-as-
sociated diarrhea, inflammatory bowel disease, 
osteoporosis, HCV HSV/HIV, vaccine, anti-caries 
antibody, and microbicide (Sack et al., 2015). More-
over, several pharmaceutical companies with plant-
based production facilities established commercial 
platforms for nonpharmaceutical products, such 
as cosmetics, veterinary pharmaceuticals, technical 
enzymes, research reagents, and media ingredient, 
as a manner to generate revenue during costly clin-
ical studies (Sack et al., 2015).
It is important to be aware that, as for all medi-
cal interventions, safety and legal issues are re-
quired for production and usage of plant-made 
pharmaceuticals. Depending on the plant pro-
duction system, different biosafety rules apply. 
Metabolites produced in cell suspension cultures 
based on medicinal plants are treated as natural 
products, whereas recombinant proteins pro-
duced in plants are considered products of GM 
organisms and, therefore, follow different regula-
tions. The development of plant cell suspension 
cultures as a platform for plant-made pharma-
ceuticals have been encouraged, partly because 
of the lack of a coherent regulatory framework 
for whole plant-derived pharmaceuticals (Fisher 
et al., 2015). Consequently, the first plant-derived 
recombinant pharmaceutical protein approved 
for human use was produced in plant cells. Not-
withstanding, there are impressive efforts to in-
corporate the latest regulatory innovations of 
industry-like platforms into whole plant-based 
manufacturing processes and to define updated 
guidelines (Fischer et al., 2015). With innovative 
and optimized production processes that can 
be scaled up and appropriate regulatory and 
biosafety frameworks, plant-derived recombinant 
proteins may offer high-volume and cost-effective 
delivery systems for many medical applications in 
this century (Mangan, 2014).
 
Examples of veterinary pharmaceuticals pro-
duced in feed include GM seeds for antibiotic re-
placement in animal farming, such as rice grains 
with human lactoferrin and/or lysozyme as an-
tibacterial and immunity-stimulating agents in 
chickens and pigs (Humphrey et al., 2002; Hu et 
al., 2010). Recently, Arabidopsis seeds have been 
transformed with an antibody against entero-
toxigenic Escherichia coli and used as a proof of 
concept for a passive oral immunization-based 
approach for piglets (Virdi et al., 2013).
Plant biotechnology for  
industrial applications
Innovations on output traits aiming at supporting 
sustainable processes in the chemical and fuel 
industry are lagging behind other plant biotech 
developments. To our knowledge, the only prod-
26
uct approved for commercialization is the Amflo-
ra potato produced by BASF Plant Science (http://
www.sciencemag.org/news/2013/12/eu-court-an-
nuls-gm-potato-approval). This GM potato produc-
es starch composed almost exclusively of amylo-
pectin because the gene coding for starch synthase, 
involved in the synthesis of amylose had been 
switched off by RNAi strategy. As for certain indus-
trial uses of starch only the thickening properties of 
amylopectin are required, the gelling amylose com-
ponent is undesirable in many products and can in-
terfere with certain processes. The chemical mod-
ification or separation of these two components is 
associated with increased consumption of energy 
and water. The European Commission approved 
the Amflora potato for industrial use in 2010 and 
cultivation started on a small scale in the Czech Re-
public, Sweden, and Germany. However, in January 
2012, BASF Plant Science decided to stop marketing 
the Amflora potato in Europe due to lack of accept-
ance of GM crops in Europe and relocated its head-
quarters from Germany to the USA. In 2013, the 
European Union annulled the approval for BASF’s 
Amflora potato. 
 
Potato has also been engineered to pro-
duce high-amylose starch by suppression of 
the starch-branching enzyme SBE1 and SBE2 
through RNAi. Still at R&D stage, the production of 
high-amylose starches can be used in the produc-
tion of packaging material as well as film and coat-
ing from natural resources (Menzel et al., 2015).
Other biochemical pathways for the production 
of molecules for the chemical industry are ac-
tively engineered, but most are still at R&D stage, 
including the tailoring of oil composition for use 
as biofuel and bio-based lubricants in camelina 
and Jatropha curcas (Kim et al., 2014; Kim et al., 
2015); altered lignin content and composition to 
develop more efficient biofuels and biomaterial 
conversion processes in poplar, sorghum, and 
sugarcane (Fu et al., 2011; Bottcher et al., 2013; 
Van Aker et al., 2014). Sugarcane has also been 
transformed with microbial genes that produce 
cellulose-degrading enzymes to produce self-pro-
cessing plants (Harrison et al., 2011).
Plant biotechnology  
for phytoremediation
There are a rapidly increasing number of scientific 
publications relating to phytoremediation and an 
expanding number of ways in which plants can 
be used for effective remediation of contaminat-
ed soil, sludge, sediment, ground water, surface 
water, and wastewater. Several case studies have 
demonstrated that GM technologies have suc-
cessfully enabled phytoremediation to be tailored 
towards specific pollutants. Examples include 
model plants developed to degrade 2,4,6-trinitro-
toluene (TNT), hexahydro-1,3,5-trinitro-1,3,5-tri-
azine (RDX), trichloroethylene (TCE), and polychlo-
rinated biphenyls (PCBs) (Rylott et al., 2015). Focus 
is now turning from model plant systems to the 
transfer of this technology into plant species suit-
able for remediation in the field. One example is 
the transfer of rabbit cytochrome P450, 2E1 into 
poplar trees (Doty et al., 2007), based on the pio-
neering approach of expressing a single human 
2E1 in tobacco for increased degradation of TCE, 
vinyl chloride, carbon tetrachloride, chloroform 
and benzene (Doty et al., 2000; James et al., 2007).
Conclusion
Biotechnology provides to many of the challenges 
that our world faces today, from feeding and fuel-
ling a growing population, tackling a worldwide 
epidemic of neglected and chronic diseases, to 
mitigating the environmental impact of modern 
human societies. Plant biotechnology with focus 
on seed-varietal improvement, such as GM tech-
nology and molecular-assisted breeding, has gen-
erated products that help agriculture to achieve 
enhanced yields in a more sustainable manner. 
GM technology has brought significant improve-
ments to earned income, life quality, and per acre 
productivity. The global value of transgenic seed 
alone has been estimated at US$ 15.7 billion, rep-
resenting 35% of the approximately US$ 45 billion 
commercial seed market (James, 2014), which is a 
formidable achievement, considering the very lim-
ited number of commercialized crops and traits. 
Relevant is also that farmers in developing coun-
tries touched approximately 50% of the economic 
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gains of the GM technology and that GM crops 
generated a provisional benefit of US$ 68.21 bil-
lion between 1996-2013 (Brookes and Barfoot, 
2015a) for growers of which 94.1% or more than 
16.9 million were smallholder and resource-poor 
farmers from developing countries (James, 2014).
 
Although impressive, these figures are less re-
markable when challenged with the statistics of 
800 million people around the world, or 78% of 
the world’s poor people, who live in rural areas 
and rely on farming, livestock, aquaculture, and 
other agricultural work for their subsistence (www.
worldbank.org/en/news/feature/2014/11/12/
for-up-to-800-million-rural-poor-a-strong-world-
bank-commitment-to-agriculture) and for whom 
the GM technologies do not satisfactorily reach 
the needs in the least developed countries. Al-
though more than half of the global GM crop area 
is located in developing countries, the major GM 
crops commercialized today, i.e. soybean, maize, 
and canola, except cotton, are grown on large 
farms in Latin America and do not match the in-
terests of most smallholder farmers in the least 
developed countries. Crops of relevance to mar-
ginal environments, such as millet (Pennisetum 
glaucum), groundnut (Arachis sp.), cowpea, com-
mon bean (Phaseolus vulgaris), chickpea (Cicer ari-
etinum), pigeon pea (Cajanus cajan), cassava, yam 
(Dioscorea batatas), and sweet potato, to name a 
few, have been mostly ignored by GM technology.
 
Because of their restricted trade, these so-called 
neglected underutilized crop species (NUCS) 
present little economic interest for commercial 
seed companies, but they have the potential to 
play an important role in the improvement of 
food security by contributing to food quality and 
dietary diversity. NUCS may also increase sustain-
ability of agriculture, because they are believed to 
be well adapted to niche-specific environments, 
such as marginal and harsh lands, and to need 
a low input. As such, NUCS can help mitigate the 
impact of climate change on food production. 
However, these crops have been abandoned by 
researchers and farmers in favor of major crops 
that are sometimes promoted even in less suit-
able areas (Chivenge et al., 2015). Moreover, the 
limited information on the genetic potential, 
agronomy, water requirements, and nutrition of 
NUCS remains a hindrance to their development 
and competitiveness. Therefore, actions have to 
be taken to overcome the constraints and obsta-
cles for the cultivation of NUCS in regions where 
the uncertain climatic future can hamper food 
security, including acceleration of research to im-
prove genetics and management as well as cul-
tural acceptability and marketing.
 
Biotechnology tools can quicken the genetic im-
provement of NUCS. The GM approach can be 
used to introduce directly the desired sustaina-
ble management and the valuable output traits 
into varieties well adapted to local growing con-
ditions. A major technological constraint is plant 
transformation that is critical for the development 
of biotech crops, for which GM techniques, such 
as transgenics, cisgenics, or by precision breed-
ing, are required in the developmental process. 
The lack of efficient transformation protocols and 
breeding programs for geographical niche crops 
is in blatant contrast with the continuous striv-
ing for simpler, more robust, and more efficient 
transformation protocols for crop species for in-
tensive agriculture.
 
There have been significant advances in the de-
velopment of GM crops that can deliver food with 
health benefits beyond basic nutrition and in tar-
geting small-market crops and a few NUCS for 
quality traits. These so-called second-generation 
traits will soon reach the market. The innovations 
coincide with an increasing consumer demand 
for healthy and nutritious food. The public sector 
shares a great deal of the research done in this field 
and public-private partnerships excel in translating 
the proof-of-concept to a marketable product.
 
Plant-made pharmaceuticals have become a ma-
jor focus point since 2010, when realistic oppor-
tunities for commercial development emerged. 
Plant-manufacturing platforms for pharmaceu-
ticals or molecular farming open interesting 
prospects for low-income countries, where large 
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quantities of medicines need to be provided on a 
regular basis. Cost-effective local focus and nee-
dle-free deployment can be of great help for the 
treatment of tropical diseases.
 
In the industrial sector, plant biotechnology has 
the potential not only to generate more produc-
tive biomass feedstocks and minimize inputs, but 
also to develop more efficient biofuels, chemicals, 
and bio-material conversion processes. A num-
ber of nonfood crops improved with sustainable 
management have gone through the regulatory 
process. Additionally several biochemical path-
ways are currently being explored for the devel-
opment of quality traits for the chemical industry 
and for phytoremediation (Ricroch and Hénard-
Damave, 2015).
 
Of the greatest technological gaps in the commer-
cialization of second-generation biofuels along 
with chemicals are the conversion processes that 
are costly, environmentally threatening, and time 
consuming. Advanced nonfood feedstocks have 
to be developed that can grow on marginal lands 
and simultaneously can decrease the costs of 
lignocellulosic biomass pretreatments. Numer-
ous projects are under consideration that aim at 
engineering lignin content and monomer compo-
sition to optimize lignin degradation (Harfouche 
et al., 2014).
 
Examination of the fast uptake of biotech crops 
on millions of hectares globally and of the current 
R&D pipelines impacting numerous plant species 
indicates that plant biotechnology will be a major 
tool to overcome the challenges of sustainabili-
ty and development. Developing and emerging 
economies have taken the lead in terms of adop-
tion of biotech crops and also in approvals of new 
transgenic crop varieties (James, 2014). As more 
actors become involved in R&D and more tech-
nologies are adapted and applied to new regions 
and local crops, the more developing countries 
will play a leading role in agricultural biotechnolo-
gy. In the near term, most of the developing world 
will continue to rely on development assistance 
and innovations, as well as on technology part-
nerships and joint ventures with companies from 
developed countries that look for access to large 
developing markets. However, as research capac-
ities increase, public sector institutes and private 
firms in emerging and low-income economies are 
likely to develop new biotech crops on their own. 
In the not too distant future, agricultural biotech 
research in developed countries could be sur-
passed in the same manner that production has 
already been.
 
The opportunities offered by plant biotechnolo-
gy have never been greater, but neither have the 
challenges been, among which the most daunt-
ing is public perception and its influence on the 
regulation of biotech crops. All GM crops are sub-
mitted to a rigorous battery of tests and regula-
tory scrutiny prior to commercialization. Typically, 
the properties of the GM crops are compared to 
those of the corresponding non-GM variety with 
respect to various potential risk factors. Such 
comparative analyses include agronomic, molec-
ular, compositional, toxicological, and nutritional 
assessments. Regulatory systems must ensure 
that all steps are in place to guarantee biosafe-
ty, but they must also ensure that none of these 
steps is unnecessary. Currently, the biggest con-
straint to commercialization of transgenic prod-
ucts is the regulatory delay, including, among oth-
ers, test repetition, slow review time, and requests 
by regulators for additional information, often not 
necessary to demonstrate safety, and lack of clar-
ity with respect to the regulatory requirements. 
Another source of delay is political interference 
in the biosafety regulatory process that hampers 
technologies developed by public-sector insti-
tutions or small private firms that, compared to 
large multinational corporations, have less finan-
cial flexibility to absorb the costs until the regu-
latory authority finally renders its decision (Bayer 
et al., 2010). Thus, the extensive time needed to 
complete a regulatory file may significantly reduce 
the net benefits of GM products.
 
The costs of compliance with biosafety regulation 
also deter low-income and emerging economies 
from considering GM technologies as a solution 
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to agricultural problems. Biotech developers 
must take into account not only the countries 
where the cultivation of the new biotech crops 
could take place, but also where the consump-
tion of such crops might ultimately occur. So, an 
emerging country that wants to export GM food 
to the developed world is confronted with regula-
tory frameworks that do not give it much latitude. 
Moreover, low-income and emerging economies 
will not be able to keep pace with the ever-chang-
ing regulatory requirements of the developed 
world and will clearly restrict their decision to ap-
ply GM technology.
 
Public perception of GM crops and food is influ-
enced by numerous factors, including access to 
information or misinformation, commercial ac-
tions by corporations, moral and ethical beliefs, 
and perceptions of personal benefit from the 
technology. Anti-GMO activists diffuse misinfor-
mation to uphold the belief that harm will come 
to those who consume foods made up of GM 
ingredients, heightening anxiety with the mass 
public as well as with public authorities (Blancke 
et al., 2015). This concerted opposition to GM 
crops resulted in a number of complex legal and 
regulatory issues that have halted cultivation and 
stymied plant research in Europe with disastrous 
consequences to the development of new crops 
varieties and their introduction to markets world-
wide. The best example is Golden Rice that has 
still not been approved for release in spite of its 
urgent need and readiness for well over a decade. 
Should concerns of this nature persist, R&D ef-
forts will probably be restricted to large agribusi-
ness corporations that will continue to focus on 
major intensive agriculture crops.
 
Nevertheless, there is no time to waste. The 
world’s overpopulation and the pressures on the 
Earth system require all the ingenuity human be-
ings can deliver. To ensure that the biotechnol-
ogies live up to the expectations, they will have 
to focus on the priorities that could slow, limit, or 
halt research and development, including neg-
ative public opinion and the lack of regulatory 
harmonization. Needless to say that markets and 
technology alone cannot promote the sustainable 
development of human societies. A deep trans-
formation of societal values in a holistic manner 
will be required that can only be achieved with 
strong political will.
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Abstract
Since the 1970s, biotechnology has influenced to 
the economic growth of many countries. In Brazil, 
the development of a national biotechnology pol-
icy occurred only in 2007. To date, the greatest 
biotechnological contribution in the country 
has undoubtedly been in the agribusiness sec-
tor, which is responsible for approximately 23% 
of Brazil’s Gross Domestic Product. Genetically 
modified (GM) crops, particularly soybean (Glycine 
max), maize (Zea mays), and cotton (Gossypium hir-
sutum), are the best examples of this biotechno-
logical application that increased between 3% and 
4% in 2014 (exceeding 42 million hectares), which 
is 4.6% higher than in 2013 and is the equivalent 
of 1.9 million hectares. Brazil harbors the second 
largest cultivated acreage of GM crops worldwide 
and a substantial growth is projected in the next 
few years. Currently, 50 transgenic events are au-
thorized for commercialization in Brazil, of which 
two, an imidazolinone-tolerant soybean and a 
golden mosaic virus-resistant common bean, are 
the direct outcome of national technology and 
public sector. Maize became the crop plant with 
the largest number of transgenic traits released 
in Brazil, accounting for 29 events and others in 
the pipeline for approval and commercialization, 
followed by cotton (12 events), and soybean (7 
events). The rapid increase in the adoption of GM 
crops results from the technical commission re-
sponsible for biosafety in Brazil, which is one of 
the most effective worldwide. Pest control, among 
other constraints in the agricultural sector, has 
been the subject of intense investigation by the 
Brazilian biotech sector and has received support 
from the public sector through the creation of 
programs for leveraging government and indus-
try partnerships.
Keywords: biotech crops, agribusiness, transgen-
ic plants, cotton, soybean, maize
Introduction
In the past two decades, innovation has played 
a pivotal role in economic development. The 
build-up of innovative technologies has been of 
foremost importance for successful and dynamic 
growth in developing countries (Organization for 
Economy Co-operation and Development, 2012). 
Advances and investments in biotechnology, in-
cluding those focused on health, agriculture, in-
dustry and the environment, are now crucial for 
any country to thrive on the global market.
Consequently, the application of biotechnology 
to various sectors and industries has increased 
exponentially. In 2014, 181.5 million hectares 
were grown with genetically modified (GM) crops 
worldwide in 28 countries, of which 20 devel-
oping countries and eight industrialized coun-
tries (James, 2014). Notably, approximately 53% 
(93.1 million hectares) of GM crops were pro-
duced in developing and emerging markets from 
Latin America, Asia, and Africa. The most culti-
vated transgenic crop in the world is soybean 
(Glycine max), representing over 50% of the to-
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tal transgenic crop area, followed by maize (Zea 
mays) and cotton (Gossypium hirsutum) (James, 
2014). A particular meta-analysis of the impacts 
of 147 commercialized transgenic crops over the 
last 19 adoption years (1995 to 2014) empha-
sized the multiple significant benefits generated 
by biotechnological (biotech) crops, including 
their contribution to a 37% reduction in chemical 
pesticide use, an 22% increase in crop yields, and 
a 68% increase in farmer profits (Klümper and 
Qaim, 2014).
Since the beginning of the 1970s, government 
institutions and agencies in Brazil, including Bra-
zilian Development Bank (BNDES), Brazilian Inno-
vation Agency (FINEP), National Counsel of Tech-
nological and Scientific Development (CNPq), and 
Brazilian Federal Agency for Support and Evalua-
tion of Graduate Education (CAPES), have invest-
ed in and provided support for the development 
of innovative products and processes in the coun-
try. An important step was the release of the Na-
tional Innovation Law in 2004 (Brasil, 2004). This 
legislation sought to encourage innovation within 
the public sector (particularly at universities) and 
to incite partnerships between academic institu-
tions and the private sector. Another initiative to 
coordinate the biotechnology policy was the cre-
ation of the National Biotechnology Committee 
to manage the implementation of government’s 
biotechnology policies (Brasil, 2007).
Recently, the Scientific American Worldview 
(http://www.saworldview.com/scorecard/ 
2 0 1 5 - s c i e n t i f i c - a m e r i c a n - w o r l d v i e w - 
overall-scores/) has released an overview of the 
performance of 54 nations in Biotechnology In-
novation, in which was aggregate performance 
in seven categories - Productivity, Intellectual 
Production Protection, Enterprise Support, In-
tensity, Education/Workforce, Foundations, and 
Policy & Stability. Overall, Brazil is in second posi-
tion among the Latin America’s countries, behind 
only the Chile, but even so several biotechnologi-
cal sectors must be better exploited, such as the 
related to biopharmaceutical products, once the 
country imports the great majority of medicines. 
Indeed, in the last two decades, Brazil has been 
a leader in the use of GM crops and in the de-
velopment of agricultural biotech products. In 
2014-2015, approximately 42.2 million hectares 
of biotech crops were under cultivation, unclud-
ing three major crops, maize, soybean and cot-
ton, at an adoption rate of 89.2% in the three 
cultures analyzed (Céleres, 2014; James, 2014; 
Céleres, 2015). Since 2009, the country ranks sec-
ond worldwide regarding the GM planted area, 
losing out to only the United States (73.1 million 
hectares), but Brazil was ahead of other BRIC 
countries, such as Russia and India, in terms of 
biotechnological advances.
Development of GM crops in Brazil
By 2020, the global population will reach ap-
proximately 7-8 billion people. Providing ade-
quate nutrition for all these people will be a great 
challenge, particularly in Asia, Africa, and Latin 
America, where the majority of the population 
is located. The intensification of food produc-
tion and distribution, associated with an increase 
in productivity and a reduction in agricultur-
al costs, are key factors to meet this challenge 
(www.worldometers.info/world-population).
Despite the production growth over the last 30 
years, pests continue to be the major causes 
of yield losses during the pre- and post-harvest 
periods (Carlini and Grossi-de-Sa, 2002; Ferry et 
al., 2006). Annually, the world average yield loss 
reaches approximately 42% (Paoletti and Piment-
el, 2000), resulting in a damage of up to US$ 250 
billion (Oerke et al., 2012). Even though more than 
2.5 million tons of pesticides are applied world-
wide, over 40% of the entire production is still 
lost prior to harvest by several pests, including 
insect pests and other phytopathogens (Grube 
et al., 2011; Ceresana Research, 2012). In con-
trast, the use of tolerant/resistant crop cultivars 
is considered the most efficient, cost-effective, 
and least environmentally damaging pest control 
method available.
Genetic engineering has enabled the generation 
of technologies that reduce losses and increase 
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crop yields. GM varieties provide improved farm-
ing practices and enhance the quantity and 
quality of agricultural commodities, boosting 
the farmers’ income and promoting economic 
growth. In the case of transgenic plants tolerant 
to herbicides or resistant to insects, management 
of invading plants and insects is facilitated and 
the application of pest-controlling substances is 
reduced. The available plants on the market that 
harbor both characteristics represent an efficient 
alternative for farmers. In addition to their agro-
nomic advantages, these varieties also favor the 
preservation of biodiversity.
The Brazilian Trade Balance in agribusiness has 
increased by 320% from US$ 25.90 billion in 2003 
to US$ 75.1 billion in 2015 (MAPA, 2015; Figure 1). 
This increase is higher than the overall Brazilian 
Trade Balance that went through many variations 
during the last decade, from US$ 46.46 billion in 
2006 to a deficit of US$ 3.9 billion in 2014 (MDIC, 
2013; MAPA, 2015). In 2014, the Brazilian Trade 
Balance closed with a surplus of US$ 5.5 billion 
for the agribusiness sector and in 2015, the ag-
ribusiness sector represented more than US$ 
391 billion of the country’s Gross Domestic Prod-
uct (GDP) (www.comexdobrasil.com/brasil-pro-
jeta-aumentar-em-us-20-bilhoes-as-exporta-
coes-do-agronegocio-ate-2018). The contribution 
of agribusiness to the Brazilian Export Balance 
is higher than any other sector in the country. In 
2013, 41.24% of the income from exports was re-
lated to agribusiness products (MDIC, 2013). Agri-
business is also responsible for the employment 
of approximately 35% of the working population 
of Brazil (Riedel, 2013; http://www.canaldoprodu-
tor.com.br/print/69844). Currently, Brazil holds 
7% of the global market for agricultural products 
and is expected to retain 10% of the global sector 
in 2018.
In the early 1990s, the first examples of the utili-
zation of GM crops in Brazil were controversial. At 
the time when farmers in the south of the country 
Figure 1. Brazilian trade balance from 1980 to 2015. Black and green bars correspond to the overall amount 
of Brazilian Trade Balance and the amount represented by the agribusiness in Brazil, respectively. Values 
are given in US$ Billion. Adapted from (MDIC, 2014; MAPA, 2015).
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started planting the first transgenic soybean, all 
transgenic seeds came from Argentina, because 
the cultivation and commercialization of GM 
crops in Brazil was approved only in 1995. Howev-
er, three years later, a “moratorium” on GM crop 
commercialization was established and upheld 
until 2003-2004. In 2005, after a broad political 
and social debate, a new regulatory framework 
resolved the legal conflicts, resulting in a new 
phase of plant biotechnology in Brazil. In fact, 
the number of commercial releases of transgen-
ic crops has significantly increased in Brazil after 
endorsement of this efficient and science-based 
approval system, known as the Biosafety Law.
In 2014-2015, approximately 42.2 million hec-
tares of GM crops were cultivated in Brazil, rep-
resenting a 4.6% increase compared to 2013 and 
an adoption rate of 89.2%, more specifically, of 
93.2% for GM soybean, 72.6% for GM summer 
maize, 90% for GM winter maize, and 65.1% for 
GM cotton (Céleres, 2014; James, 2014). Of the 
42.2 million hectares of the GM crop area, GM soy-
bean was cultivated on 29.1 million hectares (68% 
of the total area), followed by GM maize (summer 
and winter) covering 12.5 million hectares (29.6%) 
and by GM cotton with 0.6 million hectares, an in-
crease of 25.1% over 2013 (Céleres, 2014, 2015; 
James, 2014) (Figure 2).  According to projections, 
the GM planted crop area will increase by 3.9% 
in 2015-2016 compared to that in 2014-2015, 
reaching 44.2 million hectares and an adoption 
rate of 90.7% for three products, soybean, maize, 
and cotton (Céleres, 2015). The high growth 
of the biotech crop area in Brazil represents a 
consolidated adoption and a large contribution 
to the Brazilian GDP, equivalent to more than 
US$ 0.5 trillion.
Biotech maize is responsible for the greatest 
increase in farmers’ income (58%), followed by 
soybean (39%) and cotton (3-4%) (Céleres, 2012). 
Considering the enhanced demand for agricul-
tural products, it is clear that expansion of the 
agricultural production will be needed and that 
GM crops will play a major role. Brazil is expect-
ed to cultivate 16.2 million hectares of GM cotton, 
178.4 million hectares of GM maize and 293.0 mil-
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Figure 2. Biotech Cultivation area in Brazil. Black, green, and light-green bars correspond to the total area 
used for agriculture in Brazil, for GM crops, and for non-GM crops in Brazil, more specifically for the planta-
tion of cotton, maize, and soybean, respectively. In more than 89% of the total agricultural area transgenic 
plants are cultivated. Approximately 93.2%, 82.4%, and 65.1% of all soybean, maize, and cotton planted in 
Brazil are transgenic, respectively. (Adapted from CONAB, 2014; Céleres, 2014).
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lion hectares of GM soybean within the next ten 
years, reaching a production worth of US$ 118.2 
billion (Céleres, 2012). Furthermore, a high adop-
tion rate is foreseen for GM crops with combined 
traits (such as insect resistance [IR] and herbicide 
tolerance [HT]) that has recently been welcomed 
by Brazilian farmers. The use of single-trait tech-
nology is rapidly decreasing compared to stacked 
traits, with a considerable contribution from the 
IR/HT soybean commercialization. From the tech-
nological data farmers will obviously prefer the 
stacked traits to the single feature due to their 
significant benefits.
The potential offered through the adoption of GM 
soybean, maize, and cotton crops clearly show 
important economic and environmental gains for 
both farmers and society. The economic benefits 
of biotech crops in Brazil were evaluated to be 
US$ 24.8 billion for the periods from 1996-1997 
and 2012-2013 and US$ 6.3 billion for the 2013 
year alone (Céleres, 2013, 2014). Additionally, 
based on provisional data, an annual economic 
assessment of the value of the use of GM crop 
technology in agriculture at the farm level, cover-
ing the benefits from biotech crops over a 10-year 
period (2003-2013) revealed that Brazil gained 
US$ 11.8 billion and, of which US$ 3.4 billion in 
2013 alone (Brookes and Barfoot, 2015).
Soybean
In Brazil, soybean cultivation is intense and agricul-
ture is often associated with utilization of advanced 
technology and modern cropping systems. Hence, 
the first transgenic event authorized in Brazil was 
Roundup Ready (RR) from Monsanto, a GM soy-
bean with tolerance to the herbicide glyphosate, 
conferred by the transgenic event GTS 40-3-2 (CT-
NBio, 1998). Since the release of soybean RR for 
planting and commercialization in Brazil in 2003-
2004, the GM crop adoption rate rapidly increased 
and is currently approximately 93.2% with approx-
imately 85% of all soybean cultivars grown repre-
senting the RR technology.
Two other transgenic soybean events that were 
approved for commercial planting in 2010 are 
also herbicide resistant (A2704-12 and A5547-127 
[Liberty Link] of Bayer SA) and show tolerance to 
glyphosinate ammonia (GA) (Table 1), with the ad-
vantage of high degradability and low toxicity to 
animals and the environment. Soil microorganisms 
rapidly degrade the glyphosate herbicide by using 
the molecule as a nitrogen source and releasing 
phosphorus and CO2 (CTNBio, 2010a, 2010b).
 
In the same year, the MON87701 & MON89788 
(Monsanto) event, which confers both tolerance 
to the herbicide glyphosate and resistance to 
insects, was approved for commercial planting. 
Both features were derived from crosses ob-
tained by classical breeding by means of already 
genetically modified parentals containing either 
of the transgenic events (CTNBio, 2010c). In 2011, 
15 different cultivars that contained this event 
were planted in the country.
In 2009, a new IR GM soybean event (BPS-
CV127-9, known as Cultivance™), developed 
through a partnership between the Brazilian gov-
ernment company (Empresa Brasileira de Pesqui-
sa Agropecuária [EMBRAPA]) and the private com-
pany Badische Anilin- und Soda-Fabrik (BASF) was 
approved for commercialization. This transgenic 
event was obtained by insertion into soybean of 
the Arabidopsis thaliana csr1-2 gene. This csr1-
2 gene encodes an acetohydroxy acid synthase 
protein conferring tolerance to imidazolinone 
herbicides due to a point mutation that results in 
a single amino acid substitution; the serine resi-
due at position 653 was replaced by asparagine 
(S653N). The Cultivance™ soybean event is the 
first GM soybean developed in partnership with 
a national research institution and is expected 
to be commercialized in Brazil in 2016. Recently, 
another soybean event has been approved, DAS-
68416-4 from Dow Agrosciences, with both IR 
and HT traits (CTNBio, 2015a). Currently, at least 
two other events are in the pipeline that contain 
genes coding for HT proteins and/or stacked 
traits (Coelho, 2013, 2015; CTNBio, 2015a).
The release of different events for the same trait 
is a strategic measure, because it contributes 
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Plant Company Event Commercial Name Regulatory  
Approval 
(Year)
Transgene Product Insect  
Resistance
Herbicide 
Resistance
Other 
Features
Soybean Monsanto 
Company
GTS-40-3-2 Roundup Ready™ Soybean 1998 / 2003 CP4 EPSPS* X
MON87701 & 
MON89788
Intacta™ RR™ 2 Pro 2010 CP4 EPSPS*; Cry1Ac X X
BASF & 
 Embrapa
BPS-CV-127-9 Cultivance™ 2009 CSR-1-2* X
Dow 
 Agroscience
DAS68416-4 Enlist™ Soybean 2015 AAD-12*; PAT* X X
Bayer 
 CropScience
A5547-127 Liberty Link™ Soybean 2010 PAT* X
A2704-12 Liberty Link™ Soybean 2010 PAT* X
Maize Monsanto 
Company
MON810 YieldGard™, MaizeGard™ 2007 Cry1Ab X
NK603 Roundup Ready™ 2 Maize 2008 CP4 EPSPS* X
NK603 & 
MON810
YieldGard™ CB + RR 2009 CP4 EPSPS*; Cry1Ab X X
MON89034 YieldGard™ VT Pro 2009 Cry1A.105; Cry2Ab2 X
MON89034 & 
NK603
Genuity® VT Double Pro™ 2010 CP4 EPSPS*; Cry1A.105; 
Cry2Ab2
X X
MON88017 Yield Gard™ VT™ Rootworm™ 
RR2
2010 CP4 EPSPS*; Cry3Bb1 X X
MON89034 & 
MON88017
Genuity® VT Triple Pro™ 2011 CP4 EPSPS*; Cry1A.105; 
Cry2Ab2; Cry3Bb1
X X
NK603 & T25 Roundup Ready™ Liberty 
Link™ Maize
2015 CP4 EPSPS*; PAT* X
Bayer 
 CropScience
T25 Liberty Link™ Maize 2007 PAT* X
Syngenta 
Seeds, Inc.
Bt11 Agrisure™ CB/LL 2008 PAT*; Cry1Ab X X
GA21 Roundup Ready™ Maize, 
Agrisure™ GT
2008 mEPSPS* X
Bt11 & MIR162 & 
GA21
Agrisure™ Viptera™ 3110 2010 mEPSPS*; Cry1Ab; 
Vip3Aa20*
X X
Bt11 & GA21 Agrisure™ GT/CB/LL 2009 PAT*; mEPSPS*; Cry1Ab X X
MIR162 Agrisure™ Viptera™ 2009 Vip3Aa20* X
MIR604 Agrisure™ RW 2014 mCry3A* X
Bt11 & MIR162 & 
MIR604 & GA21
Agrisure™ Viptera™ 3111, 
Agrisure™ Viptera™ 4
2014 Cry1Ab; mCry3A*; 
Vip3Aa20*; mEPSPS*; 
PAT*
X X
Dow 
 Agrosciences
DAS-40278-9 Enlist™ Maize 2015 AAD-1* X
DuPont TC1507 & NK603 Herculex™ I RR 2009 CP4 EPSPS*; PAT*; 
Cry1F
X X
MON810 & 
TC1507 & NK603
Power Core™ 2011 CP4 EPSPS*; PAT*; 
Cry1Ab; Cry1F
X X
TC1507 & 
MON810
TC1507Xmon810 2011 PAT*; Cry1Ab; Cry1F X X
TC1507 & 
MON810 & 
MIR162
Not available 2015 Cry1Ab; Cry1F; 
Vip3Aa20*; PAT*
X X
MON810 & 
MIR162
Not available 2015 Cry1Ab; Vip3Aa20* X
MIR162 & NK603 Not available 2015 Vip3Aa20*; CP4 EPSPS* X X
MIR162 & TC1507 Not Available 2015 Cry1F; Vip3Aa20*; PAT* X X
TC1507 & MIR162 
& NK603
Not available 2015 Cry1F; Vip3Aa20*; PAT*; 
CP4 EPSPS*
X X
Table 1. Genetically Modified Crops Approved for Commercialization in Brazil.
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*  Abbreviations: 2mEPSPS: 5-enolpyruvyl shikimate-3-phosphate synthase enzyme (double mutant version); AAD-1: aryloxyalkanoate 
 dioxygenase 1 protein; AAD-12: aryloxyalkanoate dioxygenase 12 protein; AC1: sense and antisense RNA of viral replication protein, i.e., 
no functional viral replication protein is produced; CEL1: CEL1 recombinant protein; CP4 EPSPS: 5-enolpyruvylshikimate-3-phosphate 
synthase enzyme from CP4 Agrobacterium tumefaciens strain; CSR-1-2: modified acetohydroxyacid synthase large subunit (AtAHASL); 
mCry3A: modified Cry3A; mEPSPS: modified 5-enolpyruvylshikimate-3-phosphate synthase enzyme; PAT: phosphinothricin N-acetyltrans-
ferase enzyme; Vip3Aa20: vegetative insecticidal protein.
1 Resistance to virus 
2 Volumetric increase of wood.
Plant Company Event Commercial Name Regulatory  
Approval 
(Year)
Transgene Product Insect  
Resistance
Herbicide 
Resistance
Other 
Features
TC1507 & 
MON810 & 
MIR162 & 
MON603
Not available 2015 Cry1Ab; Cry1F; 
Vip3Aa20*; CP4 EPSPS*; 
PAT*
X X
TC1507 & 
MON810 & 
NK603
Optimum™ Intrasect 2015 Cry1Ab; Cry1F; CP4 
EPSPS*; PAT*
X X
DuPont & Dow 
Agrosciences
TC1507 Herculex™ I, Herculex™ CB 2008 CP4 EPSPS*; Cry1Ab X X
TC1507 & DAS-
59122-7
Herculex™ XTRA 2013 PAT*; Cry1F; Cry34Ab1; 
Cry35Ab1
X X
Monsanto 
& Dow 
 Agrosciences
MON89034 & 
TC1507 & NK603
Power Core PW/Dow 2010 CP4 EPSPS*; PAT*; 
Cry1A.105; Cry2Ab2; 
Cry1F
X X
Cotton Monsanto 
Company
MON531 Bollgard™ I 2005 Cry1Ac X
MON1445 Roundup Ready™ Cotton 2008 CP4 EPSPS* X
MON531 & 
MON1445
Bollgard™ I Roundup Ready™ 
Cotton
2009 CP4 EPSPS*; Cry1Ac X X
MON15985 Bollgard™ II 2009 Cry1Ac; Cry2Ab X
MON88913 MON88913-8 2011 CP4 EPSPS* X
MON15985 & 
MON88913
Bollgard™ II Roundup Ready™ 
Flex™ Cotton
2012 CP4 EPSPS*; Cry1Ac; 
Cry2Ab2
X X
Bayer 
 CropScience
LLCotton25 Fibermax™ Liberty Link™ 
Cotton
2008 PAT* X
GHB614 GlyTol™ 2010 2mEPSPS* X
T304-40 & 
GHB119
TwinLink™ 2011 PAT*; Cry1Ab; Cry2Ac X X
GHB614 x T304-
40 & GHB 119
GlyTol™ TwinLink™ 2012 2mEPSPS*; Cry1Ab; 
Cry2Ac
X X
GHB614 & LLCot-
ton25
GlyTol™ Liberty Link™ Cotton 2012 2mEPSPS*; PAT* X
Dow 
 Agrosciences
281-24-236 & 
3006-210-23
WideStrike 2009 PAT*; Cry1Ac; Cry1F X X
Bean Embrapa Embrapa 5.1 Embrapa 5.1 2011 AC1 (sense and anti-
sense) *
X1
Eucalyptus FuturaGene H421 Not Available 2015 CEL1* X2
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to both increased food security and agronomic 
productivity. The use of HT varieties with differ-
ent action mechanisms provides farmers with an 
improved way to manage resistant weeds due to 
selective pressure.
Maize
Brazil is the third largest producer and exporter 
of maize worldwide, after the United States and 
Argentina, but is only the fourth in terms of culti-
vation area of GM maize, surpassed by the United 
States, Canada, and Chile (www.gmo-compass.
org/eng/agri_biotechnology/gmo_planting/341.
genetically_modified_maize_global_area_under_
cultivation.html). In Brazil, the main insect pests 
of maize are caterpillars, including the fall army-
worm (Spodoptera frugiperda), the corn earworm 
(Helicoverpa zea), and the sugarcane borer (Di-
atrea saccharalis), which is also a corn pest. These 
insect pests cause crop losses of up to 35% and 
require dozens of insecticide applications for ef-
fective control during a culture cycle (Gallo et al., 
2002; Caccia et al., 2014).
As protection against these typical losses, Mon-
santo, Bayer, and Syngenta released three GM 
maize events in Brazil in 2007 (Table 1). MON810 
(YieldGuard™) from Monsanto of Brazil Ltd. was 
developed with a cry1Ab gene derived from the 
bacterium Bacillus thuringiensis that encodes the 
Cry1Ab protein (Bt protein) that is toxic to insects 
of the order Lepidoptera (CTNBio, 2007a). In 
2011, Brazil recorded 113 cultivars modified with 
the MON810 event.
The Bayer Company released the event T25 (Lib-
erty Link™) with the pat gene that provides trans-
genic maize crops with tolerance to herbicides, 
but a court ruling temporarily annulled the com-
mercial approval. In 2010, a new ruling definitively 
confirmed the approval for the whole country (CT-
NBio, 2007b) (Table 1).
In 2008, Syngenta Seeds Ltd. obtained approval 
for the commercial launch of the BT11 event, an 
IR maize obtained by the introduction of a genetic 
construct containing an insecticidal Btk gene and 
the pat gene as a selection marker. The Btk gene 
was obtained from B. thuringiensis var. kurstaki 
that encodes the Cry1Ab protein and confers re-
sistance to S. frugiperda, H. zea, and D. saccharalis 
(CTNBio, 2008a).
The need to increase the insect resistance with 
the pyramiding strategy while keeping the her-
bicide tolerance led Dow Agrosciences Seeds & 
Biotechnology of Brazil to partner with DuPont 
of Brazil to release improved transgenic corn 
events. In 2008, the commercial maize Herculex™ 
(TC1507) was approved in Brazil. The previous 
event included the pat and cry1f genes that pro-
vide tolerance to herbicides and resistance to in-
sects, respectively (CTNBio, 2008b).
In 2013, the GM maize, commercially denominat-
ed Herculex™ XTRA (TC1507 & DAS-59122-7), in-
cluded the produced PAT protein, responsible for 
the increased in herbicide tolerance and three Bt 
toxins (Cry1F, Cry34Ab1, and Cry35Ab1). Whereas 
Cry34Ab1 and Cry35Ab1 were involved in plant 
defense against coleopteran insects, Cry1F con-
trolled lepidopteran pests (CTNBio, 2013). This 
event was approved for commercialization after 
the successful partnership between Dupont and 
Dow Agrosciences.
The partnership between Dow Agrosciences and 
Monsanto of Brazil created MON89034 & TC1507 
& NK603 (Power Core PW/Dow). Released in 2010, 
it included the produced CP4 EPSPS and PAT pro-
teins to increase tolerance to glyphosate, togeth-
er with three Bt toxins (Cry1Ac.105, Cry2Ab2 and 
Cry1F) that significantly enhanced the resistance 
against S. frugiperda (CTNBio, 2010d) (Table 1).
In 2014, Syngenta Seeds Inc. released two trans-
genic corn events in Brazil: MIR604 and a combina-
tion of Bt11 & MIR162 & MIR604 & GA21 (CTNBio, 
2014). Whereas MIR604 (commercially known as 
Agrisure™ RW) displayed resistance against insects 
by expressing the mCry3A protein, the other event 
showed both herbicide tolerance and insect resist-
ance by expressing five foreign proteins, Cry1Ab, 
mCry3A, Vip3Aa20, mEPSPS, and PAT (Table 1).
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By 2015, maize is the crop with the largest num-
ber of transgenic traits released in Brazil, total-
ing 29 different events. Until 2014, Monsanto in 
Brazil Ltd. had the largest number of approved 
events, but in 2015, Brazilian DuPont (a division of 
Pioneer Seeds) released seven new events, all in-
volving insect resistance and herbicide tolerance 
(CTNBio, 2015b, 2015c). In the same year, Mon-
santo of Brazil Ltd. issued only one new event for 
herbicide tolerance (Table 1) (CTNBio, 2015d) and 
Dow Agrosciences a new GM corn, DAS-40278-9, 
commercially known as Enlist™, with increased 
tolerance to herbicides (CTNBio, 2015e).
Cotton
In terms of planted area, cotton is the third bio-
tech crop in Brazil, covering an estimated area of 
0.6 million hectares that represent over 65% of 
a total planted area of the 0.9 million hectares in 
2014-2015 (www.abrapa.com.br/estatisticas/Pa-
ginas/area-producao-produtividade-brasil.aspx; 
James, 2014; Pispini et al., 2014). Approximately 
23.6% of the transgenic cotton cultivated in Bra-
zil is tolerant to herbicides, 31.2% is resistant to 
insects, and 10.3% contains both traits. Most cot-
ton cultivation is located in the Midwest (approx-
imately 60%) and northeast (approximately 36%) 
regions of the country, particularly in the states 
of Mato Grosso, Bahia, and Goiás (Céleres, 2014; 
James, 2014; Pispini et al., 2014). 
The first approved transgenic cotton was the vari-
ety Bollgard™ I (event MON531) in 2005 that con-
fers resistance to the leaf worm (Alabama argilla-
cea), the pink bollworm (Pectinophora gossypiella), 
and the apple caterpillar (Heliothis virescens). By 
means of the commercial variety Coker 312, Mon-
santo introduced the gene encoding the Bt toxin 
Cry1Ac into the vector PV-GHBK04 and trans-
formed cotton plants via Agrobacterium tumefa-
ciens. The produced protein provided increased 
resistance against the three pests (CTNBio, 2005).
Three years later, Monsanto released the event 
MON1445 (Roundup Ready™), while Bayer simul-
taneously created LLCotton25 (Liberty Link), both 
of which are herbicide-tolerant GM cotton (Table 
1) (CTNBio, 2008c, 2008d). In 2009, events with 
both traits – tolerance to herbicide and resistance 
to insect pests – arrived on the market with two 
different releases: Bollgard™ I + Roundup Ready™ 
(RR) from Monsanto and WideStrike from Dow 
Agrosciences (Table 1) (CTNBio, 2009a). Where-
as Monsanto fused both proteins used in Boll-
gard™ I and RR (Cry1Ac and CP4 EPSPS) cotton, 
Dow Agrosciences introduced the first transgenic 
cotton with Cry1F protein, in addition to Cry1Ac 
and PAT proteins. Pyramiding of the Cry toxins al-
lowed an extension of the activity against insect 
pests, because the attacks of additional pests, 
such as Helicoverpa zea, Spodoptera frugiperda, 
Spodoptera exigua, Spodoptera eridania, Pseudo-
plusia includens, and Trichoplusia ni, could be con-
trolled as well (CTNBio, 2009b).
To date, 12 events of transgenic cotton have been 
approved for cultivation and commercialization in 
Brazil (Table 1), two of which provide insect resist-
ance, five increase herbicide tolerance, and the 
other five present both traits. Since 2005, cotton 
production and productivity have increased (al-
though varying over the years) and are expected 
to keep growing, because the amount of cultivat-
ed GM cotton continues to expand in Brazil.
Common beans
Brazil is the largest producer of beans in the 
world, with a production of 3.3 million tons per 
year, ahead of India (3.0 million tons), China (1.9 
million tons), and Mexico (1.3 million tons) (CON-
AB, 2013; www.almanaquedocampo.com.br/
verbete/exibir/89). The most common species 
cultivated in Brazil are Phaseolus vulgaris (com-
mon bean), which is found all over the Brazilian 
territory, and Vigna unguiculata (cowpea), which 
is mainly cultivated in the Amazon and northeast 
regions. Bean cultivation extends to all states of 
Brazil as a single system or intercalated with oth-
er crops. Previously considered a subsistence 
crop in small properties, the common bean is 
now adopted in production systems that require 
the use of intensive technologies, such as irri-
gation, pest control, and mechanical harvesting 
(Salvador, 2012).
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As a traditional food, beans are one of the main 
components of the Brazilian diet and are con-
sumed in large quantities. The grains of this leg-
ume represent an important source of protein, 
iron, and carbohydrates, particularly for popu-
lations from developing tropical and subtropical 
countries (http://www.agricultura.gov.br/vegetal/
culturas/feijao/saiba-mais). 
In addition to this high demand, another reason 
for the increase in bean import is the supply main-
tenance due to the losses caused by pathogens 
and pests. Many diseases affect the common bean 
that, in addition to yield reduction, also depreciate 
the quality of the product. These diseases may be 
of fungal, bacterial, or viral origin. The golden mo-
saic virus is one of the most devastating diseases 
of the common bean in several Brazilian states. It 
is economically important in the south of Goiás 
and Minas Gerais, as well as in the northern part of 
Paraná and Mato Grosso do Sul. This virus is capa-
ble of causing 100% yield losses, depending on the 
region and infection time. The symptoms become 
apparent in the infected plants when two to four of 
the trifoliate leaves start to develop a yellowish color 
(Wendland, 2011).
Although a number of techniques have been test-
ed and used to control the virus, there is an ur-
gent need to develop more efficient strategies for 
disease control. Hence, in 2011, EMBRAPA creat-
ed the world’s first GM common bean. It was also 
one of the world’s first examples of a transgenic 
crop that was completely developed by a public 
institution (CTNBio, 2011). Ten institutions con-
tributed, including four universities, six EMBRAPA 
units from four different states, and the Federal 
District. The GM event, designated Event 5.1, was 
generated with the RNA interference (RNAi) strat-
egy and was obtained through the insertion of 
transgenes into the nuclear genome of the bean 
through a biolistic technique (Aragão et al., 1996). 
The cultivation of transgenic beans will be an im-
portant tool for the control of the golden mosaic 
virus, not only in Brazil, but also in other coun-
tries that suffer from the disease, including India, 
Myanmar, China, the USA, and Mexico.
Eucalyptus
In Brazil, 7.6 million hectares were used for plant-
ing trees, a 2.8% increase compared to 2012 (7.39 
million hectares). Eucalyptus (Eucalyptus) spe-
cies represent 72% of all trees planted in Brazil 
and 20.7% correspond to pine (Pinus sp.) trees. 
Approximately 81% of the eucalyptus produced 
in the country, or more than 180 million m³, 
is converted into cellulose and paper (ABRAF, 
2010; Indústria brasileira de árvores [www.iba.
org]). The commercialization of eucalyptus for 
the production of cellulose, paper, laminate 
flooring, and charcoal contributed to 6% of 
the Brazilian Sectorial GDP in 2013 (approxi-
mately US$ 20.7 billion) (www.iba.org). Several 
areas are dedicated to eucalyptus plantations 
and 2% of all of the locally planted area are 
found in the State Minas Gerais. The city of 
Itamarandiba is one of the largest eucalyptus 
producers in Brazil (ABRAF, 2010). Consider-
ing the global market, Brazilian participation in 
forestry production represents 2%. The coun-
try occupies the 11th position in global paper 
production, representing 2.2% of this market 
(http://bracelpa.org.br/bra2/?q=en/node/228) 
and the 7th position in the global cellulose 
production market, corresponding to 4.2% of 
the country’s participation in this sector. How-
ever, Brazil’s largest market in the eucalyptus 
sector is in the lumber trade. With a partici-
pation of 4.3% in the global production, the 
country occupies the 5th position in this sector 
(http://bracelpa.org.br/bra2/?q=en/node/228).
Brazilian eucalyptus presents a strong potential 
for expansion in the international market over the 
next few years. Therefore, in 2015, the first GM 
eucalyptus (H421) from FuturaGene Brazil Tech-
nology, a company associated with the National 
Research and Development Association of Inno-
vative Companies (ANPEI) was approved in Bra-
zil. The new eucalyptus event aims at improving 
wood production by producing a protein capable 
of enhancing the volume of tree trunks (CTNBio, 
2015f). This approval provided a new vision for 
Brazil as a pioneer in the release of GM eucalyp-
tus for commercial purposes.
45
Biosafety risk assessment -  
the Brazilian case
The use of GM crops in agriculture has exponen-
tially increased during the last decade. The high 
adoption rate is thought to reflect the growing 
benefits and satisfaction for the whole food pro-
duction chain, but public and scientific concerns 
have arisen regarding the environmental impact 
and safety of GM crops. Therefore, each country 
has created a legal framework to evaluate the bi-
osafety and, sometimes, other possible effects of 
commercialization, including social and economic 
issues. Thus, in many countries, including Brazil, 
before GM crops are authorized for commer-
cial purposes, national authorities conduct risk 
analysis procedures, which vary from one country 
to another.
Risk analysis includes three main components: 
risk assessment, risk management, and risk com-
munication (Figure 3). Risk assessment can be de-
fined as the identification of potential health or 
environmental hazards (adverse effects) and the 
determination of the probability that an identi-
fied hazard will occur (Organization for Economy 
Co-operation and Development, 2012). There-
fore, biosafety, comprising health and environ-
mental issues, is evaluated by risk analysis.
Risk management can be defined as the meas-
ures that must be taken to minimize or mitigate 
a potential hazard or adverse effect that has 
been identified in the risk analysis (including 
monitoring/surveillance) (Organization for Econ-
omy Co-operation and Development, 2012). Risk 
management also includes the process of weigh-
ing policy alternatives in the light of the risk as-
sessment results and other relevant evaluations 
(Johnson et al., 2007). Risk communication is 
the interactive exchange of information and sci-
ence-based opinions concerning risk among risk 
assessors, risk managers, consumers, and other 
stakeholders (Johnson et al., 2007).
Therefore, risk analysis constitutes an ample ac-
tivity that considers the information concerning 
Figure 3. Risk analysis flowchart, including risk assessment, management, and communication (adapted 
from Wolt et al., 2010). The biosafety risk assessment for commercial release of GM organisms is conducted 
by the Brazilian Technical Council of Biosafety (CTNBio), the Internal Commission of Biosafety (CIBio), and 
the National Council of Biosafety (CNBS). The members of CIBio and CTNBio are chosen by the Minister 
Chief of Staff, under major authorization by the President of Brazil (upper right corner).
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the risks to health and the environment (obtained 
during the risk assessment), as well as the eco-
nomic, political, moral, and ethical issues. In Brazil, 
risk assessment is conducted exclusively by the 
Brazilian National Biosafety Technical Commis-
sion (CTNBio), whereas the social and economic 
aspects of the commercialization are analyzed 
separately by a Council of Ministers, the National 
Council on Biosafety (CNBS) (Brasil, 2005; Nord-
ström, 2015), because the social and economic 
impacts related to the commercialization of GM 
products often require evaluations that are dif-
ferent from those involving risks to health and 
the environment.
In Brazil, CTNBio is composed of scientific spe-
cialists with Ph.Ds in biosafety, biotechnology, en-
vironment, biology, and human or animal health, 
whereas CNBS comprises only ministers, who have 
the state legitimacy to assess issues that may have 
socio-economic impacts in the country. This sepa-
ration minimizes the eventual ideological influenc-
es on the decision-making process and makes the 
Brazilian biosafety system pragmatic and efficient.
As a matter of fact, since this regulatory frame-
work was approved in 2005 by the 11.105 Law 
(Brasil, 2005), approval for the use of GM events 
in Brazil has rapidly increased, with 50 varieties of 
GM maize, cotton, soybean, common bean, and 
eucalyptus authorized for commercialization to 
date (Figure 4). Consequently, with the adoption 
of biotechnology in the field, more than 89% of 
the cultivars are now represented by transgenic 
plants (Figure 2). In addition to the use of trans-
genic plants for agriculture, Brazil is also investing 
in GM vaccines, diagnostic tests, and the produc-
tion of enzymes, hormones, and biofuels, some of 
which are produced as recombinant proteins in 
transgenic plants.
Figure 4. Number of events of GM crops approved by CTNBio for commercial release in Brazil. After the 
Biosafety Law (Brazil, 2005), the number of authorized varieties started to increase. (Adapted from Paes de 
Andadre et al., 2012;  CTNBio, 2015).
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Conclusions
The 2013-14 season marks the 10th anniversary of 
the use of the first GM seeds in Brazil. The coun-
try’s farmers now cultivate 50 biotech crop vari-
eties, including soybean, maize, cotton, common 
bean, and eucalyptus. Following the commer-
cial release of the golden mosaic virus-resistant 
bean developed by researchers from EMBRA-
PA, the Institution is now working in partnership 
with other countries, including Japan, on several 
drought-tolerant cultivars, such as soybean, cot-
ton, sugarcane (Saccharum officinarum), maize, 
and common beans (Ruane, 2013). EMBRAPA 
plays an important role in the development and 
future release of GM crops in Brazil, in collabo-
ration with international private companies and 
research institutions.
Moreover, other GM crop plants with differ-
ent traits, including GM rice (Oryza sativa) with 
increased yield, GM wheat (Triticum sp.) with 
drought stress tolerance (MAPA, 2013), and GM 
cotton with insect and nematode resistance, are 
also being developed in Brazil. Field trials of IR and 
HT GM sugarcane and GM Sorghum (Sorghum sp.) 
with increased sugar accumulation and biomass 
production will also be approved for cultivation in 
Brazil within the next few years.
In the last decade, the adoption of GM crops has 
produced considerable advances in crop manage-
ment and productivity, which have been accom-
panied by a remarkable change in the agricultural 
sector in Brazil that makes it a very competitive 
market, due to the arrival of large corporations. 
Consequently, a scaffold of knowledge protection 
and an enhanced openness of public institutions 
toward the private sector have become necessary 
(Lopes et al., 2012).
The majority of the Brazilian territory lies in the 
tropics, with unique soil and climate characteris-
tics, intense biotic and abiotic stresses, complex 
farming structures, and diverse patterns of tech-
nological infrastructure and logistics. Thus, inno-
vation in genetics and plant breeding to develop 
improved seeds and adapted production systems 
will be crucial for the country, particularly consid-
ering the increase in food demand in the predict-
ed scenarios of climate change (Assad et al., 2008; 
Lopes et al., 2012).
Thus far, the interrelationship between Brazilian 
entrepreneurial farming and agricultural research 
has resulted in the rapid implementation of trans-
genic crops, with clear benefits of their use.  Over 
the next decade, new varieties of sugarcane, cit-
rus (Citrus sp.), eucalyptus, and GM crops with 
traits such as resistance to both nematodes and 
insects, tolerance to other herbicides, and toler-
ance to water stress and saline soils are expect-
ed to arrive on the market. The future also points 
toward the creation of transgenic plants harbor-
ing enhanced nutritional properties or producing 
drugs. A prerequisite for these advances will be 
the continued strengthening of the strategic part-
nerships between public and private institutions.
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Abstract
The story of genetically modified (GM) crops in 
Argentina is still unfolding and is one the world 
has paid close attention for over the last 18 years. 
Currently, the country ranks third, behind the 
United States of America and Brazil, in GM crop 
area at the world level. The economic impacts of 
the introduction of GM technologies in Argentina 
have been very important. A key factor has been 
the occurrence of a strong synergy between her-
bicide-tolerant soybean (Glycine max) and no-till 
farming practices. The cumulative gross benefits 
resulting from the use of GM crops from 1996 to 
2010 have been estimated at US$ 72.65 billion. 
During that same period, 1.8 million jobs have 
been created as an indirect consequence of the 
introduction and adoption by farmers of agri-
cultural GM technologies. Thanks to the imple-
mentation of these new technologies, the global 
supply has been estimated to increase by 216.1 
million tons over these 15 years. The benefits 
from this supply shock have spilled over to world 
consumers, generating savings in food expendi-
tures estimated at US$ 89.0 billion. The case of 
GM crops in Argentina has been, undoubtedly, 
one of success. Long-term sustainability of these 
production systems as well as a number of insti-
tutional issues need to be assessed if the country 
is to consolidate this achievement.
Introduction
Research and Development (R&D), defined as 
new knowledge created and applied to increase 
the quantity and/or quality of biomass produced 
by human intervention, has driven progress in 
agriculture throughout history. In many countries 
with a long-standing tradition as export of agricul-
tural commodities, productivity gains attributable 
to changes in technology have been higher in ag-
riculture than in any other sector for a good part 
of the 20th century. That has been the case, for 
instance, in the United States of America (USA), 
until the advent of the digital era with computer, 
communication, and information technology.
The unavoidable increase in the demand for safe 
and good-quality food of a growing population, 
which is foreseen to reach 9 billion in 50 years, 
will challenge science and technology applied to 
agriculture. Both the attention and hopes of the 
world are focused on countries and regions with 
large food surpluses, that is, the biggest players 
in the international market of agricultural prod-
ucts. Nevertheless, in the less developed nations, 
the key factors that determine the advances in 
agricultural development, have implications in 
the very sensitive issue of food security for urban 
consumers, in the improvement of the farmers’ in-
come, and in an overall prospect of poverty allevi-
ation thanks to the availability of more affordable 
and safe food. As farmers are price takers, their 
income is tied directly to the yield of the products 
under their control. It is in this context that the 
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role of genetically modified (GM) crops in reshap-
ing the world agriculture will be described in this 
chapter. Argentina’s experience offers concrete 
evidence of the full expression of its potential and 
of the key role played in this story by a respon-
sible and effective institutional environment. This 
chapter is based on two reports (Trigo et al., 2009; 
Trigo, 2011) and looks into the impacts of availa-
bility and adoption of GM crops in that country, 
emphasizing both the benefits for the domestic 
economy and for the global consumers. In addi-
tion, some of the noneconomic advantages will be 
analyzed, resulting from the adoption of the GM 
technology by the farmers of Argentina, and some 
of the underlying drivers behind this process will 
be discussed briefly.
Evolution of the Argentinean agriculture
The history of agriculture in Argentina over the 
last century is one that shows a positive long-
term trend regarding the area planted with grains 
and oilseeds (Figure 1). Between 1900 and 2008, 
this area increased more than five-fold, from 5 to 
almost 28 million hectares. A strong growth took 
place in the first three decades, driven mostly 
by mechanization, which implied a capital-driv-
en process. Both the Great Depression and the 
restrictive domestic policies induced later a de-
crease in investments in the sector, all severely 
reducing the cultivated land from 18 million hec-
tares in 1940 to approximately 10 million in 1950. 
In the 1960s, thanks to the Green Revolution, the 
improved dwarf wheat (Triticum sp.) varieties and 
the high-yielding hybrid maize (Zea mays) turned 
out to be two major technological milestones that 
steered a renewed innovation-based productivity 
growth cycle unabated ever since. In 1991, no-till 
farming (NTF) started to be massively adopted. 
NTF consists basically on sowing of seeds at the 
required depth with a minimum disturbance of 
the soil structure. This is achieved through the 
use of specially designed machinery to elimi-
nate the need for plowing and other previously 
required tillage practices. In 1996, the first GM 
herbicide-tolerant (HT) soybean (Glycine max) va-
rieties were available. These GM crops induced 
a synergy with NTF of such a magnitude that it 
surpassed all expectations, vastly outperforming 
even its counterparts in the USA, the center of or-
igin of both technologies.
As further evidence of the importance of innova-
tion and technology in the history of agriculture 
in Argentina, Figure 2 shows how both labor and 
land productivity have evolved between 1908 
and 2007. In 1908, Argentina was already a ma-
Figure 1. Evolution of the area planted with grains and oilseeds in Argentina (1900-2008) (Cap, 2012).
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jor player in international agricultural commodity 
markets: each farm worker produced 7.5 tons of 
grains and oilseeds and one hectare of land yield-
ed one ton of products. A century later, 58.2 tons 
of grains and oilseeds were produced per farm 
worker with a yield of 3.14 tons per hectare. 
A study on the sources of the growth in the Ar-
gentinean farm sector (Lema, 2010) has con-
firmed the overwhelming preeminence of tech-
nical change among them (Figure 3). From 1963, 
approximately the start of the second wave of 
sustained expansion, to 2009, the agricultural 
sector recorded a growth of over two-thirds due 
to increases in the total productivity factor (TPF), 
the ratio of output and input quantities, a figure 
rarely seen in farm sectors of Argentina’s size. 
There is one caveat that should be brought up: 
the reported contribution of land to this process 
(20%) is most likely an overestimation, because 
land use expansion cannot always be regarded as 
linearly independent of technical change. In other 
words, at least a fraction of that 20% should be 
credited to innovation, and thus the TPF contribu-
Figure 2. Technological change in Argentina: evolution of labor and land productivity in Tons of grains+oil-
seeds per worker and per hectare (1908-2007) (Cap, 2012).
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tion would even be higher than 68.3%. However, 
in the current econometric tools used to estimate 
the TPF, special situations, such as the one de-
scribed, are not built into the formulas used in the 
calculations. Theoretical econometricians should 
probably look into how to remove such method-
ological restrictions like this in order to improve 
the existing tools. 
Gm crops in Argentina
The story of GM crops in Argentina is still unfold-
ing and is one that the world has been paying 
close attention to over the last 18 years. This was 
partly because a number of variables that played 
a role in this story were simply not found any-
where else. Unexpected synergies took place on 
a scale never seen before. The sheer magnitude 
of the figures involved has shaken the founda-
tions of traditional econometric analytical tools. 
Traditional agricultural economics were at a loss 
when trying to track and model the causal rela-
tionships using those same tools. Prices have not 
driven this unprecedented shift in the supply of 
grains and oilseeds, but technological change has 
and still does, which is one of the reasons why 
this story has attracted so much attention. In the 
next sections, we will deal briefly with most of the 
issues mentioned above.
The first GM crops introduced in the Argentine-
an agriculture were soybean varieties tolerant 
to the herbicide glyphosate. These HT varieties 
were released by the national regulatory author-
ity and, subsequently, made commercially avail-
able in the 1996/1997 crop season. Since then, 
20 additional events have been approved for 
commercialization, planting, and consumption 
as food, feed, or fiber, including 15 HT, insect-re-
sistant (IR), and HT-IR maize varieties, three HT, 
IR, and HT-IR cotton (Gossypium hirsutum) varie-
ties, and two soybean varieties resistant to her-
bicides other than glyphosate. Since the creation 
in 1991 by the Argentinean Government of the 
National Advisory Commission on Agricultural 
Biotechnology (CONABIA), 1,721 applications for 
field trials have been granted. Maize, soybean, 
cotton, and sunflower (Helianthus ...) are the 
crops with the greatest number of implemented 
field trials, followed by wheat, rice (Oryza sativa), 
potato (Solanum tuberosum), and alfalfa (Glycine 
sativa). In terms of traits, there has been an im-
portant evolution from single traits (HT and IR) to 
combined or stacked traits that clearly prevail, a 
trend also observed elsewhere around the world 
(James, 2010). The vast majority of technologies 
subjected to field trials were of foreign origin.  
In the 2010/2011 crop season, the technologies 
were applied on nearly 22.9 million hectares, of 
which 19 million were cultivated with HT soybean; 
3.5 million hectares with GM maize, of which 1.6 
million with IR traits, 300,000 with HT ones, and 1.6 
million with both traits stacked; and 614,000 hec-
tares with GM cotton, of which 56,000 HT, 8,000 
IR, and 550,000 with both traits stacked (Consejo 
Argentino para la Informacíon y el Desarrollo de la 
Biotecnología; www.argenbio.org). These figures 
represent approximately 100%, 86%, and 99%, of 
the total area planted with soybean, maize, and 
cotton, respectively (Figure 4).
These numbers place Argentina third, behind the 
USA and Brazil, in GM crop area at the world level, 
followed immediately by India and Canada (James, 
2010). This adoption dynamic is almost unprece-
dented in the history of the world agriculture and 
it is only comparable to the path followed by the 
adoption of hybrid maize into the State of Iowa 
(USA) in the 1930s. Even within the boundaries of 
the Argentinean experience, the evolution of the 
use of GM technologies by its farmers parallels 
very positively with other innovative plant ma-
terials, such as wheat with Mexican germplasm, 
developed by the Center for the improvement of 
Maize and Wheat (CIMMYT), and that gave rise to 
the “Green Revolution” and hybrid maize. Both 
events took place a few decades earlier (Figure 4). 
It took 27 years for Argentinean farmers to adopt 
hybrid maize at the level reached for GM maize 
after only 13 years and 12 years were needed to 
adopt Mexican wheat 12 years, whereas in just 
four planting seasons the same adoption level 
was reached at the farm level for soybean, i.e. 
90% of total planted area. It is worth noting, how-
ever, that none of the major technologies involved 
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was a product of the local R&D system. All the GM 
technologies that received approval for commer-
cial use were created by multinational seed com-
panies and introduced into the local genetic pool. 
The predominance of foreign technologies has 
remained unchanged since the first HT soybean 
varieties were introduced for field testing during 
the early 1990s. Still no applications for field test 
permits have been filed for locally developed in-
novations in any of the major crops. This caveat 
notwithstanding, there is a wide consensus that 
the strength of local breeding programs and the 
existence of a consolidated seed industry have 
played a key role in the rapid diffusion and adop-
tion of these new technologies.
The impact of GM technologies on the 
economy of Argentina
The economic impact of the introduction of GM 
technologies – HT soybean in particular – in Ar-
gentina has been very important, not only due 
to the reduction of production costs, but also 
because they provided a renewed thrust to a 
growth cycle in agriculture. That started some 
years before thanks to economic incentives, such 
as elimination of export taxes and reduction or 
elimination of import duties on farm machinery, 
which made investment in a new technology eas-
ier and more affordable for farmers. Another key 
factor was also the strong synergy between HT 
soybean and NTF practices. Indeed, shortening 
the idle time between harvests of wheat and sow-
ing of soybean enabled double cropping through 
the use of short-cycle soybean varieties in regions 
where this land productivity-enhancing manage-
ment system had not been feasible until then. 
This real example lends support to the hypothe-
sis of the implicit assumption that the expansion 
of cultivated land on the one hand and changes 
in factor productivity on the other hand are lin-
early independent. The net effect of this synergy 
has been the emergence of a significant “virtual” 
growth in total planted acreage without an actual 
increase in the available of arable land. This ex-
pansion in cultivated land has been estimated in 
the range of 3.5 million hectares and has been 
Figure 4. Adoption rate of the different GM technologies versus other technological milestones (Trigo, 2011).
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undoubtedly one of the main economic determi-
nants in the farmers’ adoption of the new tech-
nologies. This favorable shift has been reinforced 
by the free fall in the price of glyphosate from 
US$ 10/liter by the end of the 1990s to less than 
US$ 3/liter in 2000, as a direct effect of the patent 
expiration and the occurrence of new suppliers 
on the market. At the same time, these new tech-
nologies made soybean strongly competitive with 
other crops, such as maize and sunflower. In turn, 
livestock production (beef and milk) induced an 
intensification process that, in the end, increased 
productivity in these other farm activities that 
compensated for the area reduction and sus-
tained the output levels achieved before the soy-
bean expansion had occurred. During the 1996-
2005 period, the area with pastures (both natural 
and planted) has been estimated to have suffered 
a reduction of more than 5 million hectares while 
the supply of beef and milk remained stable (Tri-
go and Cap, 2006). These productivity increases 
have not been recorded in the statistics because 
the yield indicators commonly used, namely the 
slaughtered beef heads/year and the volume of 
milk for dairy, are computed without reference to 
the area on which that output is produced.
In this context, the cumulative gross benefits for 
Argentina resulting from the use of GM crops 
during the period 1996/1997–2010/2011 have 
been evaluated to amount to US$ 72.65 billion, 
of which US$ 65.44 billion from HT soybean (US$ 
3.52 billion from the reduced production costs 
and US$ 61.92 billion from the expanded cultivat-
ed acreage), US$ 5.38 billion from the use of IR 
and HT maize (single and combined events), and 
US$ 1.83 billion from the use of IR and HT cotton 
(single and combined events). The bulk of these 
benefits (72.67%) went to the farmers, whereas 
the input industry received approximately 7.38% 
of the grand total and the Federal Government 
– thanks to revenues from export duties – the re-
maining 19.95% (Figure 5). Regarding the crops, 
the benefit distribution follows a similar pattern, 
namely farmers cultivating soybean and maize 
captured 72.4% and 68.2% of the grand total, 
respectively. However, the benefits of the suppli-
er sector differ mostly in the plant propagation 
patterns of each crop – open-pollinated soybean 
and cotton varieties versus maize hybrids – and 
the status concerning the intellectual proper-
ty rights (IPRs). The original HT genes were not 
granted patents in Argentina: ASGROW, the seed 
company that held those IPRs at the time of the 
commercial release of the GM soybean varieties, 
failed to file an application with the regulatory au-
thorities. For an extensive discussion on the situ-
ation regarding IPRs, see Trigo et al. (2002). More-
over, the farmers had the opportunity to save 
grain by using an open-pollinated plant species, 
such as soybean, as seed in the following planting 
season. This right had been granted by the pro-
visions of the 1978 International Convention for 
the Protection of New Varieties of Plants, to which 
Argentina adheres. Thus, the lack of patents and 
the grain saving became a strong incentive for an 
illegal seed market, both for soybean and cotton 
seeds, but not for maize. Indeed, hybrid seed pro-
duction results from crossing genetically homog-
enous parent lines that are not available outside 
the seed company itself and, thus, precludes the 
option available to soybean and cotton farmers. 
The effect of the differences among these GM 
crops was that seed companies gained 19% of 
the total benefits in the case of maize, but only 
3.2% and 3% in the case of soybean and cotton, 
respectively (Trigo, 2011). 
In addition to the direct economic benefits report-
ed above, the introduction of GM crops into Ar-
gentinean agriculture has also had, through a set 
of multipliers, a significant economy-wide impact, 
particularly in terms of job creation. During the 
1996-2010 period, 1.8 million jobs were created 
as an indirect effect of the introduction and adop-
tion by farmers of agricultural GM technologies in 
Argentina (Trigo, 2011). For the job creation esti-
mates, each additional dollar in goods generated 
by the adoption of GM materials (valued at border 
price, i.e., FOB prices at Argentine Ports) was sup-
posed to generate another dollar in the services 
sector (transportation, storage, etc), according to 
a procedure based on the actual “cost” of adding 
one job to the economy for each year during the 
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period under analysis in terms of GDP. For this ex-
ercise, a baseline stock was assumed of 10 million 
jobs in 1996 (when GM soybean was released) 
with annual cumulative increases or subtractions 
to account for the evolution of GDP along the dif-
ferent stages of the economic cycle (for details on 
the procedure and the complete estimation, see 
Trigo, 2011). This figure in itself is impressive, con-
sidering the relatively small size of the economy 
of Argentina, which has a workforce estimated at 
17 million in 2010. Its relevance is further empha-
sized when one considers that the period under 
analysis includes the crisis years of 2001-2003, in 
which the fixed peso-dollar exchange rate that 
was pegged at a value of one was abandoned, the 
public debt was 100 billion dollar, the economy 
shrunkened by 10.9% in 2002, and the unemploy-
ment rate skyrocketed to 21.5% (Instituto Nacion-
al de Estadística y Censos; www.indec.mecon.ar).
Figure 5. Soybeans: distribution of the cumulative benefits (1996-2011) attributable to the adaption of GM 
HT technology in Argentina. (Trigo, 2011)
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Noneconomic benefits
The expansion of GM crops in Argentina has 
moved along with an impressive acreage increase 
under NTF. This NTF is particularly meaningful 
for its environmental impacts since, on the one 
hand, it has enabled to partially reverse the neg-
ative effects (externalities) of conventional tilling 
and plowing practices on the physical structure 
of Pampean soils (Viglizzo et al., 2010) and, on the 
other hand, to significantly improve the energy 
balance in the agricultural sector (Pincen et al., 
2010).
NTF began to be utilized in Argentina by the end 
of the 1980s, because the cumulative effects of 
both water and wind erosion were already mani-
fest in many of the most fertile areas of the Pam-
pas. Continuous farming based on traditional till-
ing practices and without pasture rotations due 
to their low profitability (Secretaría de Agricultura, 
Ganadería y Pesca y Consejo Federal Agropecuar-
io, 1995) resulted in decreased yields. Therefore, 
the impact on the economic viability of farming, 
together with an enhanced availability of state-
of-the-art no-till sowing equipment, thanks to the 
deregulation and opening of the economy, and 
the reduction in direct costs due to the elimina-
tion of tillage practices, were ideal to launch the 
diffusion of NTF that, in turn, led to an increased 
productivity that made up for a portion of the 
losses incurred until that time. However, it was 
not until the introduction of HT soybean that the 
process gained momentum and NTF consolidat-
ed itself as the predominant soil management 
strategy in farms all across the country (Figure 6). 
The NTF are evolved from approximately 300,000 
hectares in 1990/1991 to nearly 25 million hec-
tares at the present time (for an in-depth discus-
sion on this process, see Trigo et al., 2010). The 
combination of NTF and HT soybean integrates 
two technological concepts: one that consists of 
new mechanical technologies that modify the soil-
crop interaction and one that is based on the use 
of a total herbicide (glyphosate), which is highly 
effective in eliminating a wide array of weeds vir-
tually without residual effect. Glyphosate persists 
in the soil between 12 and 60 days, it carries a low 
polluting risk of underground waters, it is mildly 
toxic on animals, and it does not accumulate in 
animal tissues (Pincen et al., 2010). The combined 
use of mechanical technologies and total herbi-
cides imply an increase in the use of inputs, gen-
Figure 6. Evolution of planted area with NTF and type of herbicide used.
Based on data from the Asociación Argentina de Productores en Siembra Directa (www.aapresid.org.ar) 
and the Cámara de Sanidad Agropecuaria y Fertilizantes (www.casafe.org).
Source: The authors, based on data from AAPRESID (www.aapresid.org.ar) and CASAFE (www.casafe.org).
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erally described as “hard” intensification (Figure 
6), but this intensification is, at the same time, 
environmentally friendly because it has resulted 
in a parallel reduction in the use of other herbi-
cides with high residual effects, such as atrazine. 
Although the benefits of the synergy between HT 
soybean and NTF are difficult to quantify, the po-
tentially positive effects cannot be ignored on soil 
fertility and, thus, on present and future land pro-
ductivity as well as other promising effects, such 
as contribution to the mitigation of the so-called 
“greenhouse effect” (thanks to reduced emission 
levels N02). Regarding the organic matter con-
tent of soils, in NTF systems with crop rotations, 
including wheat, maize, or sorghum, the annual 
soil losses are under 2 ton/hectare, a value much 
lower than the tolerable maximum of 10 ton/hec-
tare and below the levels recorded under other 
soil management practices (Casas, 2006). 
Between 1996 and 2009, the total fuel consump-
tion in soybean farming in Argentina increased by 
201.3 million liters (95.1%), from 211.6 to 412.9 
million liters/year, but the average consumption 
per hectare dropped by 38%, from 35.8 to 22.2 
liters/hectare, implying a decrease in carbon diox-
ide emission of 5.19 million tons when compared 
to what would have been emitted if soybean 
cropping had been based on conventional tillage 
practices (Brookes and Barefoot, 2011). On an 
annual basis, this figure represents a reduction 
of 13.5 million liters of fuel. Similar effects have 
been reported regarding the carbon sequestra-
tion impact, resulting from the use of reduced 
or no-till soil management practices: the total 
cumulative amount of carbon sequestered over 
the 13-year period was estimated at 13.82 million 
tons (Brookes and Barefoot, 2011). Impacts of the 
same nature have been described for maize and 
cotton, but with a lower magnitude, because the 
planted area planted and the time elapsed since 
these technologies had been made available to 
farmers differ significantly from the values record-
ed for soybean.
Sustainability issues associated with the 
soybean expansion
The above mentioned synergies and benefits 
do not necessarily mean that one should ignore 
the potential risks associated with the massive 
transformation of farming systems that appears 
to have been triggered by the introduction of 
GM crops into Argentina during the mid-1990s. 
Particularly important are the extensive losses of 
soil nutrients, as a consequence of the increas-
ing predominance of monoculture (especially in 
the case of soybean) and the relatively low ferti-
lization levels recorded in Argentina. Moreover, 
the potential negative effects of the more frag-
ile ecosystems of the new agricultural frontier in 
the Northeastern and Northwestern sub-humid 
areas that have gradually become suitable for 
growing soybean and, thus, have increased the 
acreage of arable land. The environmental effects 
due to changes in land use patterns are a per-
tinent issue that falls beyond the scope of this 
chapter. It is worth pointing out that, even though 
soybean represents a core component of pres-
ent-day cropping systems without pasture rota-
tions, this process had started long before soy-
bean became predominant in the farming scene 
of Argentina. Most of the areas where soybean 
is grown now had previously been planted with 
other crops. Changes in rainfall patterns that ena-
bled crop cultivation on land where was not pos-
sible before, have been identified as one of the 
probable drivers in this process (Grau y Gasparri, 
2005). Regardless of these facts, which should be 
further analyzed and discussed, sustainable farm-
ing strategies are highly relevant, given the mag-
nitude of the figures involved. The key issue that 
needs to be addressed is the long-term effect of 
the continued “export” of soil nutrients, particu-
larly phosphorus, because replacement is either 
nonexistent or insufficient. Recently, soybean has 
been found to positively respond to phosphorus 
fertilization with an increase of 500 to 730 kg per 
hectare. The cumulative amount of phosphorus 
“exported” between 1996 and 2010 has been 
estimated at more than 14 million tons of triple 
super phosphate and the restocking cost for this 
particular nutrient for the entire 15-year period 
62
under study at US$ 7.95 billion (Trigo, 2011). This 
obviously large figure accounts only for 8.41% 
of the total cumulative benefits accrued for the 
1996-2010 period.
Contributions to global food security
Argentina is one of the main players in the inter-
national soybean market – it is the third largest 
producer, exporting almost 100% of its produc-
tion; thus, in addition to the impact on the coun-
try’s own economy, positive effects can also be 
identified at the global level through contribu-
tions to the enhancement of food security. The 
implementation of the new technologies by Ar-
gentinean farmers has been evaluated to result in 
an increase in global supply of 216.1 million tons 
over a 15-year period, which would account for 
22.53% of the world’s cumulative increase in soy-
bean production for the same period (Trigo and 
Cap, 2006; Trigo, 2011). In turn, it leads to inter-
national market price levels that were significantly 
lower than those that would have prevailed with-
out them (Trigo and Cap, 2006; Trigo, 2011). The 
estimation was based on the supply price flexibili-
ty of soybean that measures the response of pric-
es to changes in output with 0.80, using as a start-
ing point for the supply price elasticity of soybean 
in the USA, the world’s biggest producer, implying 
(given that certain assumptions hold) a price flex-
ibility value of 1.25 (for a more complete discus-
sion of the methodology and calculation process, 
see Trigo and Cap, 2006). In these terms, the total 
benefits to world consumers – had Argentina not 
adopted the new technologies and had its farming 
patterns remained unchanged – represent sav-
ings in consumer expenditures of US$ 89.0 billion 
for the 1996-2010 period. Whether these savings 
have effectively been passed to the consumers 
or have been captured totally or partially as rent 
by the other links in the value chain remain to be 
seen. Notwithstanding, GM technologies have a 
considerable potential with implications concern-
ing issues of welfare economics.
Conclusion
The parallel story of GM crops and NTF soil man-
agement technologies in Argentina has been, un-
doubtedly, one of success, but it also highlights a 
set of issues that should be addressed. The eco-
nomic benefits obtained by the farmers, either 
directly or indirectly, by many other players in 
multiple value chains, and by the federal govern-
ment (generating funding for a potential increase 
in the supply of public goods) have crossed over 
the geographical boundaries to overflow onto 
world consumers. This complex web of impacts 
has resulted from the adoption of these tech-
nologies by the Argentinean farmers, but it also 
identifies some of the necessary conditions that 
should be met by a country to be able to bene-
fit from their availability, which may have little to 
do with its own R&D capacities. A key feature in 
this story is the fact that Argentina has adopted 
very early on the available innovations. This be-
havior was possible because the institutions were 
already in place that allowed almost immediately 
diffusion and transfer of these technologies to 
the farmers. By the early 1990s, both the biosafe-
ty regulations and the infrastructure required to 
assess effectively the GM technologies existed; 
furthermore, a very proactive and efficient seed 
industry enabled the rapid introduction of the 
new traits into commercial varieties that were al-
ready well adapted to the multiple agro-ecological 
conditions in the different growing areas and con-
tributed to their rapid diffusion. Had these par-
ticular features not have been present, this story 
would, most likely, have been less successful. The 
bottom line of this case leads us to conclude that, 
at least at the present state of GM technologies, 
biosafety institutions and a well-functioning seed 
market in place seem to be more important than 
a well-endowed local R&D apparatus to generate 
innovations. As GM technologies seem to “travel 
well”, it is essential for any country to have the 
right tools in place at the time of their availability 
to extract the maximum benefits.
Another relevant issue deals with the noneco-
nomic implications of the introduction of these 
technologies. The synergies between GM tech-
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nologies and no-till practices have contributed to 
generate a “win-win” outcome, combining increas-
es in productivity and output with positive micro- 
and macro-environmental impacts. Nevertheless, 
there is still need to recognize that alongside this 
virtuous cycle, there are other not so clear-cut is-
sues merit a closer look, given the magnitude of 
the changes described. The dramatic expansion 
of the area planted with soybean and the increase 
in output of grains and oilseeds as a whole have 
brought about important benefits, but have also 
induced a shift in land allocation that raises ques-
tions about the long-term sustainability of the 
current farming system, due to the detrimental 
effects on soil nutrient levels and the potentially 
negative impact on fragile ecosystems. Although 
these concerns are legitimate, they do not detract 
from the clearly positive net balance of the first 15 
years of GM crops in Argentina. However, they do 
highlight the need for appropriate policy respons-
es aimed at optimizing the management of this 
particular kind of innovations. GM technologies 
are groundbreaking events and for a successful 
implementation at the farm level they require ad-
equate biosafety and IPR frameworks for a suc-
cessful implementation at the farm level.
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Abstract
The use of genetically modified (GM) crops has 
exploded over the last decade worldwide. In 
2012, developing countries increased their share 
of the global cultivation of biotechnology crops to 
more than 50% of the total, a trend expected to 
persist in the future. In Latin America, farmers in 
11 countries planted more than 70 million hec-
tares of GM crops in 2014. The technology has 
been embraced wholeheartedly by the largest 
and wealthiest countries, such as Brazil and Ar-
gentina, but the adoption rates and policy ap-
proaches to GM crops within the less-developed 
Central American countries differ and can provide 
a window into the future of the GM Revolution. 
Whereas Costa Rica has embraced various pro-
jects, Nicaragua and Honduras, the two countries 
with the largest land areas in Central America are 
on opposite ends of the spectrum when it comes 
to growing GM crops. Furthermore, anti-GM 
groups have expended great energy to ban bio-
technology crop production in the Central Amer-
ican region. Here, we give an overview of the GM 
experiences in Costa Rica, Honduras, and Nicara-
gua and propose recommendations for improv-
ing public and private Research and Development 
(R&D) to enhance the contribution of GM technol-
ogy to support sustainable agriculture in the re-
gion. In addition, we discuss the challenges that 
hamper the abilities to create food security while 
protecting the environment. We also stress the 
need for scientists to create awareness among 
the public about the scientific facts regarding GM 
organisms.
 
Introduction
Over the course of thousands of years, agricul-
tural practices have developed a broad spectrum 
of food options. Scientific advances in molecu-
lar biology and, more recently, the application 
of modern biotechnology into agriculture, have 
steadily improved plant yield and product quali-
ty. This result has been accomplished by means 
of both traditional plant breeding and so-called 
genetically modified (GM) technology. Unlike tra-
ditional plant breeding methods, in which hun-
dreds of unknown genes are often transferred 
from one plant to another, GM technology allows 
the precise and efficient transfer of known genes 
that confer resistance to pests, diseases, herbi-
cides, and environmental stress to an otherwise 
unprotected host. It offers opportunities for im-
proving the overall nutritional characteristics of 
food by controlling quality traits, such as superior 
post-harvest storage and nutritional content (Nap 
et al., 2003). Yet, surprisingly, anti-GM groups insist 
that the precision of GM technology is inherently 
more dangerous than the wholesale transfer of 
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unknown genes between hosts. Modern biotech-
nology now plays a crucial role in food production 
and it is progressively considered a key instru-
ment for increasing and improving sustainable 
agricultural production, decreasing poverty and 
hunger, and boosting food security. GM technolo-
gy is desperately needed in the developing world, 
but much less so in developed countries where 
hunger is less of a problem.
Since the first commercial release of a GM crop in 
1996, more and more farmers have adopted the 
technology annually. GM crops are planted in 28 
countries, covering 181.5 million hectares world-
wide. Twenty years later, developing countries 
grow more hectares of GM crops than developed 
countries (James, 2014) and the GM crop fraction 
is projected to increase dramatically, especially 
in developing countries (Wieczorek and Wright, 
2012). Argentina and Brazil are among the world’s 
largest developing countries producing GM 
crops. As of 2014, eleven countries in Latin Ameri-
ca have approved GM crops for various purposes, 
namely Argentina, Brazil, Bolivia, Chile, Colombia, 
Costa Rica, Cuba, Honduras, Mexico, Paraguay, 
and Uruguay.
Below we describe the GM situation in Central 
America, focusing on the regulatory rules and 
policies implemented in Honduras, Costa Rica, 
and Nicaragua and propose recommendations 
for improving public and private Research and 
Development (R&D) to increase the contribution 
of GM technology toward improving sustainable 
agriculture in the region.
The situation in Central America
Nicaragua
There is no commercial production of GM crops 
in Nicaragua. However, for a number of years 
Nicaragua has authorized the import of GM soy-
bean (Glycine max) meal and GM corn (Zea mays) 
for animal feed. According to a United States De-
partment of Agriculture (USDA) report from the 
Global Agricultural Information Network (GAIN), 
in 2014, Nicaragua imported over 154,500 met-
ric tons (MT) of GM yellow corn from the United 
States with a total value of US$ 40.7 million and 
the GM soybean meal imports in the same year 
reached over 80,000 MT with a total value of US$ 
39.6 million (http://gain.fas.usda.gov/Recent GAIN 
Publications/Agricultural Biotechnology Annual_Ma-
nagua_Nicaragua_7-14-2015.pdf). There are no 
known reports on Nicaraguan imports of other 
biotechnology or “biotech” crops from the US or 
other countries.
The import of GM grains was first approved of-
ficially in 2005. The Ministry of Agriculture and 
Forestry (MAGFOR) issued a ministerial resolution 
(no. 034-2005, now expired) in response to a re-
quest from grain importers. The resolution was 
granted with the specific objective of allowing the 
import of 15 GM corn events for animal feed, re-
newable on a yearly basis.
From 2005 on, the Nicaraguan government 
started requiring notification of imports of GM 
organisms to comply with the provisions of the 
Cartagena Protocol on Biosafety (Secretariat of 
the Convention of Biological Diversity, 2000), of 
which Nicaragua is a signatory. Among the new 
requirements, companies interested in importing 
biotech crops are obliged to apply and file a risk 
analysis of a GM event prior to its import. In 2010, 
the Nicaraguan Parliament approved Law 705 
on “The Prevention of Risks from Living Modified 
Organisms through Molecular Biotechnology”. Its 
application, however, has been restricted due to a 
lack of procedural norms necessary for its imple-
mentation. Indeed, although the Nicaraguan Gov-
ernment approved the import of GM corn in 2005 
through the ministerial resolution 034-2005, the 
legal framework for Law 705 for the regulation of 
GM plants and animals has yet to be completed.
Law 705 introduces a wide-ranging, science-based 
platform for regulating the use of living GM organ-
isms in a broad spectrum of instances, including 
confined use, research, release into the environ-
ment, commercialization, propagation and evalu-
ation of field production, transportation, transit, 
import, and export, that are all destined for hu-
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man consumption or for processing and animal 
feed. This law not only controls the usage of GM 
crops for all agricultural purposes, but also for 
bio-medication, conservation, preservation, and 
other uses linked to biological diversity.
In keeping with Law 705, the National Commit-
tee on GMO Risk Analysis (CONARGEN) was cre-
ated to regulate entry of GM crops and to de-
termine their possible presence in the country. 
CONARGEN includes officials from MAGFOR, spe-
cifically the Chief Director of the General Direction 
for Animal and Plant Health Protection (DGPSA) 
and from the Ministry of the Environment and 
Natural Resources (MARENA). In 2014, DGP-
SA was renamed as the Institute of Agricultural 
Health and Protection (IPSA).  The presidency of 
CONARGEN alternates each year between these 
two government agencies. Other members are 
representatives from the Nicaraguan Institute 
for Agricultural Technology (INTA), the Ministry 
of Health (MINSA), various universities, such as 
the National Agrarian University (UNA) and the 
University of Central America (UCA). There is one 
representative from the private sector and one 
from the environmental nongovernmental organ-
izations.
Costa Rica
Since 1992, Costa Rica has been cultivating bio-
tech crops for seed production, specifically cot-
ton (Gossypium hirsutum) and soybean with all 
seeds destined for export, although there are 
currently no central government restrictions on 
planting GM crops for domestic seed production. 
The acreage for biotech crops peaked in 2009 at 
1,697 ha, including approximately 1,500 ha of soy-
bean alone. However, it is estimated that in 2015 
only 300 ha were planted with GM crops (USDA 
GAIN report; http://gain.fas.usda.gov/Recent GAIN 
Publications/Agricultural Biotechnology Annual_San 
Jose_Costa Rica_7-15-2015.pdf), of which a large 
majority was planted with GM cotton destined for 
propagation of planting seeds and export to the 
United States. Costa Rica produces GM cotton 
and soybean seed entirely for export and not for 
local consumption.
Overall, in Costa Rica the procedures for obtaining 
authorization from the government to plant GM 
varieties are uncomplicated and do not obstruct 
production. Projects and events are approved 
on a case by case basis without specific legisla-
tion for biotech products for food consumption, 
animal feed, or food processing. Costa Rica runs 
projects to bring to market the red-fleshed GM 
“Rosé” pineapple (Ananas comosus) of Del Monte 
(patent pending).
Imports of GM grains and soybeans for animal 
feed production are evaluated with the same 
procedures used for the importation of any other 
agricultural product and follow the technical re-
quirements established by the Cartagena Proto-
col on Biosafety, a supplementary agreement to 
the United Nations Convention on Biological Di-
versity of 1993 (Mackenzie et al., 2003).
However, in 1990, Costa Rica established the 
National Technical Biosafety Commission (NTBC) 
under the leadership of the Ministry of Agricul-
ture. Under the law, the NTBC has the power to 
regulate import and cultivation of biotech crops, 
including export, research, testing, movement, 
propagation, industrial production, marketing, 
and use of transgenic and other GM organisms 
for agricultural use (Animal and Plant Health 
Protection Law 7664 of April 1997). Neverthe-
less, new legislation is under consideration that 
may pose a threat to future developments in 
biotech agriculture.
Honduras
Since 1998, Honduras has planted GM maize. Al-
though the country produces only a minor frac-
tion of the global biotech crop yield (0.001%), its 
positive GM experience illustrates the potential 
value of GM technologies for developing coun-
tries, in general, and for Central America, in par-
ticular. Honduras was the first country in Central 
America and one of only five countries in Latin 
America to allow field trials and commercial pro-
duction of GM crops (USDA GAIN report; http://
gain.fas.usda.gov/Recent GAIN Publications/Agri-
cultural Biotechnology Annual_Tegucigalpa_Hon-
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duras_7-8-2015.pdf). In 2014, Honduras planted 
34,000 ha for the commercial production of GM 
corn, including several field trials of new GM va-
rieties. GM corn is commercialized within the 
domestic market and exported to various coun-
tries, including the US, Colombia, and Argentina. 
Honduras also imports GM soybeans and corn to 
supply poultry, livestock, and fishery enterprises.
Honduras has a science-based agricultural bio-
technology regulatory system that is increasingly 
used as a good example for biotechnology policy 
and regulations by other countries in the region. 
The current administrative policy is empowered 
by the Phytozoosanitary Law of the Ministry of 
Agriculture and Livestock (SAG), modified as part 
of the Central American-Dominican Republic Free 
Trade Agreement (CAFTA-DR), and regulated 
by the Biosecurity Regulation with Emphasis in 
Transgenic Plants. Additionally, Honduras ratified 
the Cartagena Protocol in 2008 and has estab-
lished specific regulations concerning the intel-
lectual property protection of plant varieties as 
of 2012.
The National Service of Plant and Animal Health 
(SENASA) within SAG is responsible for designing 
the regulatory framework for agricultural biotech-
nology. SENASA relies on advice from the Nation-
al Committee of Biotechnology and Biosecurity 
whose members are experts from the public and 
private sectors.
Biotechnology can be used as a 
 developmental tool in Central America
In less developed countries, such as those in Cen-
tral America, the success of agricultural biotech-
nology will depend on sufficient institutional sup-
port to foster private sector investments and on 
stimulation of public efforts, mainly at universities, 
to assess and adapt the technology to the specific 
regional needs.
In 1998, the Honduran government introduced 
a concerted strategy to promote agricultural 
biotechnology, facilitating commercial production 
and field testing. The high adoption rate of GM 
crops in Honduras may be interpreted as a re-
flection of farmer satisfaction and benefit for the 
whole production chain. Data from a study com-
paring non-GM corn (traditional or hybrid) with 
closely-related GM corn revealed a significant 
increase in yield for the GM corn. The maximum 
yield per hectare was 2.7 MT for traditional corn, 
3.6 MT for hybrid corn, and 8.0 MT for GM corn.
Corn is an important food staple in Central Amer-
ica and is cultivated for local trade within each 
country. For a large majority of farmers, howev-
er, it is intended for household consumption. The 
average yield of approximately 2 MT per hectare 
in Central America is one of the lowest in Latin 
America. This low yield has various causes, includ-
ing poor soil fertility and insect damage. There-
fore, insect-resistant GM corn would present an 
alternative to chemical controls, especially bene-
fiting small farm holders.
Costa Rica is the only Central-American country 
that has engaged in the development of locally 
designed GM crops, carrying out laboratory and 
glasshouse-based research for this purpose. Cur-
rently, Costa Rican scientists are involved in re-
search aimed at the development of GM rice re-
sistant to virus and herbicides, banana (Musa sp.) 
resistant to black Sigatoka, and pineapple with in-
creased antioxidant content. It has been reported 
that field testing of biotech pineapples, bananas 
and rice are at the confined-field trial phase.
This progress in agricultural research, which may 
be explained by governmental commitment to 
education, science, and innovation, however, 
conflicts with the slow adoption of commercially 
cultivated GM crops when compared to Hondu-
ras. Although Costa Rica appears at the forefront 
of domestic GM product development in Central 
America, the farmers seem to benefit the most 
in Honduras.
In the late 1990s, Nicaragua took the lead in ef-
forts to develop biotechnology. Since 2000, the 
UCA at Managua  has been organizing and hosting 
international biotechnology conferences in the 
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region with world-renowned scientists, informa-
tive presentations, and networking opportunities 
for the scientific, nonscientific, and student com-
munities as well as coordinating field trips to local 
sites of scientific interest. The keynote speaker 
of the 2008 Conference was Professor Marc Van 
Montagu (Ghent University, Belgium), who, to-
gether with Jeff Schell, discovered a natural vector 
for plant transformation and created a procedure 
to produce transgenic plants. The Molecular Biol-
ogy Center at the UCA collaborates with Profes-
sor Van Montagu, now at the International Plant 
Biotechnology Outreach (IPBO) (Ghent, Belgium), 
to enhance human capacities, training, and edu-
cation in plant molecular biology and biosafety in 
Central America.
Similarly, and more recently, Honduras has 
also been promoting agricultural biotechnol-
ogy through a series of seminars focused on 
scientific studies regarding the use of biotech-
nology. In 2012, Honduras hosted a regional 
biotech outreach program focusing on food se-
curity, biosafety, and agricultural development. 
This event, attended by officials and scientists 
from all Central-American countries, was aimed 
at strengthening the development and safe use 
of agricultural biotechnology as a strategic plat-
form for increasing productivity and competitive-
ness in agriculture. One of the key commitments 
from this meeting was to develop a common 
vision between agricultural and environmental 
policies in the region. A number of regional and 
international institutions collaborate in these ef-
forts, including the Public Research and Regula-
tion Initiative (PRRI), the International Food Pol-
icy Research Institute (IFPRI), the Service for the 
Acquisition of Agri-biotech Applications (ISAAA) 
and the Inter-American Institute for Cooperation 
in Agriculture (IICA).
Improving public and private R&D 
to boost sustainable agriculture  
in the region
A framework for improving public and private R&D 
(capacity building) in Central America would greatly 
enhance sustainable agriculture and food security 
in the region. Biotechnology is a sine qua non of the 
modern knowledge society. Developing countries 
create capacities in biotechnology as part of their 
growth strategies. In Central America, a sizable 
share of research and innovation is conducted with-
in public institutions. Strengthening the scientific 
and technical capacities of universities and institutes 
will enable them to play a more important role in 
GM research relevant to the needs of the countries 
and to assimilate new technologies that otherwise 
offer limited incentives for the international private 
sector. Public institutions are in an advantageous 
position, because they are often closely linked to 
end-users of agricultural technology products, such 
as farmers and local rural government agencies. 
Furthermore, by facilitating the participation of pub-
licly funded research institutions in the GM crop 
development process, the developing countries will 
probably reap the benefits of agricultural biotech-
nology rapidly and efficiently and with a more sus-
tainable development approach.
Foreign donors and lending institutions (such 
as the World Bank and the Inter-American De-
velopment Bank) could provide support for the 
development of GM varieties and traits in Cen-
tral America via public-private partnerships to 
address strategic development needs, including 
those of resource-poor farmers. At the same 
time, the governments of the developing na-
tions should also contribute their own funds to 
reduce the dependence on industrialized coun-
tries and to retain decision-making control re-
garding fundamental agricultural research and 
development priorities.
Biotechnology R&D is an expensive enterprise. 
Placing a new GM product on the market can 
cost in the range of US$ 1.5-4.5 million and even 
up to US$ 15 million (Traxler, 2001). This large 
financial investment represents a major limita-
tion for less developed countries. Therefore, it 
might be advisable to establish international co-
operations with large corporations as a regional 
block to profit from this technology. This strategy 
could create the foundation of a continuous local 
biotech development.
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Most developing countries have limited or no re-
search experience with GM organisms and agri-
cultural research in general is mostly inadequate. 
One way around this dilemma would be to identi-
fy and employ existing new technologies with the 
intention of developing local capacity to innovate 
new products. Honduras and Argentina have 
been doing this successfully. In the case of Argen-
tina, genes generated in the US were introduced 
into the local germplasm base for both soybeans 
and corn (Burachik and Traynor, 2001).
Stimulating biotechnology R&D in the develop-
ing world is an arduous task. Countries must 
balance, among others, between a complex set 
of economic, social, and political goals with in-
sufficient resources and a host of environmen-
tal and scientific needs. Relevant priorities in 
terms of policy can be identified through tech-
nology assessment that contemplates different 
biotechnology options, while establishing core 
economic and social goals. The channeling of 
biotechnological development toward sustain-
able growth and food security must take into 
account the wider environment available to facil-
itate the technology, as well as the possible im-
pacts of specific GM crops on rural livelihoods. 
Moreover, for biotechnology to succeed in 
enhancing food security in Central America, 
governments may want to establish guidelines 
requiring that new GM varieties introduced 
into the country demonstrate direct benefits 
for rural development, such as enhanced crop 
yields; along with research on agronomic and 
soil conditions in the areas where new GM crops 
are planned.
Ideally, developing countries would design a com-
prehensive plan to support not only the regula-
tory framework and implementation, but also 
the development of biosafety and biotech policy. 
National Academies of Sciences have been shown 
to play an important role by facilitating debates 
and building consensus among various stake-
holders, because they are trusted institutions 
that address contentious GM issues (Aerni and 
Bernauer, 2006).
In Central America, the development of agricul-
tural biotechnology and specifically of GM crops 
must be carried out via a sustainable approach to 
agriculture that faces the specific challenges and 
opportunities brought about by these modern 
technologies. The appropriate methodology would 
be strengthened by considering economic bene-
fits within a broader framework of sustainability. 
Indeed, agricultural biotechnology has remarka-
ble potential to lower the environmental impact of 
farming through limitation of chemical treatments 
on farms, stimulation of no-tillage farming prac- 
tices, reduction of soil erosion, and efficient inten-
sification by producing more food on less land.
Appropriate policies should be established 
through good governance, ensuring that they 
act as a tool for sustainable development to con-
serve the environment for future generations. 
For instance, governments could provide funding 
for public universities to support public-interest 
research on crops considered crucial for society 
(Huffman et al., 2006) and they could endorse in-
stitutional mechanisms to facilitate access to in-
formation and critical knowledge, while address-
ing intellectual property protection (Graff and 
Zilberman, 2001; Atkinson et al., 2003).
Agricultural biotechnology could also be used to 
improve additional crops beyond the traditional 
herbicide- and insect-resistant GM traits, includ-
ing plants with reduced water requirements, 
plants that fix nitrogen, and plants that reduce 
fertilizer-caused pollution. Crops could also be 
tailored to assess global food insecurity by the 
incorporation of enhanced nutritional qualities 
or resilience to a changing climate (National Re-
search Council, 2010).
Anti-GM activism may obstruct 
 development in small countries
Despite the positive legal framework in Costa Rica, 
some anti-GM actions could prevent the potential 
development of the agricultural biotech sector. En-
vironmental activist groups have been implement-
ing a decade-long campaign against the cultivation 
and commercialization of GM crops and they have 
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recently called for legal banning of the import of 
transgenic grains and for establishing a labeling 
system for transgenic foods. In Honduras, con-
sumer groups have also been influenced by wide-
spread negative information. This same anti-GM 
activism has been quite pronounced in Nicaragua 
to the point that government is now very cautious 
about promoting agricultural biotechnology. For 
the same reason, the government has not imple-
mented the official regulations for GM approvals. 
As Nicaragua has a reasonable biotech law and 
strong intellectual property right protections, stim-
ulation of private sector investments in modern 
technologies seems plausible. However, hesitation 
and ambiguity on the part of the government may 
deter large investments in GM crop production 
and discourage biotech companies from introduc-
ing new GM crops into Central America.
The use of biotechnology and, specifically, the ge-
netic modification of plants to increase yield, to 
protect against pest invasions, and to confront is-
sues resulting from climate change is not without 
conflict. As with many other scientific innovations 
when they had first been introduced, GM prod-
ucts for animal and human consumption have 
met varying degrees of acceptance, suspicion, 
skepticism, and, frequently, outright rejection. 
There are many reasons why this spectrum of re-
sponses has been and remains in many commu-
nities in Central America.
The desire to prevent international mega-cor-
porations from controlling local seed produc-
tion and supply is, of course, paramount in the 
minds of many members of the anti-transgenic 
movement led by local and international nongov-
ernmental organizations. The regulation, or lack 
thereof, of local seed supplies is directly related to 
power and ownership issues, even of sovereignty, 
and self-determination in developing nations and 
their communities of small, independent farmers 
(Pearson, 2012). Unfair seed production agree-
ments in favor of large multinational corporations 
and tactics by these corporations, seen as “bully-
ing”, may have a detrimental effect on small farm-
ers. The struggles of the small seed producers are 
shared within the community and beyond, creat-
ing doubt and fear among an increasing number 
of farmers and their supporting organizations.
Fear, ignorance of the science behind GM food 
production, and negative reputation of foreign 
multinationals, coupled with genuine concerns for 
safety, are all used by large and small actors in the 
movement against GM import, production, and 
consumption in Central America and elsewhere. 
Many American and European anti-GM organiza-
tions actively support local initiatives in the region.
Concluding remarks
Agricultural biotechnology is a key technological 
platform to foster sustainable economies in devel-
oping countries and to enhance food security in 
the fight against global hunger. Some new varieties 
may also be developed to increase the resilience 
to climate change. In addressing all of these chal-
lenges, less-developed countries, such as those of 
Central America, need to make use of all available 
tools. In particular, it would be foolish to exclude 
GM methods because of specious political argu-
ments that have been promulgated in Europe. 
Such arguments against GM crops have no direct 
consequences in Europe because increase of its 
food production is not required. In contrast, the 
developing countries need GM crops desperately 
if they are to feed their expanding populations.
Governments should adopt appropriate pro-ag-
ricultural biotechnology policies and laws based 
on sound science and should promote a rigorous 
public relations campaign to improve the accep- 
tance of GM technology. Speaking from their own 
experience, science academies and universities 
could provide independent advice to policy-mak-
ers and the public. As the Central-American re-
gion is still in the early stages of biotechnology 
diffusion, capacity building should be strength-
ened, specifically in the area of applied research. 
New crops should be judged by their contribution 
to the needs of the Central-American countries, 
particularly those related to food requirements 
of low-income populations, and not be arbitrarily 
banned because of the production method.
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Abstract
South Africans have been growing genetical-
ly modified (GM) crops since 1999 and the area 
under cultivation has steadily increased since. 
Insect-resistant cotton (Gossypium hirsutum) was 
introduced in 1997 as the first GM crop grown by 
both commercial and smallholder farmers. In re-
cent years cotton plantings, whether GM or not, 
have decreased for economic reasons. In 2013, 
some 96% of commercial maize (Zea mays) cul-
tivation was GM carrying either Bacillus thuring-
iensis-mediated insect resistance, herbicide re-
sistance, or both. This included white maize for 
human consumption and yellow maize for animal 
feed. The crops are grown by both commercial 
and smallholder farmers. Herbicide-resistant 
GM soybean (Glycine max) is also cultivated. The 
adoption of GM insect-resistant maize has re-
sulted in increased yields and reduced pesticide 
use with associated environmental and economic 
benefits. There is also anecdotal evidence of re-
duced mycotoxin contamination in food products 
from GM insect- resistant maize. Aflatoxins have 
been implicated in oesophageal cancer, a disease 
widespread in parts of Africa where homebrewed 
maize beer is widely consumed. Recommenda-
tions for future cultivation of GM crops include 
improving access to seed by smallholder farm-
ers, provision of extension services, implementa-
tion of appropriate integrated pest management 
practices, and implementation of selective labe-
ling. New GM crops in the pipeline need to be ex-
pedited to allow field trials to occur.
 
Introduction
The area planted to genetically modified (GM) 
crops in South Africa has steadily increased since 
they were first introduced in 1997. Currently, the 
maize (Zea mays) crop covers some 2.5 million 
hectares, of which 2.14 are GM (86% adoption). 
Soybeans (Glycine max) are grown on 600,000 
hectares, of which 552,000 are GM (92% adop-
tion), whereas cotton (Gossypium hirsutum) is 
a small crop cultivated on 8,000 hectares, all of 
which is GM (James, 2014).
The Genetically Modified Organisms Act was 
promulgated in May 1997, but could not be im-
plemented until the Regulations were approved. 
As approval only happened in November 1999, 
during the intervening period, applications for 
trial or commercial releases were handled by the 
South African Committee for Genetic Experimen-
tation (SAGENE).
To give an idea of the number of applications 
SAGENE handled during 1997 alone, of a total of 
27, 13 were introduced for maize, four for cotton, 
two for soybeans, one each for canola (Brassica 
napus), strawberry (Fragaria × ananassa), euca-
lyptus (Eucalyptus obliqua), and apple (Malus do-
mestica), and four for microorganisms (Thomson, 
Genetically Modified Crops  
in South Africa
Jennifer Ann Thomson
Department of Molecular and Cell Biology, University of Cape Town, Private Bag, Rondebosch, 7701, 
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2013a). The GMO events approved for commer-
cial release in South Africa from 1997 until 2014 
are listed in Table 1.
The adoption of currently approved traits is 
seemingly reaching saturation because not all 
plantings require Bacillus thurigiensis (Bt) insect re-
sistance. Indeed, in many cases cost savings can 
be achieved by applying fungicide and insecticide 
simultaneously through overhead irrigation when 
needed. In addition, some regions are not sub-
ject to severe stalk borer pressure (James, 2014). 
However, new traits in the pipeline, such as fungal 
resistance and drought tolerance, may serve to 
further enhance adoption levels.
Cotton production has declined in recent years 
due to movement away from risky dryland re-
gions to regions under irrigation, where it has to 
compete with maize or soybeans. Additionally, 
there have been problems with cotton gin clo-
sures. Therefore, only approximately 9,000 hec-
tares were planted with GM cotton in 2014 com-
pared with 11,000 hectares in 2012, of which 95% 
contained the stacked Bt and herbicide resistance 
genes, whereas the remaining 5% was herbicide 
resistant used as refugia (James, 2014).
In addition to GM crops grown for commercial re-
leases, permits were also issued for commodity 
clearance of imported GM crops. The approved 
commodities from 2012 to 2014 are listed in Ta-
ble 2, showing that food producers in South Afri-
ca use imported GM crops as well as those pro-
duced locally.
There are a number of reasons why South Africa 
led the way among countries in Africa in introduc-
ing GM crops. One was the existence of SAGENE, 
the body which, prior to the introduction of the 
Event Crop Trait Company Year approved
TC1507xMON810 xNK603 Maize Insect resistance Pioneer 2014
Herbicide tolerant
TC1507xMON810 Maize Insect resistance Pioneer 2014
Herbicide tolerant
TC1507 Maize insect resistance Pioneer 2012
Herbicide tolerant
BT11xGA21 Maize Insect resistance Syngenta 2010
Herbicide tolerant
GA21 Maize Herbicide tolerant Syngenta 2010 
MON89034xNK603 Maize Insect resistance Monsanto 2010
Herbicide tolerant
MON89034 Maize Insect resistance Monsanto 2010 
Bollgard IIxRR flex (MON15985x MON88913) Cotton Insect resistant Monsanto 2007
Herbicide tolerant
MON88913 (RR flex) Cotton Herbicide tolerant Monsanto 2007 
MON810xNK603 Maize Insect resistant Monsanto 2007
Maize Herbicide tolerant
Bolgard RR Cotton Insect resistant Monsanto 2005
Cotton Herbicide tolerant
Bollgard II, line 15985 Cotton Insect resistant Monsanto 2003
Bt11 Maize Insect resistant Syngenta 2003
NK603 Maize Herbicide tolerant Monsanto 2002
GTS40-3-2 Soybean Herbicide tolerant Monsanto 2001
RR lines 1445 & 1698 Cotton Herbicide tolerant Monsanto 2000
Line 531/Bollgard Cotton Insect resistant Monsanto 1997
MON810/Yieldgard Maize Insect resistant Monsanto 1997
Table 1. GMO general release approvals under the GMO Act
Source: www.daff.gov.za/doc/GeneralReleaseApprovals.pdf
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GMO Act, facilitated early on farm trials and sub-
sequent commercial releases. Furthermore, an 
organization, AfricaBio aided information dissem-
ination about GM crops and held regular farmers’ 
meetings to help spread farmer-to-farmer expe-
riences. Finally, the fact that South Africa is home 
to many highly sophisticated commercial farmers 
facilitated GM crop adoption (Thomson, 2013b).
Hereafter, the various GM crops will be discussed 
based on their traits. As most of these crops are 
grown by commercial and smallholder farmers 
(less than 2 hectares), the experiences of both 
types will be covered.
Insect resistance
Bt cotton
Bt cotton has been grown commercially in South 
Africa since 1999. An analysis of the benefits of 
adoption by both small- and large-scale farm-
ers (Gouse et al., 2004) revealed that the yield 
increase was 18.5% for large-scale farmers who 
irrigated, 13.8%, for large-scale farmers under 
rainfed agriculture, and 45.8% for small-scale 
farmers. Besides the yield benefits, the adoption 
of Bt cotton also caused a decrease in the volume 
of insecticides sprayed, with associated cost and 
health benefits. As small-scale farmers do most 
of their spraying by hand, this reduction usually 
meant more time for weeding and other farm 
management activities.
According to Gouse et al. (2004), “a high percent-
age of large-scale farmers have indicated that 
peace of mind about bollworms is a very impor-
tant benefit of Bt cotton.” This confidence gave 
farmers managerial freedom to devote time to 
other crops or general farming activities. These 
farmers also noticed increased populations of 
beneficial insects, such as ladybirds and lace-
wings, in Bt cotton fields, indicating a possible 
environmental advantage due to reduced insec-
ticide applications.
The area in South Africa where most of the Bt 
cotton is grown by small-scale farmers is the 
Makhathini Flats of KwaZulu-Natal. This region is 
rich in indigenous plants and weeds that act as 
natural host plants for all the bollworm species. 
Therefore, they act as alternative refuges for the 
moths and have helped to prevent the build-up of 
Bt-resistant insects (Green et al., 2003), in contrast 
to Bt maize.
In recent years, plantings of cotton, whether Bt or 
not, have decreased partly due to the world-wide 
drop in cotton prices. The yields of 12 to 15 tons per 
ha of dryland cotton that is produced predominant-
ly by small-scale farmers are not competitive. How-
Event Crop Trait Company Year approved
BT11x59122xMIR604xTC1507xGA21 Maize Insect resistant
Herbicide tolerant
Syngenta 2014
BT11xMIR604xTC1507x5307xGA21 Maize Insect resistant
Herbicide tolerant
Syngenta 2014
BT111xMIR162xMIR604xTC1507x5307 Maize Insect resistant
Herbicide tolerant
Syngenta 2014
MIR162 Maze Insect resistant Syngenta 2014
MON89034xMON88017 Maize Insect resistant
Insect resistant
Monsanto 2014
MON87701xMON89788 Soybean Herbicide tolerant
Insect resistant
Monsanto 2013
MON89788 Soybean Herbicide tolerant Monsanto 2013
DAS-44406-6 Soybean Herbicide tolerant Dow AgroSciences 2013
DAS-40278-9 Maize Herbicide tolerant Dow AgroSciences 2012
CV127 Soybean Herbicide tolerant BASF 2012
MON89034xTC1507xNK603 Maize Insect resistant Dow AgroSciences/
Monsanto
2012
Table 2. GMO commodity clearance approvals under the GMO Act
Source: www.daff.gov.za/doc/CommodityClearanceApprovals.pdf
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ever, all the cotton planted in 2014 was expected 
to be GM, mostly carrying the Bt gene together with 
herbicide resistance (James, 2014). The decrease 
in Bt cotton cultivation by small-scale farmers, such 
as those in the Makhathini Flats area, is due to the 
above economic reasons and not to a failure of 
the technology.
Bt maize
Maize, although technically a grain, is used in 
cooking as a vegetable or starch. In many African 
countries it is the staple food that people can 
eat three times a day. White maize is consumed 
by humans, yellow maize is fed to livestock and 
poultry. South Africa is the only African country 
growing commercial GM maize that is mostly con-
sumed locally by commercial farmers producing 
approximately 96% of the crop.
GM maize was introduced in 1997, but only be-
came commercially adopted on a major scale in 
2000. Since then, GM maize plantings have in-
creased dramatically. Maize can be severely dam-
aged by the larvae of the maize stalk borer, Bus-
seola fusca, and, as with cotton, genes coding for 
Bt toxin varieties can be introduced into this crop 
to protect it. In a 2009 study of 80 farmers plant-
ing Bt maize, it was found that the two greatest 
advantages associated with these plantings were 
convenient management (88%) and increased 
productivity (42.5%), whereas 42.5% indicated 
that they perceived Bt technology to be environ-
mentally friendly (Kruger et al., 2009).
In 2014, some 86% of commercial maize plant-
ings were estimated to be GM, of which 28% car-
ried the single Bt gene and the remainder com-
prised either herbicide resistance or both traits 
stacked. The adoption was very similar for white 
and yellow maize and is now reaching saturation 
because not all plantings are subject to severe 
stalk borer pressure and, hence, do not require Bt 
insect resistance. Over 92% of commercial maize 
samples tested were positive for GM traits, either 
pure GM or co-mingled. Some traders import or 
contract farmers for non-GM grain for certain 
customers (James, 2014).
The first report on resistance of the maize stem 
borer to Bt occurred in 2007. In order to limit 
such resistance, farmers are required to plant 
refugia. Refuges are defined as habitats in which 
the target pest is not under selection pressure 
because of the toxin and, therefore, provide a 
sustainable environment for pest development. 
The principle underlying the high-dose and ref-
uge strategy is that any resistant insect emerging 
from the Bt crop is more likely to mate with one 
of the much larger number of susceptible pest in-
sects from refugia than with each other, thereby 
decreasing the selection of Bt resistance alleles 
(Bourguet, 2004).
Initial levels of refuge compliance were low and, 
even though farmers were obliged to plant a refuge 
area for each Bt maize field, only 77.7% did so dur-
ing 1998. However, this number increased to 100% 
during 2008 (Kruger et al., 2009). Although the evo-
lution of resistance of Buscola fusca can probably be 
ascribed to several factors, including rainfall and hu-
midity, the low initial levels of compliance to refuge 
requirements probably played an important role 
(Kruger et al., 2011a). Interestingly, farmers remain 
positive about the technology in spite of resistance 
development (Kruger et al., 2011b).
A different story appeared when small-scale farm-
ers were surveyed. Of the 78 farmers interviewed, 
only 59% had more than 10 years of experience 
in cultivating maize and were well aware of the 
key production constraints. Their knowledge of 
GM maize production practices was very poor 
and knowledge of the risks associated with this 
technology was completely lacking. None of the 
farmers interviewed properly understood the ref-
uge strategy. In addition, most were illiterate and 
were, therefore, unable to read and understand 
the information on the user guides (Assefa and 
van den Berg, 2010). Clearly, this issue needs to 
be addressed if small-scale farmers are to culti-
vate Bt maize.
Remedial actions taken in South Africa have includ-
ed the release of pyramided maize hybrids that 
combine two different toxin-producing transgenes, 
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Cry1A.105 and Cry2Ab2, replacing the ineffective 
single transgene. However, it remains to be seen 
whether cross resistance will occur between the 
Cry1A.105/Cry2Ab2 and the closely related Cry1Ab 
toxin. In hindsight, the survival of Buscola fusca lar-
vae noted in 1988 should have triggered actions 
to address the issue and to monitor compliance 
with refuge requirements. This retrospection also 
emphasizes that Bt crops should not be seen and 
used in isolation from other insect resistance man-
agement measures (Van den Berg et al., 2013).
Post-harvest fungus resistance
Smallholder farmers in South Africa often store 
their annual maize crop in storage cribs that are 
open to the air. If the cobs have been “nibbled” 
by insect borers, holes will occur in their kernels. 
These kernels are perfect breeding grounds for 
fungi under rainy and sunny conditions alike. 
Many fungi are Aspergillus species that produce 
aflatoxins, a known human carcinogen that has 
been linked to liver cancer (http://ehtrust.org/fact-
sheets-facts-about-aflatoxin/). Instead of using 
such infected maize directly for food, many women 
will ferment it to form beer. As aflatoxins have also 
been implicated in oesophageal cancer, it is little 
wonder that this disease is widespread in parts of 
Africa where homebrewed maize beer is widely 
consumed. One indirect benefit of  Bt maize adop-
tion that has been observed in different countries 
is reduced mycotoxin contamination (F. Wu, 2006). 
Mycotoxins are secondary metabolites produced 
by fungi that colonize crops such as maize. Insect 
damage is one factor that predisposes maize ker-
nels to fungus contamination. There is strong field 
evidence that Bt maize has significantly lower levels 
of mycotoxins that non-Bt isolines. Hence Bt maize 
is an important genetic tool for reducing mycotox-
in contamination. 
Herbicide resistance
Maize
Weeds compete with crops for moisture, nutri-
ents, and light. Uncontrolled weed growth can 
thus result in significant yield losses. Therefore, 
farmers have been spraying herbicides on their 
crops for decades. As with insecticidal sprays, 
spraying is often done by means of airplanes, with 
the result that a great deal of the spray drifts away 
from the target sites.
The best known example of transgenic herbi-
cide resistance is Monsanto’s RoundupReady®. 
The active ingredient in the herbicide Roundup 
is glyphosate which acts on an enzyme found in 
many plants, including maize and its weeds. Using 
Roundup on conventional maize fields is a tricky 
operation because the herbicide must not make 
contact with the crop. RoundupReady® maize 
produces a naturally occurring form of the tar-
get enzyme, 5-enolpyruvylshikimate-3-phosphate 
synthase (EPSPS) that is resistant to glyphosate 
and, hence, to the herbicide. The gene encoding 
the glyphosate resistant form of EPSPS was de-
rived from Agrobacterium tumefaciens, coinciden-
tally the bacterium that is used to genetically ma-
nipulate plants.
In 2014, 19% of the GM maize crop in South Africa 
was herbicide tolerant, whereas 53% was planted 
to stacked Bt and herbicide-tolerant traits (James, 
2014). South Africa is the only country in the world 
where smallholder farmers have been producing 
a GM subsistence crop for a relatively long period 
of time. A study that followed the farmers’ experi-
ence for eight seasons in KwaZulu-Natal (Gouse, 
2012) revealed that both Bt and herbicide-toler-
ant maize seeds were valued. Interestingly, the 
farmers were more willing to pay for the weed 
control convenience than for insect borer control. 
The reason is that weeds are always present and 
the herbicide-tolerant seeds are a labor-saving 
device, whereas insect infestations come and go 
from season to season. Therefore, the option of 
planting seeds with stacked genes for both traits 
would apparently be preferred.
However, smallholder farmers have experienced 
practical problems related to obtaining crop cred-
it, signing of contracts to comply with refuge plant-
ing, enforcing refugia, and obtaining small aliquots 
of GM seeds (James, 2013). However, in 2013, mar-
keting of GM seeds in packets of 2 to 25 kg saw 
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planting of 6,308 hectares of GM white maize (8% 
insect resistant, 61% herbicide tolerant and 31% 
stacked), as well as 7,180 hectares of GM yellow 
maize (0.9% insect resistant, 78% herbicide toler-
ant and 21% stacked). This successful smallholder 
adoption is expected to increase (James, 2013). In 
the Gauteng region, where much of the country’s 
maize is grown, the number of smallholder farm-
ers cultivating GM maize has increased from 10 to 
33 with the number of hectares increasing from 
20 to 1275 in 2011 to 2014, respectively (AfricaBio, 
personal communication).
One of the positive environmental impacts of 
herbicide-resistant maize is the use of no-till cul-
tivation or conservation tillage. With conventional 
maize, farmers till the soil to allow weeds to grow, 
spray with herbicides, and then wait a sufficient 
time for their degradation before planting. Now, 
they can allow weeds and maize to grow together 
before spraying. This results in reduced soil ero-
sion and better moisture retention in the soil. In 
addition, Roundup is more readily degradable by 
bacteria than many other herbicides (Balthazor 
and Hallas, 1986).
Soybean
Soybeans are not a major crop in South Africa, 
with a planted area of approximately 600,000 
hectares in 2014 (James, 2014). However, 92% of 
the crop is GM herbicide tolerant.
Traits in the pipeline
A number of different GM crops specific for 
(South) Africa have been developed by the pub-
lic sector in South Africa. These include improved 
sugarcane (Saccharum officinarum), eucalyptus, 
and grapevine (Vitis sp.) varieties, post-harvest 
damage-protected potato (Solanum tuberosum), 
and virus-resistant cassava (Manihot esculenta). 
Maize resistant to the African endemic maize 
streak virus, one of the major threats to this crop 
in Africa, and tolerant to drought, a condition that 
is becoming increasingly important due to climate 
change, has also been produced (Thomson et al., 
2014). However, no field trials have taken place 
for any of these crops. The reasons include lack 
of funding, complicated regulatory environment, 
and market uncertainties.
Another crop being developed is vitamin A-en-
riched sorghum (Sorghum bicolor), similar to the 
Golden Rice (Oryza sativa) variety (Ye et al., 2000). 
In 2005, the Bill and Melinda Gates Foundation 
funded the African Biofortified Sorghum (ABS) 
project, run by an international consortium un-
der the leadership of Africa Harvest, an Afri-
can-based international non-profit organization. 
This engineered sorghum contains the gene for 
a high-lysine storage protein from barley (Horde-
um vulgare) and has increased levels of Vitamin 
A, iron, and zinc. In 2013, the ABS initiative re-
ceived a “Patents for Humanity Award” from the 
USA Patent and Trademark Office for its efforts to 
improve nutrition, production, and availability of 
sorghum in Africa (http://biosorghum.org).
Recommendations
GM crops are clearly popular with growers, com-
mercial and smallholder alike, because of the 
agronomic advantages they offer. To quote one 
farmer from the Mpumulanga province: “On av-
erage, with GM maize I get 5 tons/hectare on dry-
land, which is 0.5 tons better than conventional 
maize and under irrigation 10 tons/hectare, which 
is 1 ton better than conventional, equivalent to 
2,000 rand (US$ 200) plus 60 rand per hectare 
for better quality” (James, 2013). Another farmer 
in the Free State province, who grows 3,000 hec-
tares of GM maize as well as 340 hectares of soy-
beans, ascribes his success in crop production to 
GM varieties (James, 2013).
The mandatory labeling of GM/GMO “goods”, in-
gredients, or components, as prescribed in Regu-
lation 7 of the Consumer Protection Act of 2008 
should have entered into force in 2011. It has elicit-
ed ongoing criticism from stakeholders in the food 
chain due to its ambiguity and complexity. There 
has been little effort on the side of the Department 
of Trade and Industry to proceed with the enforce-
ment of this regulation that might be seen by trad-
ing partners as a technical barrier (James, 2013).
My recommendations regarding currently ap-
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proved GM crops are the following:
1.  Improve access to small amounts of seed by 
smallholder farmers.
2.  Provide farmers with agricultural extension ser-
vices to help them understand how to handle 
new and improved cultivars, enabling them to 
realize the importance of planting refugia (in 
the case of Bt crops) and to encourage them 
to operate in cooperatives to better implement 
appropriate agronomic and integrated pest 
management practices.
3.  Implement the labeling requirements by includ-
ing the words “may contain ingredients derived 
from GM crops”, where appropriate. This word-
ing is necessary because South Africa does 
not require the segregation of GM and non-
GM crops post-harvest. When producers can 
prove conclusively (in a court of law if required) 
that items contain less than the prescribed 
limit of GM crop-derived ingredients (1% per 
total mass or volume), then the words “does 
not contain ingredients derived from GMOs” 
should be mentioned.
My recommendations regarding GM crops in the 
pipeline are the following:
1.  Developers are needed to bring these crops to 
field trials and beyond. Many potential investors 
view crops that are important to Africans only 
as unable to make a return on their investment. 
I challenge this view as the resultant increase 
in food security could help to turn around the 
economies of many African countries.
2.  Governments should also realize that by sup-
porting this technology they can improve food 
security, nutritional security, and add to eco-
nomic growth.
3.  The South African regulatory authorities should 
rethink their current tendency to view any 
“home-made” GM crop as representing a great-
er risk than imported ones because of the lack 
of international biosafety data. Government 
authorities need to realize that African sci-
entists are just as capable of developing safe 
and valuable GM crops as their internation-
al counterparts and they also need to build 
their confidence in their own abilities to assess 
risk effectively.
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Abstract
The West-African cotton (Gossypium hirsutum) 
industry has a huge economic potential. In par-
ticular, Benin, Burkina Faso, Ivory Coast, and Mali 
play an important role as exporter on the world 
market. Still, the cotton sector is also subject to 
a number of risks that can threaten the sustaina-
bility of the cotton production in West Africa. This 
chapter overviews the challenging pest problems 
and assesses how biotechnology and, more spe-
cifically, insect-resistant cotton (Bt cotton), over-
come these problems. Introduction of Bt cotton 
in Burkina Faso and South Africa resulted in im-
portant benefits regarding yield, farmer income, 
pesticide use, and environmental and health 
impacts. When structural and institutional lim-
itations are suppressed to realize its full poten-
tial, Bt cotton can clearly contribute both to the 
economic and environmental sustainability of the 
cotton production.
 
Introduction
Cotton (Gossypium hirsutum) is an important in-
dustrial crop worldwide and the predominant 
natural fiber in the textile industry. Despite com-
petition with artificial fibers, cotton remains im-
portant and accounted for 30% of the more than 
82 million tons of textile fibers processed in 2013 
(www.icac.org/tech/Overview/100-facts-about-
cotton). In 2000, the world production of cotton 
was twice that of 1960. Even though the produc-
tion is subject to fluctuations, it still increases 
(http://faostat3.fao.org/home) (Figure 1). Farmers 
produce seed cotton that is processed into cotton 
lint, mainly for the textile industry to produce fab-
rics for clothing, furniture applications, or money 
bills. From the seeds derived from the seed cot-
ton less than 1% is used to plant cotton again 
(www.icac.org/tech/Overview/100-facts-about-
cotton). Cotton seeds are mainly applied in food 
and feed. The protein-rich seeds can  be used as 
feed for ruminants, but, because they contain the 
toxic gossypol, they are not suited for consump-
tion as such by humans and monogastric animals. 
Processing of the cotton seeds yields an edible oil 
that is suitable for cooking and human consump-
tion as well as additional byproducts utilized in 
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soaps and cosmetics (www.vib.be/en/about-vib/
plant-biotech-news/Documents/ BackgroundRe-
port_BT_Cotton.pdf).
Cotton is a subtropical crop and is grown either 
under irrigation or in sub-humid and semi-arid 
locations with an annual rainfall between 50 and 
150 cm (ECOWAS-SWAC/OECD, 2006). Because 
of the high vulnerability to insect infestations, 
cotton is currently grown in a few tropical loca-
tions only. In 2013, the top producers of seed 
cotton were China (18.93 million tons [Mt]), India 
(18.91 Mt), USA (7.63 Mt), and Pakistan (6.24 Mt) 
(http://faostat3.fao.org/home). The West-African 
production levels are quite low (2.35 Mt). Nev-
ertheless, the four main cotton-producing coun-
tries in West Africa, Benin, Burkina Faso, Ivory 
Coast, and Mali, play an important exporter role 
on the world market. Export of high-quality cot-
ton accounts for approximately 80% of the total 
production of the entire region. The cotton indus-
try is seen as an important source of economic 
growth as well as a social safety net for the re-
gion, especially in rural areas because it secures 
farmers’ income and generates employment. As 
a result, cotton is often referred to as ‘white gold’ 
(Redifer et al., 2014; Vitale and Greenplate 2014; 
http://faostat3.fao.org/home).
Despite its economic potential, the cotton indus-
try is also subject to a number of risks, such as 
price fluctuations of inputs (i.e. fuel, fertilizers, 
and pesticides) and cotton on the world market, 
changing weather conditions, and emergence of 
pests and/or pesticide resistance. All these can 
threaten the sustainability of the cotton produc-
tion in West Africa (Redifer et al., 2014, Vitale and 
Greenplate, 2014). In this chapter, we look at the 
pest problems that challenge the cotton produc-
tion and how biotechnology and, more specifical-
ly, insect-resistant cotton (Bt cotton), can play a 
role to overcome these problems. Furthermore, 
we aim to evaluate the contribution of Bt cotton 
to sustainable cotton production in Burkina Faso 
and South Africa. Specifically reviewing the intro-
duction of Bt cotton into these countries, we will 
take into account the lessons learned and analyze 
whether it can serve as a role model in other cot-
ton-growing countries in West Africa to increase 
the sustainability of the cotton sector.
Cotton production sustainability and the 
role of Bt cotton
Cotton production is subject to a number of risks, 
among which its susceptibility to a wide range of 
insect pests, such as the caterpillars Helicoverpa 
armigera (cotton bollworm), Pectinophora gossypii 
(pink bollworm), and Heliothis virescens (tobacco 
bollworm), was responsible for the largest eco-
Figure 1. Global production of cotton seed (green) and lint cotton (grey) (M tonnes) (source: FAOSTAT, 2015)
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nomical losses before efficient management strat-
egies were put in place (www.cottoninc.com/fib-
er/Agricultural Disciplines/Entomology/). For West 
Africa, the cotton bollworm has been reported to 
be the main threat and to be able to cause up to 
90% damage when untreated (Vitale and Green-
plate, 2014). The larvae feed on cotton terminals, 
small squares, such as blooms, large squares, 
and bolls, provoking important losses (Boyd et al., 
2004). As traditional pest control measures have 
become less efficient, other alternatives have 
been explored.
The common Gram-positive soil bacterium Ba-
cillus thuringiensis (Bt) produces crystal (Cry) 
proteins with an insecticidal activity. Large-scale 
screening of different Bt strains has revealed over 
700 cry gene sequences, of which some without 
known invertebrate target, but many effective 
against insect pests (Palma et al., 2014). More 
importantly, these Cry proteins that are specific 
to a limited number of insect species belonging 
to the orders of Lepidoptera, Diptera, Coleop-
tera, Hymenoptera, Homoptera, Othoptera, and 
Mallophaga, are not toxic to humans (Bravo et 
al., 2012). The Cry proteins are ingested as pro-
toxins and processed in the insect gut into Cry 
toxins, which recognize and bind specific recep-
tors in the insect gut wall, with pore formation 
(Bravo et al., 2012) or apoptosis (Zhang et al., 
2006) as a result. Eventually, the insect dies due 
to starvation and to bacterial or other infections 
(www.vib.be/en/about-vib/plant-biotech-news/
Documents/BackgroundReport_BT_Cotton.pdf).
As Cry proteins of B. thuringiensis are highly effec-
tive as well as specific against a number of insect 
pests, they were used as bioinsecticides already at 
the end of the 1930s (Schnepf et al., 1998; Bravo 
et al., 2012), but these commercial preparations 
that often contained a mixture of spores and 
crystals were not widely adopted. Inefficiency was 
high because of the non-optimal spray coverage 
and because rain showers washed off the pesti-
cides. Moreover production costs were relatively 
high and  the formulation was sensitive to UV deg-
radation (Krattiger, 1997). The plant genetic trans-
formation technology triggered the interest in Bt 
applications because they can bypass these disad-
vantages: spraying is no longer required, because 
the crops produce the Cry proteins themselves 
and, thus, are protected throughout their life cycle 
(www.vib.be/en/about-vib/plant-biotech-news/
Documents/ BackgroundReport_BT_Cotton.pdf). 
Biotechnology can greatly contribute to agricul-
tural challenges. Bt-mediated insect resistance 
was one of the first commercialized traits, namely 
in 1995, when the Bt potato (Solanum tuberosum) 
resistant to the Colorado potato beetle (Leptino-
tarsa decemlineata) was the first Bt crop approved 
for commercialization in the USA (James and Krat-
tiger, 1996). Since then, the Bt trait has been suc-
cessfully introduced into a number of crops, such 
as maize (Zea mays), brinjal or eggplant (Solanum 
melongena), poplar (Populus sp.), potato, and cot-
ton and has resulted in a worldwide adoption. In 
2014, 55 million hectares of insect-resistant Bt 
crops were planted (James, 2014).  In 1996, Bt cot-
ton was grown for the first time in the USA on 1.7 
million acres (approximately 688,000 ha). Bollgar-
dTM (Monsanto, St. Louis, MO, USA) cotton pro-
duced one Cry protein (Cry1A[c]) that conferred 
resistance against Helicoverpa armigera (cotton 
bollworm), Pectinophora gossypii (pink bollworm), 
Bucculatrix thurberiella (cotton leaf perforator), 
Trichoplusia ni (cabbage looper), and Estigmene 
acrea (Drury) (saltmarsh caterpillar) (Krattiger, 
1997). Since this first successful introduction, 
biotech cotton has been adopted by many cot-
ton-growing countries and new biotech cotton va-
rieties have been developed, such as herbicide-tol-
erant (HT) cotton or biotech hybrid cotton that 
produces two or more Bt toxins with different ac-
tion modes or combined with herbicide tolerance 
(James, 2014). BollgardII cotton synthesizes two 
proteins from Bacillus thuriengiensis: Cry1Ac and 
Cry2Ab and was developed by introducing the cry-
2Ab gene into transgenic cotton that already con-
tained the cry1Ac gene. These two Cry toxins are 
recognized by different receptor sites on the mid-
gut wall of the insects. Cry1Ac is effective against 
Helicoverpa armigera and Helicoverpa punctigera 
(Australian bollworm) as well as against Earias vit-
tella (rough bollworm), Pectinophora gossypii, and 
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some other Lepidoptera spp. The addition of Cry-
2Ab increases the efficacy by extending the peri-
od in which it effectively controls Helicoverpa spp. 
(www.monsanto.com/global/au/products/docu-
ments/bollgard-ii-technical-manual.pdf). An addi-
tional advantage is that the possibility that a target 
insect develops resistance simultaneously against 
the two different Cry toxins will be extremely rare 
(www.vib.be/en/about-vib/plant-biotech-news/
Documents/BackgroundReport_BT_Cotton.pdf).
In 2014, 15 countries, namely India, USA, China, 
Pakistan, Australia, Burkina Faso, Brazil, Argen-
tina, Paraguay, South Africa, Myanmar, Mexico, 
Colombia, Sudan, and Costa Rica, grew a total of 
25.1 million hectares of Bt cotton, constituting 
68% of the global cotton planted area (James, 
2014). In Africa, Bt cotton had already been intro-
duced in 1998 (Gouse et al., 2004), when it had 
been approved for commercialization in South Af-
rica. It took another 10 years for the first commer-
cial release in Burkina Faso and in 2012, Sudan 
was the third African country to adopt Bt cotton 
(James, 2014). To date, 73.8% of the cotton plant-
ed in Burkina Faso and 80% in Sudan is Bt cotton. 
Even though South Africa grows a relatively low 
acreage of cotton, the adoption rate of Bt cotton 
is high and reached 95%, whereas the remaining 
5% is HT cotton planted as refuge area to manage 
insect resistance development (James, 2014).
The wide-scale adoption of insect-resistant (IR) 
cotton has resulted both in a positive environ-
mental and economic impact when compared 
to conventional farming practices. In 2012, the 
global farmer income gains from the use of IR 
cotton have been estimated at US$ 5.3 billion. 
These gains resulted mainly from increased yields 
thanks to reduced crop damage, especially in de-
veloping countries, but also from decreased input 
costs, mostly in developed countries (Brookes and 
Barfoot, 2014). The number of insecticide sprays 
could be reduced significantly, corresponding 
to important savings in insecticide-active ingre-
dients: 205.4 million kg cumulatively from 1996 
to 2012 or a reduced environmental impact of 
28.2% (as measured by the Environmental Im-
pact Quotient). An additional positive effect from 
using biotech IR cotton is the decreased fuel us-
age, namely 17 million liters in 2012 (Barfoot and 
Brookes, 2014).
The cotton industry in Burkina Faso
Cotton was already produced in West-Africa dur-
ing the colonial period at the beginning of the 
20th century. In 1949 under the French admin-
istration, the Compagnie française pour le dével-
oppement des fibres textiles (CFDT) was founded 
and contributed to the development of the cot-
ton industry (Perret, 2009). The CFDT applied the 
parastatal industry model: a vertical coordination 
between producers and company. Under a par-
astatal structure, the company provides inputs, 
such as seeds, pesticides, and fertilizers, and 
technical advice to the farmers. After the grow-
ing season, the company buys the yield at fixed 
prices from the farmers, who in this manner pay 
off their input credit, and takes up transportation, 
ginning, and marketing (Theriault and Serra, 2014; 
Tumusiime et al., 2014).
After independency in the early 1960s, state-
owned enterprises set up the parastatal model 
and promoted cotton production (Theriault and 
Serra, 2014; Tumusiime et al., 2014). After the 
independence of Haute-Volta, renamed Burkina 
Faso in 1984, the CFDT partnered with the govern-
ment and private investors to found the Sociéte 
Voltaïque/Burkinabé des Fibres Textiles, abbre-
viated SOFITEX (Redifer et al., 2014). The cotton 
production increased as producers gained access 
to chemical fertilizers, insecticides, herbicides, 
and improved cotton seeds. Land expansion also 
contributed to intensify the cotton production (Vi-
tale and Greenplate, 2014), namely from 74,000 
ha in 1981 to 406,000 ha in 2003 (Redifer et al., 
2014). This was of great importance for the eco-
nomic development and rural livelihoods.
However, in the late 1990s, the world prices col-
lapsed and the sector faced an economic crisis. 
The sector was also subject to bad governance and 
mismanagement. Input credits were given also to 
non-cotton farmers, even though cotton revenue 
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remained the principal mean to cover the loans. 
In addition, some farmers sold their inputs on the 
black market without repaying their loans (Theriault 
and Serra, 2014). The economic crisis led to struc-
tural and market-oriented reforms. The sector was 
partially liberalized and two new additional ginning 
companies, Faso-Coton and Société Cotonnière du 
Gourma (SOCOMA) were established. This howev-
er did not result in a price competition between the 
three companies (Tumusiime et al., 2014) because 
they each manage their own production zone and 
retained a parastatal structure. SOFITEX controls 
the West and approximately 80 to 90% of Burkina 
Faso’s total cotton production, SOCOMA the East, 
and Faso-Coton the center (Bassett, 2014; Redif-
er et al., 2014). Market coordination and contract 
enforcement were improved by installing region-
al cooperatives restricted to cotton farmers only, 
whereas a national inter-professional association 
grouped the unions of the farmers, the Union Na-
tionale des Producteurs de Coton du Burkina Faso 
(UNPCB; the national cotton producer association 
or growers’ union) and the ginners, Association 
Professionnelle Des Sociétés Cotonnières du Bur-
kina (APROCOB, the professional association of 
cotton companies of Burkina) (Theriault and Serra, 
2014; Redifer et al., 2014; Vitale and Greenplate, 
2014). As a consequence, the involvement of the 
producers in the companies increased, while the 
government’s role in decision making was reduced 
(Tumusiime et al., 2014).
Despite these reforms, the cotton produc-
tion level decreased between 2006 and 2011 
(http://faostat3.fao.org/home). One reason is that 
the costs for fertilizers had increased and simul-
taneously the cotton prices dropped, imposing a 
serious pressure on the sector. To tackle these 
short-term risks, two publicly managed schemes 
were installed: the “Stabilization Fund” in 2007 
and the “Input Fund” in 2012. In short, farmers re-
ceive subsidies from the Stabilization Fund when 
cotton prices are low and funds are returned in 
years with high cotton prices. The Input Fund en-
sures that input costs, in particular fertilizers, are 
affordable by supplying credits at reduced costs 
(Redifer et al., 2014).
In the last years, Burkina Faso’s cotton production 
has recovered, reaching 766,000 tons in total in 
2013 (http://faostat3.fao.org/home), representing 
3.5% of Burkina Faso’s gross domestic product in 
real terms. Cotton accounted for 18% of the ex-
port earnings in 2013 and 15-20% of the labor in-
come is estimated to derive directly from it (Red-
ifer et al., 2014). Nevertheless on the long term, 
cotton prices might still continue to drop. Cur-
rently, there is a production surplus, resulting in 
significant stock volumes. The International Cot-
ton Advisory Committee predicts that “Even as-
suming reasonably lower production and higher 
consumption in the next few years, it will take sev-
eral seasons for the significant volume of stocks 
to reach a more sustainable level, and low cotton 
prices are likely to persist while the market adjusts” 
(www.icac.org/Press-Release/2015/PR-1-Low-
Cotton-Prices-A-Long-term-Problem#zoneTop-
Wrap). This situation could threaten the sustain-
ability of the cotton sector in Burkina Faso and 
concerns raise that under continuing low prices 
producers might shift away to other crops.
Bt cotton introduction in Burkina Faso
Input costs arise not only from the acquisition of 
seeds and fertilizers, but also from pesticides. In 
conventional cotton cultivation, farmers typical-
ly spray 6 times throughout the season and in 
Burkina Faso annually the aggregate insecticide 
costs can roughly be as high as US$ 60 million. 
In addition, insecticide resistance had emerged in 
Burkina Faso, with, as a consequence, not only an 
intensified insecticide use, but also a shift towards 
broad-spectrum, more toxic insecticides that 
pose significant health hazards. The decreasing 
efficiency of the conventional pest control mea-
sures triggered the interest of Burkina Faso in 
biotechnological applications as a new pest con-
trol option. In collaboration with Monsanto, two 
regional Bolgard II varieties were generated. In 
parallel, the government developed a legal frame-
work to regulate field testing and commercializa-
tion of genetically modified (GM) crops. After sev-
eral years of field trials (2003-2007), the National 
Biosafety Agency authorized the two Bt cotton va-
rieties for seed production and commercialization 
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in 2008 (Vitale and Greenplate, 2014), which were 
distributed that year by the three cotton-produc-
ing companies and planted on approximately 
8,500 ha for seed multiplication. One year later, 
the adoption rate already increased to 29% and 
reached 70% in 2014 or a total of 454,124 ha, 
demonstrating the success of Bt cotton in Burkina 
Faso (Figure 2) (James, 2009, 2014).
The parastatal structure of the cotton industry 
in Burkina Faso facilitated the introduction of Bt 
cotton (Vitale and Greenplate, 2014). The large 
number of smallholders, approximately 300,000, 
who grow cotton would result in numerous con-
tracts and agreements under the typical market-
ing model, but the vertical coordination through 
APROCOB allowed the upstream introduction 
of the technology and reduced the number of 
agreements to enforce the legal compliance and 
prevent resale and reuse of the Bt cotton seeds. 
In addition, the legal burden was shifted from the 
producers to the company. The royalties were set 
up in such a manner that the fee for the Monsan-
to technology depended on the farmer’s income. 
The gross income is calculated as the value of 
increased yield plus savings in insecticides and 
is divided between the farmers (two-thirds) and 
Monsanto and the seed companies (one-third) 
(James, 2014). Burkina Faso continues to support 
Bt cotton and a new authorization for 10 years for 
Bollgard II has been issued in 2013. Meanwhile, 
other cotton biotech varieties are explored: for 
example, Roundup Ready® Flex cotton (Monsan-
to) was in its fourth year of field trials in 2014 and 
field trials have started with the stacked Bollgard II 
x Roundup Ready® Flex cotton (ABNE, 2015).
The introduction of Bt cotton into Burkina Faso 
in 2008-2009 has also created a research pool 
regarding socioeconomic, environmental, and 
health impacts. Several studies have been con-
ducted over a period of five years (2009-2013) 
and annually reported to the Agence Nationale 
de Biosécurité, the National Biosecurity Agency 
(ANB). The following paragraphs summarize the 
main findings of these reports (I.R.E. Sanou, G. 
Vognan, J. Vitale and I. Brants, personal commu-
nication).
Yield performance (kg ha-1)
In the 2013 growing season, the yield of growers 
of Bt cotton was 14.3% higher than that of con-
ventional cotton growers (Figure 3). Moreover, 
such yield gain has been observed for each agri-
cultural campaign from 2009 to 2013, albeit with 
yearly variations that may be essentially due to 
two factors, namely raining season fluctuations 
and fertilizer mixtures. Nevertheless, it is clear 
that cultivation of Bt cotton created a substantial 
yield gain of at least 14%.
Figure 2. Adoption rate of Bt cotton in Burkina Faso.
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Bt cotton profitability (US$ ha-1)
In 2013, analyses indicated that farmers derive 
the majority of their income from growing Bt cot-
ton (on average 63.1%), implying that Bt cotton is 
an economically important crop for the country. 
For the yearly reports to the ANB, the profitability 
of Bt and conventional cotton has been analyzed 
by comparison of net incomes, by taking into ac-
count the gross income based on yield, the sale 
price of cotton, as well as the average input costs 
for seeds, fertilizers, insecticides, herbicides, and 
labor. The average costs are considered because, 
besides seed cost, each cost is able to change 
from one agricultural campaign to another in Bur-
kina Faso. In fact, during each campaign, a dialog 
framework is instituted between the government 
and the farmer’s organization UNPCB that fixes all 
prices considering the cotton currency on the in-
ternational market.
At the end of an agricultural campaign, a Bt cotton 
grower experiences on average a production cost 
quasi equivalent to a conventional cotton grower 
(US$ 319 ha-1 to US$ 312 .ha 1) (Figure 4). This in-
significant difference in production costs is due to 
the fact that even though Bt cotton farmers have 
a relevant gain in insecticides treatments, they 
incur higher seed costs. As a result, the sum of 
seeds and insecticide costs is approximately the 
same for Bt cotton (US$ 78 ha-1) and conventional 
cotton (US$ 75 ha-1). Nevertheless, farmers grow-
ing Bt cotton have a 65.1% higher net income 
than conventional cotton growers that could be 
attributed to the yield gains and concurrently in-
creased gross income.
Environmental impact
Bt cotton has been discredited at its adoption time 
due to the perception of possible environmental 
risks, but field observations show a clearly posi-
tive impact. Since its introduction in 2008, a sig-
nificant reduction in the insecticide use has been 
observed (Figure 5) (http://faostat3.fao.org/home) 
with a beneficial impact on the environment. This 
reduction results from the reduced annual num-
bers of sprays from 6 to 2 as recommended to 
control sucking insects present in the field.
The yearly reports to the ANB also assessed the be-
havior of  Bt cotton farmers regarding this recom-
mendation. On average, 1.1% of the farmers do not 
spray their fields at all, 18.9% once a year, and 80% 
report to faithfully respect the two sprays. Never-
theless, disregard of the recommended number of 
sprays is not without consequences on yield perfor-
mance (Figure 6). Indeed, two insecticide sprays to 
deal with the secondary insect pests improve yields 
on average by 17.9% and even 40.7% compared to 
one and no treatment, respectively.
Specific interviews under the research framework 
from 2011 to 2013 focused mostly on the identi-
Figure 3. Yield performance (Kg.ha-1); BG II: BGII, Bollgard II (Bt cotton); conv., conventional cotton.
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Figure 4. Average Bt cotton profitability (US$ ha-1) from 2009-2013. BG II, Bollgard II (Bt cotton); conv., con-
ventional cotton; insect., insecticides; fert., fertilizers; product., production.
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Figure 5. Use of insecticides in Burkina Faso since the introduction of Bt cotton in 2008.
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fication of beneficial species present in Bt cotton 
fields, such as termites, bees, and ants that have a 
role in the agroecosystem equilibrium. All farmers 
interviewed certified the presence of these spe-
cies. These results match outcomes of Bt cotton 
trials before commercialization, indicating that re-
duction of insecticide treatments would increase 
the presence of beneficial organisms.
Health impacts
Field surveys of the Institut National pour l’Etude 
et la Recherche Agronomiques indicated that over 
seven growing seasons (2004-2010), 50.8% of the 
cotton farmers experienced at least one pesticide 
poisoning incident, despite the extensive services in 
good management practices provided by the seed 
companies. Approximately 80.3% of these incidents 
could be attributed to the application of Lepidop-
tera-targeting insecticides. These incidents have se-
89
rious health impacts, from symptoms ranging from 
dizziness to difficult breathing and vomiting and, ad-
ditionally, they lead to economic losses as well due 
to medical costs and a loss of income, which have 
been estimated at US$ 39.22 per incident. However, 
with the introduction of Bt cotton, farmers were able 
to reduce the number of sprays. The 2011 survey 
showed a 75% decreased pesticide use for Bt cot-
ton farmers, translating into a projected reduction 
of 30,380 poisoning incidents and a positive eco-
nomic impact of US$ 1.09 million per year.
In conclusion, both the farmers and the environ-
ment have benefitted from the introduction of 
Bt cotton in Burkina Faso, not only by improving 
the safety of the working conditions but also by 
an increased net income from the yield gains. The 
2011 survey indicated that the reduced pesticide 
use combined with the enhanced yields were 
perceived by 63.5% of the farmers as the most 
important motivation to adopt Bt cotton, whereas 
for an additional 16% the limitation in health risks 
was the single most important reason.
Bt cotton introduction in South Africa
South Africa planted Bt cotton for the first time 
in 1998. The adoption rate continued to increase 
and the Bt cotton coverage reached 95% in 2007 
(with the remaining 5% HT cotton planted as ref-
uge area) (James, 2007). Bt cotton was not only 
adopted by large-scale farmers, but also by small-
holders. In the 1998/1999 season, 12% of the 
cotton-growing farmers in the Makhathini region 
planted Bt cotton. This grew to 40% in 1999/2000, 
60% in 2000/2001, and 90% in 2001/2002 (Ismael 
et al., 2002; Gouse et al., 2005). Studies indicated 
that the yield increases had the highest impact 
on the income of both large-scale and small-scale 
farmers, with the largest yield increases obtained 
by the large-scale farmers who use irrigation. 
Furthermore, the reduced number of insecticide 
sprays additionally result in decreased application 
costs. Large-scale farmers save on diesel costs 
and tractor hours, whereas small-scale farmers 
benefit from labor savings that can be reinvest-
ed into other agricultural management practices, 
such as weeding and harvesting. Together, these 
benefits generate increased farming income for 
both groups, despite the high seed costs and 
additional technology fee (Gouse et al., 2004). Of 
course, yield benefits can differ from one season 
to another, because they are also influenced by 
weather conditions and insect pressure. Analysis 
indicates that the yield increase from Bt cotton 
is higher during a wet season when insect pres-
sure is higher and the pesticides are washed off 
Figure 6. Yield performance (kg ha-1) according to the insecticides sprays in Bt cotton fields. 
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by rain than in a dry year without significant yield 
advantage. Even so, the overall impact is positive 
and weather-related variation is reduced (Gouse 
et al., 2005). Besides the economic benefits, the 
number of insecticide sprayings related to Bt cot-
ton plantings had decreased between 1998 and 
2001 with a beneficial impact on the environment 
(Morse et al., 2006). Surprinsingly, this decrease 
resulted from a reduction not only in pesticides 
targeting H. armigera,  but also in the highly toxic 
pesticides targeting secondary pests. The advan-
tage would be less clear, when the applications of 
the latter would increase again.
The issue of field-emerging  
Bt resistance and its solution
The main threat to the success of the Bt appli-
cations would be the development of insect 
resistance in the field. In the past, the cotton 
bollworm has been able to adapt to the chemi-
cal pesticides, hereby reducing their efficien-
cy. The large-scale exploitation of Bt cotton in-
creases the selective pressure and Bt-resistant 
insects have already been observed in the field 
(www.vib.be/en/about-vib/plant-biotech-news/
Documents/BackgroundReport_BT_Cotton.pdf). 
Field-evolved resistance to Cry1Ac with reduced 
crop efficacy has been reported in cotton fields in 
the USA (in 2002) and India (in 2009), both within 
less than 10 years after their commercialization. 
In 2005, only 2 years after the commercialization 
of Cry1Ac and Cry2Ab hybrid cotton, Cry2Ab- 
resistant insect populations have been detect-
ed in the USA, possibly caused by Cry1Ac cross- 
resistance. Experiments have indeed indicated 
that resistance to plants that produce two Cry tox-
ins evolves faster when they are grown alongside 
single-toxin plants (Tabashnik et al., 2013).
It is widely recognized that the level of pest re-
sistance to Bt crops will determine their long-
term efficacy. Hence, proactive measures have 
been set up to delay and manage the evolu-
tion of pest resistance (Tabashnik et al., 2013; 
www.vib.be/en/about-vib/plant-biotech-news/
Documents/BackgroundReport_BT_Cotton.pdf). 
The United States Environment Protection Agency 
imposed a number of IR management practices, 
with planting of refuge areas as a key component 
(http://www3.epa.gov/pesticides/chem_search/
reg_actions/pip/regofbtcrops.htm). Other meas-
ures include monitoring for resistance develop-
ment or for increased tolerance to the Bt pro-
tein; education of and increased communication 
among growers, producers, researchers, and the 
public; development of a remedial action plan in 
case of identified resistance.
The refuge approach is based on the assumption 
that inheritance of resistance is recessive and 
that mating between susceptible and resistant 
insects will result in progeny susceptible to the 
Bt toxin(s). The success of this strategy does 
not only depend on the recessive nature of the 
resistance, but also on a low initial frequency of 
resistance alleles and the abundant presence of 
non-Bt host plant refuges. For example, Australia 
applies a very strict refuge requirement, name-
ly 70% for one-toxin and 10% for two-toxin Bt 
cotton. The resistance frequency in Australia re-
mained below 1% for Helicoverpa armigera and 
Helicoverpa punctigera after more than a decade 
since its first release. In addition, the dose of 
Cry toxins in Bt crops has to be high enough to 
eliminate more than 99% of susceptible insects 
under field conditions. This strategy is referred 
to as ‘the high-dose rule’  (Tabashnik et al., 2013; 
www.vib.be/en/about-vib/plant-biotech-news/
Documents/BackgroundReport_BT_Cotton.pdf). 
Indeed, studies on Bt maize in South Africa have 
shown that resistance development to Busseola 
fusca (maize stalkborer) has been enhanced be-
cause the crop did not conform with the high-
dose requirement. Moreover, this was aggravated 
by  the low compliance to refuge requirements by 
South-African farmers during the first 5-7 years 
after release (Kruger et al., 2012; van den Berg et 
al., 2013).
In theory, combining different Bt toxins targeting 
the same pest into one plant, the so-called pyr-
amids or stacks, significantly lowers the chance 
of resistance development, but the example de-
scribed above indicates that resistance develops 
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faster when pyramids are grown alongside sin-
gle-toxin plants. Resistance can emerge already 
after two years in the absence of appropriate 
insect resistance management practices and sub-
optimal design of the resistance gene(s) (Tabash-
nik et al., 2013). Nevertheless, under optimal cir-
cumstances and when all factors influencing the 
development of insect resistance are taken into 
account, Bt crop efficiency can be sustained for 
15 years or more. Even with the use of Bt pyra-
mids, it is absolutely imperative that farmers are 
informed on and comply with insect resistance 
management practices when they adopt Bt crops 
to ensure their sustainability.
Bt cotton for the West-African  
cotton production
Before considering the introduction of Bt cotton 
into other West-African cotton production sys-
tems, it will be important to introduce the trait 
into local varieties adapted to the regional climat-
ic conditions to fully gain the benefits observed 
for Burkina Faso and South Africa. In addition, the 
local farmers will need to be trained to implement 
resistance management practices to ensure a du-
rable crop protection and to avoid or delay the 
development of insect resistance. When these 
important factors are taken into account, the ex-
amples described above clearly indicate that Bt 
cotton adoption into the cotton production sys-
tems is beneficial with regard to yield and farm 
income, pesticide use, and environmental and 
health impact.
However, it should be considered that the 
South-African farmers have been confronted with 
some limitations, such as difficult climatic condi-
tions, failing credit system, and monopsonistic 
cotton companies, which can all put pressure on 
the sustainability of the cotton economy (Gouse 
et al., 2005; Morse et al., 2006; Witt et al., 2006). Al-
though Burkina Faso reformed its cotton sector, it 
did not create competition. As a result, world mar-
ket prices are not always translated into producer 
prices which in 2011, led even to farmer protests 
(Bassett, 2014). In contrast, studies have shown 
that in the absence of a well-functioning credit 
market, parastatal structures improved growth in 
the cotton sector (Tumusiime et al., 2014). In Bur-
kina Faso, the reforms tackled the challenges on 
a global level by establishing a funding mecha-
nism to balance the impacts of seasonal varia-
tions in input and/or international cotton prices 
(Redifer et al., 2014).
In conclusion, it is clear that Bt cotton presents im-
portant benefits that contribute both to econom-
ic as well as environmental sustainability, but the 
structural and institutional limitations should be 
addressed appropriately to realize its full potential.
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Abstract
Comparable to the rapid adoption of the 
high-yielding crop varieties during the Green Rev-
olution, four agriculturally important countries of 
South Asia are at the forefront in implementing 
genetically modified (GM) crops to reduce pro-
duction cost and increase food production. India, 
Pakistan, and Myanmar were the first to approve 
the commercial cultivation of the first generation 
of insect-resistant Bt cotton (Gossypium hirsutum). 
Likewise, Bangladesh was the first country in the 
world to commercialize insect-resistant Bt brinjal 
or eggplant (Solanum melongena) varieties to in-
crease domestic vegetable production. Approxi-
mately 1.7 billion people live in South Asia, with 
the majority depending on agriculture for liveli-
hood, employment, and economic activity. India, 
Bangladesh, and Pakistan are also home to the 
poorest people in the world. Furthermore, South 
Asia suffers from malnutrition and hunger that are 
rampant in the rural areas. These countries are 
also vulnerable to climate change and seasonal 
weather disturbances that often result in severe 
losses in crop production and decreased income 
for farm communities. These four South Asian 
countries have either set up or are in the process 
of setting up policies and regulatory frameworks 
and have adopted GM crop technologies to help 
address agricultural constraints and improve 
their farmer’s livelihoods in the 21st century.
 
Overview of agriculture in South Asia
Agriculture is at the heart of employment, liveli-
hood, and economic activities in the South Asian 
regions, including the countries of the South Asian 
Association for Regional Cooperation and Myan-
mar. Agriculture contributes to one-third to two-
thirds of the gross domestic production and em-
ploys two-thirds of the population. In the 1970s, 
the introduction and rapid adoption of semi-
dwarf and high-yielding crop varieties and hybrids 
enabled smallholder farmers to achieve break-
throughs in yield and production, helping these 
countries to feed the ever growing population. Of 
the approximately 1.7 billion people in 2015, the 
populations of India, Pakistan, Bangladesh, and 
Myanmar are estimated to be 1,250 million, 182 
million, 156 million, and 53 million, respectively. 
In these countries 42% of the world’s population 
is estimated to earn less than US$ 1.25 per day 
(http://www.worldbank.org/en/news/feature/ 
2014/03/24/south-asia-regional-brief), with the 
Eastern States of India and Bangladesh as the 
dark spots of rural poverty. In addition to ex-
treme poverty, malnutrition, and hunger are 
rampant in these rural parts. The South Asian 
countries are also vulnerable to climate change 
and seasonal weather disturbances that put a 
tremendous pressure on agriculture for meeting 
food security. As noted in Table 1, India has to 
feed its 1.25 billion people from the ever shrink-
ing arable land of 157 million hectares and the 
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availability of arable land per person has de-
creased to 0.05 hectare per person in Bangladesh 
(http://data.worldbank.org/region/SAS). On the 
contrary, the demand for food in terms of cal-
ories increases in each country, because food 
consumption shifts toward non-vegetarian food 
with an increasing income (Table 1). At the na-
tional level, the productivity of the major crops 
is either stagnant or decelerating, thus widening 
the gap between demand and supply in the food 
production system. In recent years, the availabil-
ity of food grains, pulses, edible oil, vegetables, 
and fruit has decreased (Choudhary et al., 2014a). 
Similarly, the average cereal yields in the ma-
jor Asian countries are among the lowest in the 
world (Table 2). With the exception of maize (Zea 
mays) and cotton (Gossypium hirsutum), the yields 
of other crops, including rice (Oryza sativa), wheat 
(Triticum sp.) and millets are stagnant and need 
to increase to maintain the food supply. Many 
countries are at risk of crop damage due to pests 
and diseases and sometimes crop failures result 
from the effects of climate change. The South 
Asian region often registers significant yield de-
creases that require the introduction of improved 
crop varieties and farming practices. These new 
crops should not only withstand biotic and abiot-
ic stresses, but also help smallholders to create 
more resource-efficient and resilient farming sys-
tems. The adoption of improved crop varieties is 
indispensable for competitive agriculture, which 
remains at the heart of rural transformation.
Globally important GM Crops
In 2014, GM crops were planted over 181 million 
hectares in 28 countries, spanning from North 
and South America, Africa, Europe, Asia, and Oce-
ania. More than 18 million farmers benefited by 
planting crops that were resistant to insects and/
or tolerant to herbicides. Of these 28 countries, 
four of them are South-Asian countries, namely 
India, Pakistan, Bangladesh, and Myanmar (James, 
2014). The insect-resistant (IR) and herbicide-tol-
erant (HT) traits are two of the major innovations 
that are effectively utilized by smallholder farmers 
in both industrial and developing countries. No-
tably, the IR and HT traits are the most advanced 
technologies in the agricultural sector that are 
packaged into the simplest form of crop inputs 
known as seed. Firstly, the familiarity to seed 
makes this technology preferred by the small-
holder farmers, leading to a rapid uptake of GM 
crops in both industrial and developing countries. 
Secondly, both IR/HT traits are accessible in lo-
cal crop varieties that are grown and known for 
decades. The IR trait, which is available in single 
and double genes, tackles effectively the major 
insect pests of crops, such as cotton, maize, and 
Country Population 
(millions)
Total arable (Mha) Arable land  
(ha/person)
Rural population  
(% of total  
population)
Employment in  
agriculture (% of 
total employment)
Small farms  
(millions) 
India 1250 157 0.13 68 51 93
Pakistan 182 21 0.12 62 45 -
Bangladesh 156 8.7 0.05 67 - 17
Myanmar 53 10.4 0.20 67 - -
Table 1. Key Agriculture Indicators in South Asia 
Country Wheat 
(Mha)
Rice (Mha) Maize (Mha) Soybean (Mha) Cotton (Mha) Cereal* Yield  
(kg/ha)
India 29 42 9.0 10 12 2,962
Pakistan 8.5 2.5 1.0 - 3.0 2,722
Bangladesh 0.4 11 0.2 0.04 0.05 4,357
Myanmar 0.1 7 0.45 - 0.35 3,641
Table 2. Area and Yield of Major Crops in South Asia 
*Cereal: wheat, rice, maize and millets
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brinjal or eggplant (Solanum melongena). The first 
generation of the single-gene IR trait (cry1Ac gene) 
imparts effective resistance to the American boll-
worm Helicoverpa armigera in cotton and Leu-
cinodes orbonalis, known as the Shoot and Fruit 
Borer (FSB) of brinjal. The double-gene IR trait 
controls both Helicoverpa armigera and Spodop-
tera pests in cotton. Uniquely, GM crops are also 
available with stacked traits of IR/HT. In addition 
to controlling the insect pests through the IR trait, 
the HT trait helps farmers to kill weeds by spray-
ing herbicides on HT crops without damaging the 
crop. Stacking of the IR and HT traits offers farm-
ers an advanced and environmentally friendly 
alternative to tackle multiple constraints, such as 
effective control of specific insect pests and effi-
cient management of weeds.
Approval and adoption of GM crops in 
South Asia
In 2002, India was the first South Asian country 
to approve the commercial planting of Bt cotton 
(Table 3). It was a breakthrough to revive the ail-
ing cotton sector in the country that was then 
characterized by a stagnation in terms of produc-
tion, a decelerating yield trend with consequently 
overreliance on import for many decades. Before 
2002, Indian cotton farmers suffered consider-
able losses due to the heavy infestation of Heli-
coverpa armigera, thus requiring often numerous 
insecticide sprays. Half of the total amount of in-
secticides used in the country was consumed for 
cotton alone before the commercial approval of 
Bt cotton in 2002 (Kranthi, 2012). Figure 1 shows 
percent reduction of insecticides on cotton with 
Country Biotech 
crop
Approval Biotech area in 
2014 
Total area Adoption Date  
of signature
Date of entry 
into force
India Cotton 2002 11.6 Mha 12.25 Mha 95% 01/23/2001 09/11/2003
Pakistan Cotton 2010 2.85 Mha 3.2 Mha 88% 01/04/2001 05/31/2009
Myanmar Cotton 2010 318,000 ha 360,000 ha 88% 05/11/2001 05/13/2008
Bangladesh Brinjal 2013 12 ha 50,000 ha <1% 05/24/2000 05/05/2004
Nepal 03/02/2001 09/11/2003
Bhutan - 09/11/2003
Maldives - 09/11/2003
Sri Lanka 05/24/2000 07/26/2004
Afghanistan - 05/21/2013
Table 3. Approval of insect resistant (Bt) Crops in South Asia
Figure 1. Percent reduction of insecticides on cotton with respect to total insecticides and pesticides used 
in agriculture in India, 2001 to 2012. Source: Kranthi (2012); Choudhary, et al. (2014).
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respect to total insecticides and pesticides used in 
agriculture in India, 2001 to 2012. A large number 
of insect-resistant Bt cotton varieties that express 
single cry genes were successfully developed and 
released between 2002 and 2006. In 2006, the 
Government of India released the double-gene 
Bt cotton hybrids that contained the cry1Ac and 
cry2Ab genes. In subsequent years, double-gene 
Bt cotton hybrids were approved that controlled 
both Helicoverpa armigera and Spodoptera. These 
hybrids were widely adopted by cotton farmers 
across the country. In the meantime, four other 
events of Bt cotton that express different variants 
of the cry gene(s) were approved as well. Howev-
er, the smallholder cotton farmers preferred the 
double-gene Bt cotton hybrids over the other Bt 
cotton events. In the 2002-2014 period, cotton 
farmers, irrespective of farm size and income, re-
placed the commonly used chemical-based crop 
protection methods for the insect-resistant Bt 
cotton method that is a more efficient and cost-ef-
fective crop protection (Choudhary et. al., 2014a). 
In the same period, farmers grew Bt cotton over a 
very large acreage, covering irrigated, rainfed, and 
semi-irrigated areas of the country. By 2014, the 
area under Bt cotton cultivation had increased 
to over 11.6 million hectares, corresponding to 
95% of the total cotton area in the country (Table 
3). Approximately 7 million smallholder farmers 
representing more than 95% of the total cotton 
farmers in the country adopted Bt cotton in the 
10 cotton-growing states (James, 2014). Thus, Bt 
cotton has become an integral part of the cotton 
cultivation in India.
Following the success of Bt cotton in India, the 
neighbouring country Pakistan, became the sec-
ond South Asian country to approve the com-
mercial cultivation of the single cry gene-based 
Bt cotton varieties in 2010 (Table 3). Eight Bt cot-
ton varieties expressing the cry1Ac gene, includ-
ing the Mon531 event developed by Monsanto 
and one Bt cotton hybrid expressing the fused 
cry1Ac and cry1Ab genes (GFM event) developed 
by Pakistani public-sector institutes and local 
seed companies, received approval for commer-
cial cultivation by the Punjab Seed Council (PSC). 
Later, the former federal Ministry of Food and 
Agriculture and the federal National Biosafety 
Committee (NBC) of the Pakistan Environmental 
Protection Agency (Pak EPA) endorsed the PSC 
decision for commercial release of Bt cotton (at 
http://environment.gov.pk/national-biosafe-
ty-center-nbcs-directorate/). In the subsequent 
years, the PSC approved additional varieties of Bt 
cotton, totalling 30 Bt cotton varieties and two Bt 
cotton hybrids in 2014. Notably, in the fifth year 
of cultivation of Bt cotton varieties and hybrids, 
Bt cotton was cultivated in 2.85 (88%) out of 3.2 
million hectares of cotton and approximately 
700,000 smallholder cotton farmers planted and 
benefited from Bt cotton in 2014. It is noteworthy 
that Bt cotton occupied almost the entire cotton 
crop acreage in the Punjab and Sindh provinces 
and a substantial part in Baluchistan and Khyber 
Pakhtunkhwa – four important cotton-growing 
provinces of Pakistan.
In 2010, Myanmar (formerly known as Burma) 
officially released the commercial cultivation of 
a long-staple Bt cotton variety, designated “Silver 
Sixth” and popularly known as “Ngwe chi 6”, that 
had been developed, produced, and distributed 
by the State-owned Myanmar Industrial Crops 
Development Enterprise. In the same year, the 
National Seed Committee of the Ministry of Ag-
riculture and Irrigation officially registered “Ngwe 
chi 6” for commercial cultivation and it was used 
unofficially for the first time by farmers in 2006-
2007. During this period, this Bt cotton variety 
became very popular in all major cotton-growing 
regions, including Western Bago, Mandalay, Mag-
we, and Sagaing. At the time of official release, 
the “Ngwe chi 6” Bt cotton was estimated to be 
grown by 375,000 farmers on approximately 
270,000 hectares (an average of 0.7 hectares of 
Bt cotton per farm) (Choudhary and Gaur, 2010), 
whereas in 2014, it occupied the entire long-sta-
ple acreage of 318,000 hectares (88%) of 360,000 
hectares of cotton in Myanmar (Table 3). Approx-
imately 454,000 smallholder farmers planted the 
Bt cotton variety in 2014. Until now, “Ngwe chi 6” 
is the only long-staple Bt cotton variety released in 
Myanmar (James, 2014) and has been approved 
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in the absence of a national biosafety system, 
of which the formulation is being processed 
and considered by the national assembly in the 
near future.
In contrast to the approval of feed and fiber 
GM crops in the world, Bangladesh – the most 
densely populated country in South Asia - took 
a historical decision on 30 October, 2013 to ap-
prove the official release of four GM varieties of 
Bt brinjal (eggplant) for a limited commercial cul-
tivation. As such, Bangladesh became the first 
country in the world to approve the cultivation 
and consumption of Bt brinjal, namely resistant to 
FSB. Brinjal is grown over approximately 50,000 
hectares throughout the year, and suffers regu-
lar and heavy yield losses due a very destructive 
insect pest, the FSB that is difficult to control by 
conventional insecticides. However, during heavy 
infestation, farmers have no other option than to 
apply insecticides, sometimes every other day, 
up to a total of 80 applications per season. This 
has serious implications for producers, consum-
ers, and also the environment. The Government 
of Bangladesh through its National Committee 
on Biosafety of the Ministry of Environment and 
Forests approved the release of four Bt brinjal va-
rieties produced by the Bangladesh Agricultural 
Research Institute: Bt Brinjal-1 variety, popularly 
known as Uttara, for planting in the Rajshahi re-
gion; Bt Brinjal-2 (Kajla) in the Barisal region; Bt 
Brinjal-3 (Nayantara) in the Rangpur and Dhaka 
regions; and Bt Brinjal-4 variety, known as Iswardi/
ISD006, for planting in the Pabna and Chittagong 
regions (Choudhary and Gaur, 2014). On 22 Jan-
uary 2014, the seedlings of these four Bt brinjal 
varieties were distributed by the Honorable Min-
ister of Agriculture, Ms. Matia Chowdhury, to 20 
smallholder farmers, who became the first Bang-
ladeshi farmers to plant Bt brinjal over 2 hectares 
in four representative regions, namely Gazipur, 
Jamalpur, Pabna, and Rangpur in the spring. Sub-
sequently, the Bangladesh Agricultural Research 
Institute distributed seedlings to 100 additional 
farmers in the winter of 2014. In total, 120 farm-
ers planted Bt brinjal varieties over 12 hectares 
in four intensive brinjal-growing areas of Bangla-
desh (James, 2014) (Table 3). The Government of 
Bangladesh is expected to release five additional 
Bt brinjal varieties in the near future to provide a 
wider choice to brinjal growers also in other areas 
of the country and plans to bring 20,000 hectares 
(approximately 40%) of the total 50,000 hectares 
across 20 districts under nine Bt brinjal varieties 
in the next five years.
Biosafety and regulatory system of GM 
crops in South Asia
Nine countries of the South Asian region have 
ratified the Cartagena Protocol on Biosafety (Sec-
retariat of the Convention of Biological Diversity 
2000) from 2003 to 2013 (Table 3). The Conven-
tion of Biological Diversity of 1993 recognizes the 
potential of modern biotechnology to contribute 
to human well-being, while taking cognizance 
that modern biotechnology could have negative 
effects on environment and human health. It 
emphasizes the need to regulate the risks asso-
ciated with the use of living modified organisms 
(LMOs) and calls for the legally mandatory inter-
national instrument on biosafety in the form of 
the Cartagena Protocol on Biosafety that came 
into force in 2003. The Protocol focuses on the 
transboundary movement of the LMOs and seeks 
to lay down an internationally acceptable frame-
work to provide an adequate level of protection 
against the possible adverse effects of LMOs on 
biodiversity and human health. The Cartagena 
Protocol mandates the parties to establish an 
advanced informed agreement procedure to 
ensure that countries can take informed deci-
sions regarding the importation of such organ-
isms into their territory. The Cartagena Protocol 
also establishes a Biosafety Clearing House to 
facilitate the exchange of information on LMOs 
and to assist countries in the implementation 
of the Protocol. India was the first country in 
the South Asian region to ratify the Protocol in 
2003 and Afghanistan the last that assented 
in 2013. 
Although many South Asian countries have adopt-
ed the protocol (Table 3), only a few have recog-
nized biosafety and regulatory systems for testing, 
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commercial approval, and import and export of 
the LMOs. India, Pakistan, and Bangladesh are the 
three South Asian countries that have established 
a working biosafety and regulatory system on GM 
crops (Table 4). Prior to joining the Cartagena Pro-
tocol on Biosafety, India notified the Environmen-
tal Protection Agency Rules on “the manufacture, 
use, import, export, and storage of hazardous 
micro-organisms, genetically engineered organ-
isms, or cells 1989”, commonly referred as the 
EPA Rules 1989. The EPA Rules 1989 provides 
the legal and institutional framework for granting 
approvals for testing and commercialization of 
GM crops from the research stage to large-scale 
commercial use. The Ministry of Environment and 
Forest administers the apex biotech regulatory 
committee, the Genetic Engineering Appraisal 
Committee (GEAC), whereas the Review Commit-
tee on Genetic Manipulation functions under the 
supervision of the Department of Biotechnology. 
The EPA Rules 1989 mandates each institute to 
have an Institutional Biosafety Committee before 
projects are undertaken that involve recombinant 
DNA technology. Bt cotton is the only GM crop 
evaluated and approved for commercial cultiva-
tion by GEAC in 2002. Although the GEAC thor-
oughly evaluated Bt brinjal and declared it safe 
for environmental release in 2009, a moratorium 
had been imposed on its commercial release in 
2010 (MOEF, 2010). The GEAC-led Indian regula-
tory system has successfully evaluated the safe-
ty, efficacy, and performance of numerous GM 
crops that involved many traits, including insect 
resistance, herbicide tolerance, nitrogen use 
efficiency, hybrid vigor, salinity, and drought 
tolerance.
Similarly, tthe Pak-EPA of the Ministry of Climate 
Change administers the National Biosafety Com-
mittee, an apex regulatory committee with the 
mandate to approve the commercial release of 
GM crops in Pakistan. Other regulatory commit-
tees include the Technical Advisory Committee 
and the Institutional Biosafety Committees (Table 
4) that were set up with the notification of the 
Pakistan Biosafety Rules 2005, issued under the 
Pakistan Environmental Protection Act 1997 of 
the Ministry of Climate Change. Accordingly, the 
National Biosafety Guidelines 2005 were devel-
oped and notified to provide a roadmap, proce-
dures, and protocols to evaluate the safety and 
efficacy of GM crops in Pakistan. The Pak-EPA also 
institutionalizes the National Biosafety Centre to 
coordinate the evaluation process among differ-
ent committees. In 2010, Pakistan approved the 
commercial release of its first GM crop, Bt cotton.
In recent years, Bangladesh has created a unique 
biosafety regulatory system under the Bang-
ladesh Biosafety Rules 2012 and the Biosafety 
Guidelines of Bangladesh 2007, comprising key 
biosafety committees led by the National Com-
mittee on Biosafety that is administered by the 
Ministry of Environment and Forests. Another 
committee is the National Technical Committee 
on Crop Biotechnology of the Ministry of Agricul-
ture that evaluates and recommends decisions 
to the National Committee on Biosafety on GM 
crops and to the Biosafety Core Committee of the 
Ministry of Environment and Forests. This pro-
vides the obtained technical comments and rec-
ommendation on GM crops and informs the In-
stitutional Biosafety Committees of the respective 
institutes that assess and monitor the research 
and development activities of GM crops at the 
Country Regulatory Agency Administrative  Ministry Approved GM crops
India Genetic Engineering Appraisal Committee (GEAC) 
Review Committee on Genetic Manipulation 
(RCGM)/Institutional Biosafety Committee (IBSC)
Ministry of Environment, Forests and Climate 
Change (MOEF&CC)/Department of Biotechnology 
(DBT)
Cotton
Pakistan National Biosafety Committee (NBC)/Technical 
Advisory Committee (TAC)/Institutional Biosafety 
Committee (IBC)
PAK-EPA/Ministry of Climate Change Cotton
Bangladesh National Committee on Biosafety (NCB)/National 
Technical Committee for Crop Biotechnology 
 (NTCCB)/Biosafety Core Committee (BCC)/ 
Institutional Biosafety Committee (IBC)
Ministry of Environment and Forest (MOEF)/Ministry 
of Agriculture (MOA)
Brinjal
Myanmar National Seed Committee (NSC) Ministry of Agriculture and Irrigation (MOAI) Cotton
Table 4. Regulatory agencies on GM crops in key South Asian countries 
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institute level (Hussain and Lagos, 2014). These 
committees coordinate the biosafety assessment 
of GM crops from laboratory experiments all the 
way to approval for commercial release. NCB is 
the apex decision making body on approving the 
commercial release of GM crops in the country. In 
October 2013, the NCB approved the commercial 
release of the country’s first GM insect-resistant 
Bt brinjal. Bangladesh is an exemplary model for 
the successful public-private partnership and de-
livery of the benefits of Bt brinjal to resource-poor 
farmers in South Asia. Bt brinjal was developed by 
the Bangladesh Agricultural Research Institute in 
collaboration with the private Indian seed compa-
ny Mahyco and had been facilitated by the Agri-
cultural Biotechnology Support Project, funded by 
the United States Agency for International Devel-
opment. It was the first collaborative project on 
GM crops between India and Bangladesh.
The biosafety regulatory framework of other 
Asian countries is either at the draft or conceptual 
stage. Myanmar is the only country in South Asia 
that approved the commercial cultivation of a GM 
crop, a long staple Bt cotton variety “Ngwe Chi 
6”, without a national biosafety system in place. 
However, this Bt cotton variety “Ngwe Chi 6”was 
approved by the National Seed Committee of the 
Ministry of Agriculture and Irrigation in 2010. In 
the past, the Ministry of Agriculture and Irrigation 
with the help of the Global Environment Facility 
of the United Nations Environment Programme 
(UNEP GEF) drafted the Myanmar National Bi-
osafety Framework 2006 that aims at balancing 
the use of biotechnology with ensuring human 
health and biodiversity (www.unep.org/biosafe-
ty/files/MMNBFrep.pdf). In the meantime, Myan-
mar has benefited from the large-scale planting 
of Bt cotton from 2006 to 2014. At national level, 
cotton production has more than doubled from 
271,069 MT in 2006-07 to 618,220 MT in 2012-
13 (James, 2014). Yields of the long staple cotton 
increased to 2,100 kg per hectare as compared 
to the yield of 450 kg per hectare for short staple 
cotton. Brookes and Barfoot (2014) estimated an 
enhanced farm income at US$293 million for the 
period 2006 to 2013 and the benefits for 2013 
alone at US$28 million. In this context, therefore, 
the draft biosafety framework needs a critical revi-
sion for developing a cost- and time-effective reg-
ulatory system to officially introduce double gene 
Bt cotton varieties in the country. Similarly, the 
UNEP GEF assisted Sri Lanka to draft its National 
Biosafety Framework 2005 and the Guidelines for 
the Safe Use of Recombinant DNA Technology in 
the Laboratory 2005 (LKNBFrep.pdf). The biosafe-
ty framework was prepared to ensure that poten-
tial risks resulting from modern biotechnology 
applications and its products would be minimized 
and that biodiversity, human health, and envi-
ronment would be protected in a maximum way 
(Gupta et al., 2014). Meanwhile, the Government 
of Sri Lanka notified the Food (Control of Import, 
Sale, and Labeling of Genetically Modified Foods) 
Regulation 2006 to ensure the proper regulation 
of the transboundary movement of GM crops. 
The Government of Sri Lanka is also drafting the 
National Biosafety Act to create a workable frame-
work for experimentation, export, import, and 
commercial release of GM crops. Other South-
Asian countries, including Bhutan, Afghanistan, 
and Maldives have very limited activities involving 
GM crops.
Impact of GM crops in South Asia
Four South Asian countries have harnessed enor-
mous benefits from GM crops as evidenced by 
the rapid uptake and expansion of GM crop culti-
vation. India achieved a near 95% adoption of Bt 
cotton at the national level between 2002 to 2014 
and similarly of 88% in both Pakistan and Myan-
mar between 2010 and 2014 (Table 3). Notably, 
the adoption of Bt cotton was distributed even-
ly among all the cotton-growing areas in these 
countries, irrespective of farm size and status 
of farmers in the society. Empirical studies show 
significantly reduced cultivation cost and increase 
in cotton production due to the wide-scale adop-
tion of Bt cotton. Further, the adoption of Bt cot-
ton allowed farmers to reduce insecticide sprays 
for the management of Helicoverpa armigera 
from on average more than 24 to only 2-3 sprays 
per season. Uniquely, the market share for cot-
ton insecticides as a percentage of total insec-
102
ticides decreased from 46% in 2001 to 20% in 
2011 and, more specifically, from 71% in 2001 
to 3% in 2011 for the insecticide against cotton 
bollworm (Choudhary et al., 2014a). The same 
trend was observed in Bt cotton areas of Paki-
stan and Myanmar. In Pakistan, a Bt cotton study 
noted important health and environmental ad-
vantages in terms of reduced incidence of acute 
pesticide poisoning and increased higher farm-
land biodiversity with reduced soil and ground-
water contaminations, respectively (Kouser and 
Qaim, 2013).
On the production side, Bt cotton contributed 
not only to an increase in productivity at farm 
level, but also in doubling the cotton production 
in India and Myanmar. In Myanmar, farmers in-
creased the long-staple cotton yield by 125% 
from 2006-2007 to 2013-2014, resulting in a net 
income estimated at US$ 138 million for the pe-
riod 2006 to 2013 and at US$ 28 million benefits 
for 2013 alone (Winn and Vasquez, 2011). In In-
dia, the acreage expanded rapidly from 9 million 
hectares to 12 million hectares, thus developing 
non-traditional cotton areas in the semi-arid trop-
ics. Consequently, the national cotton production 
increased from 13.6 million bales in 2002-2003 to 
39 million bales in 2013-2014, almost a tripling of 
cotton production in twelve years. Figure 2 shows 
a strong correlation between the large-scale 
adoption of Bt cotton and a positive trend in cot-
ton production, regardless of yearly fluctuations 
in cotton yield (Choudhary and Gaur, 2015).
As a result, the South Asian input to the global 
cotton production improved from 20% in 2001 
to 33% in 2014. In India, the average cotton yield 
evolved from 308 kg lint per hectare in 2001-2002 
to more than 500 kg lint per hectare in 2013-
2014. Bt cotton enhanced farm income by US$ 
16.7 billion in the twelve year period 2002 to 2013 
and US$ 2.1 billion in 2013 alone. Hence, farmers 
across the countries preferred to grow Bt cotton 
because it became comparatively more profitable 
than other crops, such as millets and legumes. 
In Pakistan, the gains from the large-scale cultiva-
tion of Bt cotton were limited to the production 
costs and were not observed on cotton produc-
tivity, largely due to a lack in proper supply of Bt 
cotton varieties, adverse weather conditions, and 
infestation by the cotton leaf curl virus in the ma-
Figure 2. Impact of Bt cotton on the cotton production in India (1950 to 2015). Source: Blaise et al. (2014); 
adapted from James (2014).
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jor cotton-producing Punjab province. Notably, at 
the national level, Bt cotton had been estimated 
to deliver a total benefit of US$ 701/hectare, in-
cluding the health and environmental benefits 
of US$ 195/hectare (Kouser and Qaim, 2013). 
Translation of these benefits into gross benefits 
would have provided economic gains from Bt cot-
ton varieties for Pakistan of US$ 615 million for 
2010-2013 and US$ 368 million for 2013 alone 
(Brookes and Barfoot, 2014).
The commercial approval of Bt brinjal in Bangla-
desh, although limited to 12 hectares and grown 
by 120 farmers in 2014, demonstrated the effec-
tiveness of the Bt technology in the field also for 
brinjal. In line with the data generated during the 
field experiments, Bt brinjal substantially reduced 
insecticide sprays, namely by 70-90%, diminish-
ing the production cost of unblemished fruits, 
enhancing yield (by at least 30%) and fruit mar-
ketability, and thus increasing income and return 
from the local market. In terms of value, farmers 
spent less on pesticide sprays resulting in a net 
economic benefit of US$ 1,868 per hectare over 
non-Bt brinjal (Choudhary et al., 2014b). Empirical 
results suggest that the large-scale cultivation of 
Bt brinjal could generate a substantial economic 
benefit for approximately 150,000 brinjal growers 
in Bangladesh.
Experiences from four GM crops growing coun-
tries in South Asia indicate a rapid adoption and 
acceptability of GM crops by smallholder farmers. 
It has been demonstrated that the Bt technology 
is scale neutral and has delivered similar benefits, 
if not more, to smallholder farmers in develop-
ing countries as to the large scale farmers of in-
dustrial countries. Figure 3 captures the trend in 
adoption of Biotech cotton by large scale farmers 
in USA from 1996 to 2015 as compared to the 
smallholder Bt cotton farmers in India from 2002 
to 2015.      
Future prospects of GM crops  
in South Asia
Crop improvement by integrating the best bio-
technological traits and optimal germplasm re-
mains the key priority for most of the South Asian 
region. Biotechnological traits have opened an 
enormous opportunity to complement conven-
tional selection and mutation breeding. From the 
vast experience of growing GM crops in India, Pa-
kistan, Myanmar, and Bangladesh, GM crops obvi-
ously offer the possibility to tackle challenges rou-
Figure 3. Adoption of biotech cotton by famers in the USA and India, 1996 to 2015. 
Source: Analyzed by Bhagirath Choudhary, 2015
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tinely encountered by farmers and, therefore, to 
help improve crop productivity, enhance income 
and ensure livelihood. As of now, the countries 
in South Asia have only experienced the IR ben-
efits of GM crops. The opportunities of promising 
commercial GM traits cultivated in other parts of 
the world need to be explored to advance the 
crop improvement paradigm. These traits include 
HT, virus resistance, drought tolerance, quality 
traits, and above all multiple trait stacking to opti-
mize resource utilization and to maximize input- 
output return.
Ongoing field experiments in South Asia (Table 
5) of GM crops include IR/HT, but also nutritional 
enhancement, disease resistance, nitrogen use 
efficiency, and salinity tolerance. A dozen crops 
with these GM traits have either been analyzed 
in laboratories or are at the event selection and 
confined-field trial stages in India, Pakistan, and 
Bangladesh. These crops and traits are likely can-
didates for commercial approval in the South 
Asian region in the near (1-3 years) to medium 
term (2-5 years).
The continuation of field experiments and possi-
ble commercial approval hinge on multiple factors 
that differ from country to country. Bangladesh 
forges ahead with great emphasis on GM crops 
developed preferably by public-sector institutes. 
Besides Bt brinjal, Bangladesh is testing Asia’s first 
late blight-resistant (LBR) potato (Solanum tubero-
sum) varieties, developed by the public sector in-
stitute Bangladesh Agricultural Research Institute 
and the Potato Research Centre and facilitated by 
the United States Agency for International Devel-
opment led the Agricultural Biotechnology Sup-
port Project. This LBR potato carries a resistance 
gene from a wild-type potato (Solanum bulbocast-
anum) species that would significantly reduce 
the amount of fungicides and result in increased 
potato yield and quality. Golden rice is another 
public-sector product developed by the Bangla-
desh Rice Research Institute in collaboration with 
the International Rice Research Institute and has 
been field-tested in the last couple of years. Re-
cently, Bangladesh field tested the IR cotton vari-
ety developed jointly by Supreme Seed (Dhaka) in 
association with the Hubei Provincial Seed Group 
Co. (China) in the field. This Bt cotton variety was 
Country Crop Gene/Traita Organizationb Status
Bangladesh Brinjal  
(5 additional 
varieties)
Cotton
Potato
Golden Rice
IR
IR
LBR
NE
BARI
Supreme-Hubei Seeds
BARI/ABSP-II
BARI/IRRI
Final stage
Import approval and field testing
Confined field trials
Confined field trials
India Cotton
Maize
Mustard
Brinjal
Brinjal
Chickpea
Rice
Rice
Rice
IR and HT
IR/HT
PQ
IR
IR
IR
NUE
ST
AP
Mahyco/Monsanto
Monsanto
Delhi University
Mahyco
Bejo Sheetal/Ankur/Rasi
Sungro Seeds
Mahyco
Mahyco
BASF
Pending commercial approval
Biosafety research level 2 stage
Final Stage
Under moratorium
Biosafety research level 1 stage
Biosafety research level 1 stage
Biosafety research level 1 stage
Biosafety research level 1stage
Event selection trial
Myanmar Cotton IR (double gene) MOAI Final stage
Pakistan Cotton
Maize
Sugarcane
Wheat
IR and HT
IR and HT
-
-
Monsanto
Monsanto, Pioneer, Syngenta
NIBGE 
NIBGE
Import permit granted; no trials yet
Advanced field trials
Field trials
Field trials
Table 5. Status of GM field trials in key South Asian countries, 2015
a  AP, Agronomic Performance; IR, Insect Resistance; HT, Herbicide Tolerance; LBR, Late Blight Resistance; NE, nutritional enhancement; 
NUE, nitrogen use efficiency; PQ, product quality, ST, salinity tolerance.
b  ASBP-II, Agricultural Biotechnology Support Project II; BARI, Bangladesh Agricultural Research Institute; BASF, Badische Anilin und Soda 
Fabrik; IRRI, International Rice Research Institute; MOAI, Ministry of Agriculture and Irrigation; NIBGE, National Institute for Biotechnology 
and Genetic Engineering.
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field tested in the Kharif (monsoon) 2015 season 
for evaluating the safety, efficacy, and agronomic 
performance. Bangladesh aims at increasing cot-
ton production to offset the huge import of raw 
cotton from India and China and to sustain the 
growing textile industry in the country.
Pakistan suffered an enormous opportunity cost 
in not taking full advantage of Bt cotton due to the 
absence of a comprehensive policy on GM crops, 
protection of plant variety system, and uncertain-
ty surrounding biosafety regulation. The policy 
and regulatory uncertainty compounded when 
the Federal Government of Pakistan enacted the 
18th Amendment in pursuant of the Constitution 
(18th Amendment) Act 2010 that devolved many 
federal subjects, including environment, to the 
Provinces in April 2010. Subsequently, agricul-
ture, environment, and biosafety matters were 
reorganized between the Federal level and the 
Provinces and also among various ministries at 
the Federal level. At present, the National Biosafe-
ty Centre (NBC) functions under the Environmen-
tal Protection Agency (EPA) and is administered 
by the Ministry of Climate Change. For the last 
two years, NBC is working without any permanent 
staff and the EPA officials are temporarily looking 
after the NBC affairs with a very limited technical 
capacity to handle cases related to field trials and 
commercial approval of GM crops. In 2016, two 
important GM crops that await commercial ap-
proval include Bt/HT cotton and Bt/HT maize.
Myanmar drafted a National Biosafety bill in 2006, 
but realized that it needs to be reviewed and en-
acted by the parliament before other GM crops 
can be introduced into the country.
Bhutan maintains its GM-free status as far as cul-
tivation is concerned, following the decision in 
April 2011 to ban GM crops issued by the Ministry 
of Agriculture and Forestry. However, the coun-
try allows the import of processed and semi-pro-
cessed GM products that are incapable of repro-
duction and of which the safety assessment has 
been conducted in the country of origin (Yang-
zom, 2014). As of 2015, Bhutan is considering the 
enactment of the Biosafety Bill 2014 that should 
clear the way for experimentation, commercial 
release, and import and export of GM foods in 
the future.
The future prospects of GM crops in India re-
main unclear after the moratorium on Bt brinjal 
imposed by the Ministry of Environment and 
Forests in February 2010, although it had been 
approved in October 2009. However, after the 
moratorium period, the regulatory system has 
become indecisive, causing delays and discontin-
uation of field testing of GM crops. The additional 
requirement of the “no objection certificate” from 
(the) State(s) prior to conducting field trials has 
further complicated the regulatory system. In 
2014, the country has made significant strides 
on the regulatory front by granting approval for 
field trials of IR/HT maize in Maharashtra in the 
kharif 2014 season and of GM mustard (Brassica 
juncea) in Punjab and New Delhi in rabi (spring) 
2014 season. Other GM crops, such as brinjal, 
rice, and chickpea (Cicer arietinum) that received 
permission to undergo field trials are awaiting 
the “no objection certificate” from the respective 
States. In the same year, GEAC also approved 
four biotech events of soybean (Glycine max) for 
import and use as feed. In 2016, India is expect-
ed to consider the commercial approval of GM 
mustard (Brassica juncea) with enhanced hetero-
sis. Table 5 presents a comprehensive list of GM 
crops that are under field trials and nearing com-
mercial approval in India.
In 2016, India is likely to either approve or reject 
the commercial release of Bt/HT cotton devel-
oped by Mahyco, GM mustard by Delhi University, 
and Bt/HT maize developed by Monsanto. These 
three GM crops have completed the required 
tests for safety, efficacy, and agronomic perfor-
mance. These crop developers are expected to 
submit the final biosafety dossiers for commercial 
release to GEAC in 2016. Therefore, it is impor-
tant for the country to overcome the bottlenecks 
in the current regulatory system and critically 
evaluate the potential of GM crops in improving 
production and productivity of important crops.
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Finally, it is noteworthy to recognize that the farm-
ers in India, Bangladesh, Pakistan, and Myanmar 
have adopted GM crops, including Bt cotton and 
Bt brinjal. Although the experience of growing GM 
crops has been remarkable, but limited to cotton 
and brinjal only, a large number of GM crops and 
traits are being field tested in the South Asian re-
gion. GM crops, such as Bt/HT cotton, Bt/Ht maize, 
Bt chickpea, Bt brinjal, Golden rice, LBR potato, and 
GM mustard are important crops for smallholder 
farmers in South Asia. These GM crops and other 
crops in the pipeline will only be cultivated provid-
ed the governments in the respective South Asian 
countries show strong political will and support 
that are essential to ensure that these GM crops 
reach the South Asian farmers. The way forward 
for the South Asian counties is to develop South-
South collaborations to avoid “reinvention of the 
wheel” and promote the Public-Private Partner-
ships to quickly deliver GM crops to those who 
need them the most.
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Abstract
Advances in forest biotechnology have the poten-
tial to deliver step changes in woody biomass pro-
ductivity and process efficiency and an expansion 
of quality, scope, and scale of forest products and 
services. Well-placed, well-managed plantations 
of yield-enhanced, yield-protected tree varie-
ties could deliver far more than simply meeting 
market fiber demand. By using degraded land, 
above- and belowground carbon sequestration 
and avoided deforestation impacts would be con-
siderable. Transfer and uptake of best practices 
to developing countries could help address rural 
development, food security, and poverty allevia-
tion objectives of the Post-2015 Development 
Agenda of the United Nations. Driven by appro-
priately designed supply chain transformation 
initiatives, responsible procurement policies, and 
consumer-driven awareness, investments in bio-
mass-based chemicals and fuels could be part of 
means to ease fossil-fuel dependency, uncouple 
growth from emissions, and open a new era for 
sustainable materials. Advances in imaging and 
mapping technologies, coupled with progress in 
field-sensing technologies will allow precision ag-
riculture and forestry to be deployed effectively 
in ways that spare high conservation value areas 
and identify areas for ecosystem restoration. 
Underpinning all these aspects will provide new 
standards for incorporation of the free prior and 
informed consent of local communities and for-
est-dependent populations, including transpar-
ency and verification.
 
Introduction
To prevent natural resources from becoming 
binding constraints for development, the world 
economy must be better reconciled within the 
finite global ecosystem. With limited scope for 
sustainable resource throughput, ensuring well 
being within planetary boundaries will require 
transformational changes in resource use effi-
ciency to meet increasing, diversifying, and shift-
ing demands. In practical terms, step changes 
in productivity and process efficiency will be re-
quired as well as expansion in quality, scope, and 
scale of products and services.
The social, economic, and environmental dimen-
sions of forests and forestry will permeate every as-
pect of this transformation – from driving new en-
ergy solutions and supporting rural development, 
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to mitigating climate change and safeguarding the 
ecosystems on which future generations will de-
pend. Sustainable production practices coupled 
with novel woody biomass utilization have the po-
tential to steer the transition toward a low-carbon 
development trajectory – a bioeconomy – that 
would reduce dependency on fossil fuels and 
uncouple growth from emissions. In June 2012, 
during a side event of the Food and Agriculture 
Organization of the United Nations (FAO), Inter-
national Council of Forest and Paper Associations, 
Associação Brasileira de Celulose e Papel, and 
partners at Rio +20 entitled “Forests: the heart of 
a green economy”, we presented a systems-based 
view of the needs to attain this goal (available at: 
http://www.futuragene.com/en/presentations.aspx).
This proposal of doing more with less outlined the 
building blocks of an innovation-driven, technolo-
gy-rich trajectory for the forestry sector toward a 
world in which 9 billion people will live well in 2050 
within planetary boundaries. In this change theory, 
there are three critical assumptions. Firstly, a funda-
mental prerequisite is to bring together an interde-
pendent clustering of forest and forestry stakehold-
ers (private sector, non-government organizations, 
government, the United Nations system, finance, 
and research community) to design and implement 
a bioeconomy based on sustainable production, 
trade, and consumption of forest products. Second-
ly, scientific and technological innovations will be im-
plemented that will drive biomass productivity and 
process efficiency and expand the quality and scope 
of products and services on scale and time. Thirdly, 
mechanisms for technology transfer and enhanced 
international cooperation will be required to enable 
conveying biomass-based industrial development 
tools and practices to developing countries. Implicit-
ly, the mechanisms are to favor uptake of advanced 
technology by smallholders and enhancement of 
their access to local and international markets.
All assumptions, addressing the political, social, 
economic, and technological barriers to the im-
plementation of a forest biomass-based bioecon-
omy would need to be adopted in unison. There-
fore, the immediate requirement is a new vision 
on forest policy cohesion, local and international 
cooperation, and scientific collaboration.
In our opinion, the potential for this vision to 
emerge is real, based on the premise that in-
vestment in a forest biomass-based bioecono-
my is the cheapest, most accessible, and dura-
ble option for simultaneously achieving climate 
change mitigation and sustainable development 
agendas. The experience of the Brazilian plant-
ed forest sector provides insights into a possible 
forest biomass-based solution and the required 
impact-delivering conditions. The priority areas 
are intensification of sustainable plantation man-
agement, increase in downstream products and 
services based on woody biomass, frameworks to 
direct research to meet productivity challenges 
and to provide technology governance, diffusion 
and uptake, down to the local level, and mecha-
nisms to guide consumer acceptance of scientific 
and technological innovations for sustainable in-
tensification. This chapter takes a critical look at 
this vision viability, convergence of the individual 
components of the trajectory, validation of the 
assumptions made, and assessment of the influ-
ences of recent trends in the political landscape.
The productivity challenge
The ways in which strategies for transforming 
land, water, and energy use are designed and im-
plemented will be decisive in determining future 
well-being within planetary boundaries. Currently, 
the patterns of land and resource use and scale 
and intensity of changes in land use threaten the 
ecological infrastructure of the planet. From a 
climate perspective alone, agriculture, forestry, 
and other land use account for just under 15% 
of anthropogenic greenhouse gas emissions (ap-
proximately 10-12 gigaton (Gt) CO2 equivalent/
year) (Smith et al., 2014). There is robust evidence 
and high levels of agreement that “Leveraging the 
mitigation potential in the [forest] sector is extreme-
ly important in meeting emission reduction targets” 
(Smith et al., 2014). Forests, sustainably managed 
forestry operations, and forest products are car-
bon sinks: whereas forests cover only 12% of the 
planet, they store 66% of all terrestrial carbon, 
providing 30% of the total mitigation capacity 
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needed to abate the rise in atmospheric carbon 
over the next 20 years (Dobbs et al., 2007), ab-
sorbing roughly 50% of fossil fuel-based green-
house gas emissions in 2009 (Stevens et al., 
2014). Any realistic climate change attenuation 
or adaptation strategy must invoke a comprehen-
sive forest protection plan. Prevented defores- 
tation would provide 5.8 of the estimated 17 Gt 
CO2 equivalents necessary to keep atmospheric 
carbon concentrations below 450 ppm, of which 
planted forests could provide 1.5 Gt CO2 equiv-
alents (Dobbs et al., 2007). By halving deforesta-
tion, net benefits of approximately US$ 3.7 trillion 
over the long term (Eliasch, 2008) (counting only 
the avoided damage costs of climate change) 
could be generated, taking advantage of the 2 
billion hectares of degraded land that are avail-
able for reforestation, of which 75% in Africa 
(Minnemeyer et al., 2012). A coordinated effort is 
imperative to slow, halt, or reverse deforestation 
and forest degradation from 13 million hectares 
per year.
Leadership is required to successfully integrate 
the future role of forests, sustainable forestry, 
and forest product trade and consumption in this 
complex agenda, because wood harvesting could 
triple to approximately 10 billion m3 in 2050 (WWF, 
2011a/b/c/d, 2015). As market demand for food, 
fiber, and fuel will increase in the coming decades, 
so will the impact on the planet’s natural resourc-
es. The costs of inaction are not acceptable: the 
global economic cost of climate change caused by 
deforestation is estimated to possibly reach US$ 1 
trillion a year (net present value) by 2100 (Eliasch, 
2008). Therefore, actions to halt or slow deforest-
ation by responsible investment in agriculture are 
needed, conceivable, and effective.
What is needed is a step change in the efficiency 
of production that can only be achieved through 
a technological upgrade to intensify existing prac-
tices for agricultural commodity production. The 
development of appropriate technologies and 
standards to guide development and use will be 
an essential prerequisite for ensuring a sustaina-
ble and general next innovation wave.
Sustainable intensification of woody 
biomass productivity
The forest sector faces the significant challenge 
of reducing logging pressure on natural forests, 
while meeting growing, diversifying, and shifting 
demands. Plantations are increasingly being seen 
as part of the solution (Forest Stewardship Coun-
cil [FSC], 2012), because they produce more wood 
on less land than natural forests and, hence, 
could spare land for other uses. In 2006, whereas 
tree plantations comprised only 7% of total forest 
area, they provided 50% of industrial roundwood 
(Jagels, 2006). These “Intensively Managed Plant-
ed Forests” provided 40% (Kanowski and Murray, 
2008), yielding far more wood per hectare than 
natural forests, especially close to the equator.
However, to meet future demands and avoid 
logging of natural forests, the plantation area 
will need to double by 2050: roughly 250 million 
hectares of new plantations (WWF, 2011a/b/c/d 
2015). The Forests Solutions Group of the World 
Business Council for Sustainable Development 
(WBCSD, 2012) defined a set of clear forestry 
sector deliverables to ensure the transition to a 
world in which “9 billion people live well and within 
the limits of the planet”, including increasing forest 
carbon stocks by 10% (239 Gt CO2 or 6.8 Gt CO2/
year between 2015 and 2050) by: (i) significantly 
reducing tropical deforestation by 5 million hec-
tares per year (savings of nearly 5 Gt CO2/year); 
(ii) reducing harvest in modified natural forests 
by 4 million hectare per year (for instance by de-
creasing fuel wood harvesting with savings of 0.7 
Gt CO2/year), and (iii) tripling yield and harvest of 
planted forests from 800 million m3 to 2.7 billion 
m3 from 7% to 11% of the world’s forests to meet 
demands for wood, paper, and biomass (sav-
ings of 2.35 Gt CO2/year and a net gain of 1.5). 
Enhancement and protection of yields of plant-
ed forests would be achieved “through genetic 
improvements that emphasize a mix of plant traits 
(drought tolerance, insect resistance, product char-
acteristics) and adaptation to different forest types 
and locations” (WBCSD, 2012).
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How does sustainable plantation 
 management work in practice?  
The example of the Brazilian  
Planted Forest sector
The experience of the planted forest sector in 
Brazil provides a striking example of how a blend 
of policy measures, voluntary actions, adoption 
and diffusion of technology, and multi stakehold-
er engagement can transform plantation produc-
tivity from a situation of environmental and social 
crisis. Twenty years ago, plantation-based pro-
duction was considered with concern and oppo-
sition, including from conservationists and social 
nongovernmental organizations. Their worries 
were real, particularly where deep failures of for-
est governance systems and land-tenure issues 
contributed to social deprivation, inequality, and 
environmental degradation.
In Brazil, the development of principles and crite-
ria for sustainable forest management by FSC co-
incided with social and environmental policies of 
the government and plantation strategies of com-
panies to increase intensity, efficiency, and quali-
ty of pulp production. This convergence provided 
a strong incentive for companies and plantation 
owners to plant on degraded land and to save and 
restore protected reserves, all under guidance of 
international conventions and guidelines, such as 
the Convention on Biological Diversity, the Interna-
tional Labour Organization declaration on Funda-
mental Principles and Rights at Work, the FAO Vol-
untary Guidelines for Responsible Management 
of Planted Forests, and the Committee on World 
Food Security (CFS) Voluntary Guidelines on the 
Responsible Governance of Land Tenure (VGGT).
As soon as policy and governance frameworks 
for plantation management are in place, they can 
drive the investments that underpin a globally 
competitive industry that, in turn, can restore de-
graded lands, conserve biodiversity, and support 
rural livelihoods. To date, the experience in Brazil 
has shown that such a goal can be been achieved 
without transferring the additional costs to con-
sumers with the following key impacts. (i) For 
each hectare of forest planted, an average of 0.6 
hectares of natural forest is restored, thus estab-
lishing ecological corridors and mosaics on lands 
that were previously degraded and representing 
a net positive gain of almost 3 million hectares of 
secondary forest and a significant contribution to 
ecosystem functions, such as biodiversity pres-
ervation and carbon storage, absorbing roughly 
64 million metric tons of CO2 from the atmos-
phere every year. (ii) Brazilian plantations-based 
companies work with local communities to agree 
collectively on best practice and integrate rough-
ly 13,000 families into the forestry industry chain 
through outgrower programs in over 1,000 mu-
nicipalities in some of the poorest and most re-
mote areas of the country. In 2013, Brazilian 
plantations-based companies invested US$ 64 
million in social programs, adding multiple values 
to the quality of life of local communities. (iii) Pro-
duction outsourcing is common practice: Suzano 
Pulp and Paper Company sources up to 30% of its 
fiber from outgrowers, mostly smallholders, and 
has helped groups to become certified, covering 
22,400 hectares of plantations and 13,000 of nat-
ural forest to date, thus, providing outgrowers a 
price premium, making income per hectare four 
fold higher than ranching, which is the main rural 
activity in most of the production regions. (iv) To-
day, 100% of the market pulp is produced from 
only 0.7% of all arable land, creating more than 
4.4 million direct and indirect jobs and significant-
ly reducing the pressure to bring natural forest 
areas into production. The joined livestock and 
forestry programs of the Ministry of Agriculture 
targets 70 million hectares of land for integrating 
productivity-enhancing approaches in agriculture 
and forestry.
In Brazil today, the process of developing and im-
plementing policy and standards for plantation 
management has created a framework for an 
on-going dialog around the topic of plantations. 
Although a great deal remains to be achieved, 
some interim findings of significance are that (i) 
deep-rooted conflict can be overcome when lead-
ership on performance standards and coopera-
tion on actions has an impact on common objec-
tives; (ii) a sympathetic approach to ecosystems, 
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local communities, and small forest owners can 
be a viable business strategy, without additional 
costs for the consumers; and (iii) mechanisms 
to distribute and share the benefits of research 
(improvements via conventional breeding) into 
plantation productivity with smallholders can be 
a win-win situation for business and communities.
The Brazilian experience shows the power of what 
can be achieved through guarantee convergence 
between Government and company policies. This 
collaborative framework has fuelled substantial 
investments of plantation companies in improved 
forestry practices, enhanced breeding, rational 
landscape-scale forest zoning, perfected technol-
ogies, ameliorated governance, including strong 
social safeguards, and sound policies. These di-
rect and indirect social and environmental indica-
tors demonstrate the potency of voluntary com-
mitments in creating a system in which targeted 
extraction of natural resources can have a net 
positive impact on social standards and environ-
mental protection.
Market transformation: responsible 
commodity production and trade
Where and how commodities are produced, pro-
cessed, consumed, and financed present a mo-
saic of opportunities and challenges that require 
systemic transformational changes. Forests and 
the sustainable production and consumption of 
forest products are at the centre of this concern.
Sustainable productivity intensification is nec-
essary to meet the increasing demand while 
moving to net zero deforestation and degrada-
tion (Godfrey et al., 2010). Climate resilience and 
carbon neutrality could be achieved by enhanc-
ing plantation yield and developing strategies that 
provide protection against future pest and disease 
outbreaks. The exploitation of new low-volume, 
high-value pathways for the utilization of planta-
tion biomass could generate options for relieving 
dependence on fossil fuel use in the carbon-based 
chemical, specialized fiber, and polymer sector (a 
bio-economy). The Forest Products Association of 
Canada (FPAC) Biopathways study estimated a mar-
ket value of over US$ 200 billion for biomass-based 
products (FPAC, 2011).
However, to achieve an intensified productivity, the 
existing performance standards that were designed 
to manage linear incremental changes will not suf-
fice. Future standards must take the complexity of 
systemic transformational changes into account with 
a governance framework for the highly disruptive 
process of further intensification. Such a framework 
must be conceived to provide social safeguards and 
effective stewardship and to stimulate preferential 
procurement and increased consumer awareness. 
To this end, the Market Transformation Initiative 
(http://wwf.panda.org/what_we_do/how_we_work/
businesses/transforming_markets/) has been cre-
ated, offering a collaborative approach toward 
climate resilience and zero net deforestation and 
degradation through responsible agricultural com-
modity production. The created coalitions cap-
ture 40-50% of demands through leveraging 25% 
of producers.
To incorporate forest productivity into this new 
matrix, scientific and technological innovations 
for enhanced plantation productivity will have to 
be integrated into zoning and land management 
under local social license. The Brazilian experi-
ence of the plantation sector in internalizing the 
costs of ecosystem protection and social license 
could provide an invaluable guidance on what can 
be produced, by whom, and how.
 
The forest sector, the forest certification bodies, 
governments, and civil society have the opportu-
nity to be precompetitive, collectively setting new 
targets for plantation management that will feed 
the supply chains of the future. The creation of a 
governance system with resilience and ambition 
to meet these challenges will depend on dialog 
that addresses the stakeholder concerns over the 
implications of sustainable intensification, thus 
resulting in a unity of baseline criteria. Not only 
would such an alliance deliver credible solutions, 
but it would also have the legitimacy to guide and 
influence global policy arising from the Post-2015 
Development Agenda of the UN.
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The rationale for productivity gain:  
the need for scientific and  
technological innovation
The rationale for intensifying plantation produc-
tivity is based on the formulation of principles, cri-
teria, and indicators. This process is governed by 
the following framework. (i) The world economy 
must be reconciled in a finite global ecosystem, 
if natural resources are not to become binding 
development constraints. (ii) Enhanced resource 
use efficiency will be required to ensure well-be-
ing within planetary boundaries, while meeting 
increasing demand. (iii) In practical terms, step 
changes in productivity and process efficiency will 
be necessary as well as enhanced quality, scope, 
and scale of products and services. (iv) Improved 
process efficiency and scope of products can only 
be achieved by increased dependence on scien-
tific and technological innovation. If the principal 
means to achieve resource use efficiency is to 
produce more from less through an intensifica-
tion of existing practices and, in turn, relies on an 
increased dependence on scientific and techno-
logical innovation, then frameworks will be need-
ed to direct research to meet productivity chal-
lenges and to provide governance for technology 
utilization, diffusion, and implementation, down 
to the local level, and local users.
Therefore, the fundamental challenge and op-
portunity of our time are to develop leadership 
in the formulation of a framework that will mas-
ter production efficiency in transformative ways 
and that stimulates preferential acquisition and 
increased consumer awareness, in which the 
physical challenge is the elaboration and use of 
science and technology for the sustainable in-
tensification of forest commodity production and 
the social challenge has to ensure that technolo-
gy reaches those who need it the most. Further-
more, a behavioral transformation is required as 
well to create a governance framework for the 
highly disruptive and controversial process of 
further intensification.
Risk perception: common objections to 
genetically modified trees
Today, the position concerning genetically mod-
ified (GM) trees is similar to that regarding plan-
tations 20 years ago. The debate on GM trees is 
intimately linked with that on plantations because 
of its relevance to productivity enhancement. 
In 2000, worries over GM trees have led to the 
adoption of policies that prohibit their growth on 
land certified both by the FSC and Programme for 
the Endorsement of Forest Certification (PEFC). 
At present, the FSC Policy on GM organisms bans 
the use of GM trees, but under the Policy of As-
sociation permits field trials of GM trees outside 
the certified areas. Many of these concerns were 
catalogued in 2007 by the United Nations Envi-
ronment Programme (UNEP, 2007) and a subset 
can be found in the FSC Policy for Association.
The vast body of scientific knowledge accumu-
lated through fundamental research carried out 
since 2000 and through the experiences and 
data from the field tests on GM trees carried out 
around the world have provided answers to the 
apprehension against GM trees. A study from 
the European Commission Directorate-General 
(2010) reported that between 2001-2010, a total 
of 50 projects involving more than 400 research 
groups and representing European research 
grants of roughly EUR 200 million had been fo-
cused on GMO safety alone and the funding on 
GMO safety since 1982 was more than EUR 300 
million, involving research on environmental im-
pacts of GMOs, GMO and food safety, and risk 
assessment and management. The main conclu-
sion to be drawn from the efforts of more than 130 
research projects, covering a period of more than 25 
years of research and involving more than 500 inde-
pendent research groups, is that biotechnology, and 
in particular GMOs are not per se more risky than 
e.g. conventional plant breeding technologies”.
A sector-wide interest in the development and 
use of GM trees is primarily to provide the step 
changes needed for yield enhancement and yield 
protection. Before a widespread deployment of 
GM trees, there is a window of opportunity for 
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the FSC and GM tree-developing institutions to 
establish a common framework for the criteria 
that would govern development and utilization.
Safe use of GM technology:  
more than 700 field trials since 1988
A summary of the global status of field tests with 
GM trees in different countries has been pub-
lished (FAO, 2004). Since 1988, more than 700 
approved field trials for GM trees are reported, of 
which 28 species and 32 traits were tested in the 
European Union and 37 species and 36 traits in 
the USA. The large number of species and traits, 
of which many were aimed at environmental ben-
efits, can be attributed to the fact that until 2004, 
the bulk of all trial applications were from pub-
lic sector institutes, representing public sector 
interests, and curiosity-driven, non-commercial 
objectives, including species conservation (Amer-
ican elm [Ulnus americana] and American chest-
nut [Castanea dentata]), and phytoremediation. 
A large body of data was obtained that allowed 
the analysis of many of the technology-related 
concerns, such as gene flow and gene stabili-
ty, and provided a track record of biosafety and 
risk assessment.
Productivity and technology:  
producing more from less
Productivity has to be considered historically to 
understand how research priorities can be built 
to support the objectives of sustainable produc-
tivity intensification. At FuturaGene, the initial fo-
cus has been on yield enhancement to provide 
a step change to the incremental improvements 
obtained over 40 years of conventional breeding 
at Suzano Pulp and Paper Company. Thanks to 
breeding for improved tree varieties, plantation 
productivity has been doubled since the 1970s, 
meaning that the amount of land required to feed 
a 1 million ton per year of pulp mill has decreased 
from 171,500 to 73,500 hectares. If the 1970s 
productivity levels were in practice today, the eu-
calyptus plantation of Brazil would be 9.9, rather 
than 5.1, million hectares. Clonal development 
and breeding provide continuous improvements 
in quality and supply, while maintaining genetic 
diversity. Suzano has a collection of 15,000 clones 
in its breeding programs that offer a robust ge-
netic base for yield improvement, fiber quality, 
and resilience. If enhancing plantation productiv-
ity requires a continued emphasis on increasing 
technical efficiency, then genetic modification 
could be part of the solution. The technology has 
an important relevance in Brazil, where yield im-
provements of eucalyptus through conventional 
breeding are now limited and where the emer-
gence of various pests and diseases demand ur-
gent solutions to adequately protect yields.
Yield-enhanced GM eucalyptus:  
laboratory and field studies
To increase the improvements obtained over 40 
years of conventional breeding at Suzano, the 
present strategic focus is on yield enhancement. 
The most advanced GM trees in the pipeline are 
transformed with the endoglucanase-encoding 
gene from the plant Arabidopsis thaliana. This 
gene is present in all plant species and its product 
is part of normal plant development processes, 
facilitating relaxation of the crystalline matrix of 
the rigid plant cell wall during cell growth, there-
by enhancing overall plant growth. The results 
obtained in field trials under different agroeco-
logical conditions at a variety of locations in Brazil 
show an average yield enhancement of 20% com-
pared to conventional varieties, almost half of the 
entire yield gain achieved over the last 40 years 
of breeding.
Brazilian biosafety regime:  
general considerations
Laboratory and field-testing of the yield-enhanced 
eucalyptus of FuturaGene in Brazil have been 
conducted under the 2005 Brazilian Biosafety law 
11.105 and Normative 5 – GM event characteriza-
tion, environmental testing, and health and safety 
testing. The principles of the Brazilian Biosafety 
law and Normative 5 are based on the provisions 
of the Cartagena Protocol on Biosafety (Secretari-
at of the Convention of Biological Diversity, 2000), 
the Codex Alimentarius, and the precautionary 
principle (1992)4. The Brazilian Biosafety law con-
forms to decision IX/5(1) taken at the 9th Confer-
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ence Of the Parties to the Convention on Biolog-
ical Diversity in 2008 and created the National 
Biosafety Council, the National Biosafety Commis-
sion (CTNBio), the Internal Biosafety Commission, 
and the Biosafety Quality Certificate. CTNBio es-
tablishes all normatives required to perform work 
with GMOs, including Normative 5, for biosafety 
of commercial approvals.
The Brazilian Biosafety law is very strongly com-
parable with other national and regional regimes. 
A comparison with the European biosafety risk 
assessment procedures that are widely acknowl-
edged to be the most stringent in the world re-
veals the two to be essentially equivalent in terms 
of regulatory framework, risk assessment, deci-
sion process, and accompanying measures.
Under this framework, the regulatory field trials of 
FuturaGene have established field performance 
criteria and allowed the collection of biosafety 
data. The design of the studies formulated under 
the directives of the Brazilian Biosafety law ad-
dresses many of the commonly raised concerns 
and directly the decision IX/5(1) of the United Na-
tions Convention on Biological Diversity5.
A dossier was submitted to CTNBio in January 
2014, and in September 2014 at a public audi-
ence in Brasilia, and finally approved for commer-
cial use in April 2015. Approval was based on a 
rigorous examination of the data presented that 
showed a substantial equivalence to convention-
al trees, no risks to animal or human health, and 
no detrimental environmental impact. Indeed, in 
the GM event, an Arabidopsis protein is produced, 
representing a protein family present in all plants 
without homology to known allergens or toxins. 
The GM trees show no visible changes in struc-
ture, other than faster growth rate, without mod-
ifications in fiber, wood, or chemical properties 
nor in pollen morphology or viability. The environ-
mental impact of these GM trees has also been 
rigorously tested without changes in decomposi-
tion rate, nor impact on other organisms, includ-
ing aquatic species, microorganisms, insects, and 
bees. Gene flow studies have been conducted, 
tending to zero at <700 m and the invasive po-
tential of the trees is unchanged, because, as an 
exotic species, the trees cannot cross with wild 
species in Brazil. A number of studies carried 
out under a variety of agroecological conditions 
in different seasons indicate that water usage by 
the GM trees is similar to that of conventional 
varieties, in spite of the faster growth rate. Two 
of the most important insights into the impact of 
the trees on the biophysical soil characteristics 
are provided by studies on soil arthropod diver-
sity and population dynamics as well as on the 
molecular assessment of the diversity of soil bac-
teria and fungi. No differences in the arthropod, 
bacterial and fungal populations occurred when 
the soils of conventional and yield-increased GM 
eucalyptus were compared. Considering that the 
diversity and abundance of these organisms are 
highly dependent on the physical, chemical, and 
hydrological properties of their environment, and 
that any change in water use due to the increased 
4  Article 1 of the Brazilian Biosafety Law states: “This Law provides for safety norms and inspection mechanisms for the construction, 
culture, production, manipulation, transportation, transfer, import, export, storage, research, marketing, environmental release and dis-
charge of genetically modified organisms – GMOs and their by-products, guided by the need for scientific development in the biosafety 
and biotechnology area, the protection of life and human beings, of animal and plant health, and in compliance with the precautionary 
principle.”
5  (r) Reaffirm the need to take a precautionary approach when addressing the issue of genetically modified trees;
(s) Authorize the release of genetically modified trees only after completion of studies in containment, including in greenhouse and con-
fined field trials, in accordance with national legislation where existent, addressing long–term effects as well as thorough, comprehen-
sive, science-based and transparent risk assessments to avoid possible negative environmental impacts on forest biological diversity;
(t) Also consider the potential socio-economic impacts of genetically modified trees as well as their potential impact on the livelihoods 
of indigenous and local communities;
(u) Acknowledge the entitlement of Parties, in accordance with their domestic legislation, to suspend the release of genetically modified 
trees, in particular where risk assessment so advises or where adequate capacities to undertake such assessment is not available;
(v) Further engage to develop risk-assessment criteria specifically for genetically modified trees;
(z) Provide the available information and the scientific evidence regarding the overall effects of genetically modified trees on the conser-
vation and sustainable use of biological diversity to the Executive Secretary for dissemination through the clearing-house mechanism;
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productivity of the GM eucalyptus would neces-
sarily result in changes in the populations of these 
indicator organisms, we conclude, that, based on 
the studies carried out so far, the GM eucalyptus 
does not affect the soil hydrology.
Technology diffusion and future  
social impact
One of the major concerns raised against the 
development of GM trees is the consolidation of 
corporate control over land and use of natural 
resources and the deterioration of smallholder 
rights. Will smallholders have access to GM tree 
technologies and will the presence of GM tree 
plantations impact the livelihoods of local com-
munities? In the case of Suzano, the company 
strategy, voluntary agreements with landowners 
(including smallholders), and national legislation 
will determine the rate of technology utilization 
and the diffusion level to other landowners. Su-
zano has specific written procedures for engage-
ment with indigenous people, local communi-
ties, and smallholders within social responsibility 
policies and guidelines. Under these provisions, 
Suzano works closely with local communities 
and, depending on the region, indigenous peo-
ple whether directly as outgrowers, or not. The 
company considers that the use of GM trees can 
bring substantial benefits in the regions in which 
it operates. Approximately 31% of the pulp is de-
rived from over 1,000 forest outgrowers, of which 
80% are smallholders, who have currently access 
to the company’s genetic material (clones) to 
produce eucalyptus wood. Furthermore, the GM 
trees under development would be made availa-
ble for planting in the company’s own plantations 
and to the outgrowers under arrangements sim-
ilar to the existing proprietary non-GM varieties, 
in continuation of the policy of providing access 
to the best available planting material. Free, Prior 
and Informed Consent (FPIC) is part of this pro-
cess and Suzano already follows the certification 
rules regarding FPIC and will maintain them re-
garding GM tree use. The Brazilian Planted Forest 
sector as a whole has evolved through close re-
lationships with local communities to collectively 
agree on best practice and by integrating roughly 
20,000 families in the supply chain through out-
grower programs.
The relevance of the Post-2015 
 Development Agenda
A milestone for intergovernmental policy de-
velopment (UN, 2014) is the year 2015. The 
sustainable development goals, the Post-2015 
Development Agenda, and the outcomes of the 
2015 Climate Change negotiations will all be crit-
ical for determining how forests and forestry can 
contribute to future well-being within planetary 
boundaries (Milledge et al., 2014). The fundamen-
tal consideration that runs through the proposed 
outcomes is that unprecedented cohesion, coop-
eration, and collaboration on enhanced efficiency 
in natural resource use will be required to alter 
the trajectory of global development toward a 
“safe operating space for humanity” (Rockström 
et al., 2009).
Cooperation and governance
At the heart of the common interests is the pro-
motion of mechanisms to develop, introduce, and 
ensure sustainable forest management practices 
in an environment of constantly increasing fiber 
demand. Technology and innovation are core ele-
ments in this equation as well as the open dialog 
with all stakeholders regarding appropriate gov-
ernance frameworks to increase forest produc-
tivity. Currently, we strongly believe in a real and 
practical opportunity for developing, in a collab-
orative manner, the governance of technologies 
that would guide research and ensure manage-
ment and diffusion of the technology to those 
who could benefit the most.
By embedding such a framework within existing 
standards for plantation management, the impact 
of GM trees under consideration for participatory 
and negotiated land-use planning, emphasis on 
strengthening smallholder benefits, and biodiver-
sity protection would be addressed. Hence, pro-
ductivity intensification could free land for other 
use, such as food production for local markets 
and biodiversity, further decreasing the logging 
pressure on natural forests and their associated 
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communities, ecosystem services, and biodiversi-
ty. Conditions that promote diffusion and transfer 
of the technology could benefit the communities 
of outgrowers who currently access genetic ma-
terial and clones to produce wood. Such a frame-
work would fully support the findings that set for-
ward the need for sustainable intensification of 
smallholder productivity (FAO, 2014).
The certification bodies could lead this process, as 
they did for plantations, creating a framework that 
is sector wide, but built on case-by-case assess-
ment protocols and relevant national and interna-
tional laws, conventions, and voluntary standards. 
For the scientific and technological innovation a 
similar leadership is needed as the one that gener-
ated the governance frameworks for the principles 
and criteria of plantation management.
Thus, GM trees as a feedstock for a bioeconomy 
are part of the solution for market transformation. 
The GM tree debate and plantations are linked by 
the need for sustainable intensification and, like 
plantations, not all GM trees are equal and their 
impact needs to be assessed on a case-by-case 
basis. The forest sector understands the need for 
productivity enhancement and yield protection 
and is open for cooperation with the civil society 
in a constructive debate on scientific and techno-
logical innovation. Creation of public support to 
accept the social and environmental impact of 
sustainable intensification will depend on the de-
bate quality on the subject. Clearly, convergence 
on governance is needed to ensure sound forest 
management and sustainability in the face of in-
creasing demand and environmental constraints.
Existing dialog platforms provide input 
for decision making
Important concerns over the negative im-
pact of both plantations and GM trees per-
sist. However, to meet the challenge of find-
ing an acceptable way forward on plantations, 
the New Generation Plantations Platform 
(www.newgenerationplantations.org) established 
by WWF in 2007 brought together companies, 
government forest agencies, and civil society 
from around the world to explore, share, and pro-
mote improved ways of planning and managing 
plantations. The experience of the last seven 
years clearly shows that carefully designed and 
managed plantations in the right places can ben-
efit people and nature when they are developed 
through an effective stakeholder participation 
that maintains the ecosystem integrity, protects 
high conservation values, and contributes to in-
clusive green growth.
In parallel, The Forests Dialogue, (www. 
theforestsdialogue.org) is a platform and process 
that is pioneering new standards in multistake-
holder partnership and international dialog to 
resolve current and future conflicts and to define 
solutions for some of the key fracture lines that 
divide opinion – such as FPIC, Intensively Man-
aged Planted Forests, GM trees, and the Food, 
Fuel, Fiber, and Forests.
These forums provide a means to create inputs 
for an informed debate on both plantations and 
GM trees within the certification bodies, for gov-
ernments and for policy makers. Indeed, pre-
cisely agreement on these issues will determine 
how quickly and how effectively the world is able 
to make a transition toward economic, social, 
and environmental renewal. Given that the envi-
ronmental issues of plantation forestry are well 
known and that well-developed tools are availa-
ble, multistakeholder processes are the new fron-
tier to evaluate the process-based technological 
advances and to ensure inclusive local economic 
development, hence, reconciling stakeholder per-
spectives and priorities and bringing innovation 
to the local level and the family farmer.
Conclusions
An inclusive, low-carbon development model is 
required to uncouple growth from gas emissions, 
substitute fossil fuel dependency, and halt or re-
verse present cycles of deprivation, degradation, 
and inequality. In short, a revolution in resource 
use efficiency is necessary (Enkvist et al., 2007). 
The collectively faced challenges are complex and 
so are the solutions. Through vision and action, 
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sustainable intensification of plantation forestry 
provides an opportunity to enhance the quality of 
human livelihoods, while maintaining and protect-
ing the natural resources, biodiversity, and eco-
systems. The way forward is improved and con-
structive dialog on technology, enabling policies 
that stimulate the flow of needed technology and 
investment and the international cooperation in 
technology development and deployment. A ra-
tional debate on two critical aspects of this model 
is essential, namely on the supply-side interven-
tions that are vital for sustainable intensification 
of biomass supply to fuel development, transfer, 
and uptake of the model, and on the multistake-
holder convergence that is mandatory for under-
standing, acceptance, and, ultimately, governance 
of the model. The three most important conclu-
sions are that clearly identified solutions and ben-
efits for increasing the production efficiency exist, 
platforms for dialog are available, and frameworks 
to deliver timely impact on scale are emerging in 
the Post 2015 Agenda of the UN. The key action 
point is the creation of a space for stakeholder 
convergence to collectively promote a cohesive 
policy environment and to enable the switch for 
a transformational change. Progress toward a 
bioeconomy will be determined by how well col-
lective resistance to transformational change can 
be overcome.
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Agriculture and the agribusiness sector are fun-
damental to the livelihoods and food security of 
populations worldwide and form the backbone 
of the economies of many developing countries. 
The sustainable growth of the sector is key in at-
taining the United Nations Sustainable Develop-
ment Goals (SDGs) particularly Goals 1 and 2 to 
end poverty and zero hunger. These goals are as 
important as challenging because the countries 
facing extreme poverty and hunger are also often 
the ones with the highest expected demographic 
growth. In addition, climatic change and variabil-
ity is expected to result in further losses in food 
production and decreased incomes of the people 
whose livelihoods depend on agriculture. This is 
especially true in the poorest regions of the world, 
where smallholder farmers and landless house-
holds dominate the agriculture sector. This book 
highlights the adoption of biotechnology GM 
crops in agricultural systems of some developing 
and emerging countries, in Africa, Asia, Central 
and South America. Although the adoption rate, 
speed and extent was shown to be very diverse 
over the different countries there are similarities 
regarding success, bottlenecks and concerns.
 From the second half of the twentieth century on, 
agriculture has undergone extreme changes and 
exponential growth - thanks to initiatives led and 
encouraged by people like Norman Borlaug (No-
bel Peace Laureate 1970) - with the development 
of high-yielding crops, modernization of farming 
techniques, the use of hybrid seeds, synthetic fer-
tilizers, and pesticides by farmers. Even though 
this so called “Green Revolution” has allowed mil-
lions of people to be saved from starvation and 
has ensured food security in many regions of the 
world, some of the poorest countries to date, 
have not benefited to the highest extent from 
these breakthroughs in agriculture production. 
Biotechnological techniques have further opened 
up an enormous opportunity to complement con-
ventional selection and mutation breeding in in-
troducing new traits into the genetic background 
of an existing crop variety. If not encouraged, it 
might well be that these same countries will not 
benefit from what is today named the second 
green revolution. This new step in agriculture is 
based on the use of genetic engineering technol-
ogies and marker-assisted selection to develop 
new crops and foods that will take the lead in pro-
ducing increased crop yield and nutritional value. 
During the last 20 years, the adoption rate of GM 
crops has been remarkable but, remains limited 
to a few crops (mainly maize, soyabean, cotton 
and canola) and traits (mainly herbicide tolerance 
and insect resistance), which are appealing to 
growers and investors because of the agronom-
ically and economically added value they offer. 
Currently, a number of new GM crops and traits 
are being field tested in different parts of the 
world, including major food crops, such as rice 
and potato, but also crops such as chickpea, mus-
tard, and cassava that are important food crops 
in Asia, South America or Africa. These crops are 
gaining importance on the global markets as ex-
port commodities of the producing countries that 
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are developing. The new upcoming crops and 
traits are the result of multiple international re-
search initiatives started under public, private or 
public private partnerships. These research and 
development initiatives are being conducted to 
produce not only improved GM crops using a 
combination (stack) of existing traits, but also new 
types of GM plants. Newly developed crops aim at 
providing an added value not only to growers, but 
to the consumer as well (vitamin A, iron or folate 
enriched), or present a clear environmental ben-
efit (e.g. nitrogen- or water-efficient plants) with 
the potential to optimize resource utilization and 
to maximize input-output return.  The continu-
ous advancement of technologies, as for example 
the currently heavily discussed Novel Breeding 
Techniques (NBTs), and the increase of biological 
knowledge and comprehension, promises to fur-
ther extend the possibilities for the development 
of crops and traits of high quality.
The cultivation of GM crops is still very much po-
larized to a few countries with the largest areas 
of cultivation in the USA, Brazil, Argentina, India, 
Canada and China. Although only five European 
countries (Spain, Portugal, Czech Republic, Slo-
vakia and Romania) grow GM maize, Europe is a 
substantial importer of GM crops for its livestock 
industry. In the last years, different African coun-
tries conducted field trials with biotech/GM staple 
crops, including rice, maize, wheat, sorghum, ba-
nana, cassava, cowpea, potato and sweet potato. 
However, currently only three countries namely 
Burkina Faso, Sudan and South Africa, are com-
mercially growing GM crops. The reason can be 
attributed to different factors, including the low 
availability of GM crops adapted to regional con-
ditions and regulatory systems that are not yet 
fully operational in every country. Both issues are 
arguments for investors and companies to stay 
away from this market.
Indeed, the regulatory systems concerning GM 
crop cultivation pose a major bottleneck for po-
tential expansion. Laws regulating GM crop culti-
vation are still under development in some cases 
or display a high level of complexity, making com-
mercialization of GM crops difficult. In addition, a 
lack of homogeneity in regulation at an interna-
tional level is hindering commercialization in the 
global market as well. 
To consolidate the successful adoption of GM 
crops worldwide and ensure the long-term sus-
tainability of the production systems, a number of 
institutional issues need to be considered, based 
on the successes, challenges and lessons learned 
from current producers of GM crops. For exam-
ple, Argentina and other countries producing GM 
soybean, have experienced dramatic expansion 
of land allocated to production, as well as the in-
crease in output of grains and oilseeds as a whole. 
This did not only bring significant economic  bene-
fits to these countries, but it also induced a shift in 
land allocation raising questions about the long-
term sustainability of the current farming system 
due to detrimental effects on soil nutrient levels 
and the potential negative impact on fragile eco-
systems. While these concerns are legitimate, the 
cultivation of GM cultivars cannot be incriminated 
as the sole culprits, because it might be more the 
effect of a general and essential need for agri-
culture intensification. Upcoming GM crops with 
novel traits allowing cultivation under higher crop 
densities or using less water and nutrients, sup-
port sustainability in that, increased productivity 
can be achieved without further exploiting the 
scarce water and land resources. This would go a 
long way in amplifying the positive net balance of 
20 years of GM crops. It is therefore important to 
highlight the need for appropriate policy respons-
es aimed at optimizing the management of these 
innovations with adequate biosafety and regula-
tory frameworks and at establishing sustainability 
of agricultural systems. Finally, to ensure every 
country in need benefits from the transfer of 
technology and investment, international cooper-
ation in technology development and deployment 
is essential. Although investors might view crops 
important for developing countries as unable to 
make a return on investment, it could be argued 
that supporting the expansion of local crops in 
developing countries, would invariably lead to in-
creased food security, improved livelihoods and 
better incomes. This would especially be the case 
for the farming communities, who will then be in 
a better position to afford new technologies and 
inputs for their farming and off-farming activities. 
It is therefore also of major importance that the 
adoption of technologies is accompanied by de-
velopment of the entire value chains including 
processing industries and marketing in order to 
create an added value for agricultural production 
and development. 
Although nobody should claim that one technolo-
gy can solve by itself major issues such as hunger 
and poverty, adoption of GM technology com-
bined with an efficient soil, water and pest man-
agement is a promising component for a sustain-
able intensification of agriculture in many regions 
of the world.
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